PTI HOLDING INC
8-K/A, 1997-10-21
SPORTING & ATHLETIC GOODS, NEC
Previous: UNIVERSAL SEISMIC ASSOCIATES INC, 10KSB, 1997-10-21
Next: BHC FINANCIAL INC, S-3/A, 1997-10-21




       


                     U.S. SECURITIES AND EXCHANGE COMMISSION
                      Washington, D.C. 20549

                            Form 8-K

                          Current Report
                 Pursuant to Section 13 or 15(d)
              of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): August 20, 1997



                          PTI HOLDING INC.
      (Exact Name of Registrant as Specified in its charter)



      Delaware                          1-11586                    13-3590980
(State or jurisdiction                Commission               (I.R.S.Employer
of incorporation or                file number              Identification No.)
organization)



c/o 15 East North Street, Dover, DE                                     19901
(Address of principal executive offices)                              (Zip Code)



                          (302) 678-0855
       (Registrant's Telephone Number, Including Area Code)




<PAGE>



Item 2.   Acquisition or Disposition of Assets.

     On August 5, 1997,  the Company  consummated  the merger (the  "Merger") of
Flents  Products  Co.,  Inc.,  a  New  York  corporation  ("Flents"),  which  is
principally  engaged in the business of the  manufacture of wax earplugs and the
marketing and sale of earplugs and other safety and medical supplies, such as an
eye  drop  delivery  system,   styptic   devices,   and  air-filter  masks  (the
"Business"),  with  and into  the  Company's  wholly  owned  subsidiary,  Flents
Products  Co.,  Inc.,  a Delaware  corporation  ("Merger  Sub"),  pursuant to an
Agreement and Plan of Merger among the Company,  Merger Sub and Flents. From and
after August 5, 1997,  Flents had no separate or independent  existence,  having
been merged into Merger Sub.  For purposes of  financial  accounting  and income
tax,  the Merger was deemed to have  occurred  as of the  opening of business on
June 1, 1997 (the "Effective Date").

     The  principal  assets  of Flents as of the  Effective  Date of the  Merger
consisted of:  approximately  $1,024,364 of accounts  receivable;  approximately
$806,465 of inventory;  certain proprietary information (including molds, vendor
contacts and customer information) and various registered trademarks used in the
Business.

     Merger Sub  delivered at the closing (the  "Closing")  of the Merger $27.46
and 3.47  shares of the common  stock,  par value $.01 per share of the  Company
(the  "Company's  Common  Stock")  (with  associated  convertible  value  rights
described  below) to the shareholders of Flents in respect of each of the 77,756
issued and  outstanding  shares of the common  stock of Flents,  or total merger
consideration  of $4,837,085.  The merger  consideration  was paid $2,135,435 in
cash,  and  $2,701,650 in units  consisting  of 270,165  shares of the Company's
Common Stock and 270,165 Convertible Value Rights ("CVRs").  For purposes of the
Merger,  the Units were valued at $10 per Unit.  Each CVR  entitles the original
holder to up to $4.00 of  additional  Common  Stock of the Company to the extent
that the market  value of the  Company's  Common  Stock is less than  $10.00 per
share on the one-year anniversary of the Closing.

     In   addition,   at  the   Closing,   Closing,   Merger  Sub  entered  into
noncompetition  agreements  with  Stuart  M.  Lowe,  Chairman  of the  Board  of
Directors of Flents ("Low"),  W. Thomas Davies,  President of Flents  ("Davies")
and James E. Dunn, Vice President of sales of Flents ("Dunn"),  all of whom were
also  shareholders of Flents,  restricting  them from,  among other  activities,
competing with Merger Sub for a period of five years (or four years, in the case
of Davies) from the Closing.

     At  the  Closing,  Merger  Sub  also  entered  into a  ten-year  consulting
agreement with Low,  commencing on the Closing  whereby he will receive  $12,000
annually for the term of the agreement  and health  insurance for the first four
years of the term. Merger Sub also entered into a four-year employment agreement
with Davies,  commencing as of June 1, 1997,  providing for an initial  starting
salary of $180,000 per annum and options  ("Options") for the purchase of 10,000
shares of the  Company's  Common  Stock per year for the term of the  employment
agreement.  Davies will also receive  additional  Options  based on Merger Sub's
performance.  In  addition,  Merger  Sub  entered  into a  five-year  employment
agreement  with Dunn,  commencing  as of June 1, 1997,  providing for an initial
starting  salary of  $108,000  per annum and a bonus  based on the  increase  in
Merger Sub's net revenues.

     The  amount  of  consideration  paid by Merger  Sub as set forth  above was
determined by arms-length negotiations between the parties involved.  Woodbridge
Group Inc.  received a fee for its advice  rendered to Company and for arranging
the Merger,  however,  no opinion was  provided as to the fairness of the merger
consideration  in the  transaction.  The  Company's  evaluation  of  the  merger
consideration  paid in the Merger  was based upon the book value of Flents,  its
revenues and profits during its 1996 fiscal year, and its sales  prospects.  The
Company  incurred  acquisition  costs in  connection  with the  merger  totaling
approximately $412,000.

     The three major shareholders of Flents prior to the Merger were all members
of the Low family.  Four of the other five  shareholders  were all  employees of
Flents at the time of the Closing who had received their shares as stock bonuses
from Flents, and the fifth shareholder was Flents' attorney. No relation existed
prior to the Merger between any of such persons or Flents,  on the one hand, and
the Company,  any of its affiliates,  any director or officer of the Company, or
any associates of any such director or officer, on the other hand.

     The source of funds used to capitalize  Merger Sub and to effect the Merger
was the  Company's  cash  reserves.  Merger Sub  intends to  continue to use the
assets of Flents in the Business.




<PAGE>


     (a)  Financial Statements of Business Acquired.

          To be filed by amendment.


     (b)  Pro-Forma Financial Information.

          To be filed by amendment.


     (c)  Exhibits.

     Exhibit No.         Description

1    Agreement and Plan of Merger,  dated July 25, 1997, among PTI Holding Inc.,
     Flents Product Co., Inc. (a Delaware  corporation)  and Flents Product Co.,
     Inc. (a New York corporation)

2    Amendment to Agreement and Plan of Merger,  dated July 25, 1997,  among PTI
     Holding Inc.,  Flents  Product Co., Inc. (a Delaware  corporation),  Flents
     Product Co.,  Inc. (a New York  corporation),  W. Thomas  Davies,  James E.
     Dunn,  Stuart M. Low,  Robert A. Low,  Doris L.  Hirsch,  Lester C. Migdal,
     Peter C. Kohn and Mary Lou Secchi

3    Certificates of Merger for the State of New York and the State of Delaware,
     each  dated  August 5,  1997,  of Flents  Products  Co.,  Inc.  (a New York
     corporation) into Flents Product Co., Inc. (a Delaware corporation)

4    Noncompetition  Agreement,  dated August 5, 1997,  among PTI Holding  Inc.,
     Flents Products Co., Inc. (a Delaware corporation) and Stuart M. Low

5    Noncompetition  Agreement,  dated August 5, 1997,  among PTI Holding  Inc.,
     Flents Products Co., Inc. (a Delaware  corporation),  W. Thomas Davies, and
     James E. Dunn

6    Consulting  Agreement,  dated August 5, 1997,  between Flents Products Co.,
     Inc. (a Delaware corporation) and Stuart M. Low

7    Employment  Agreement,  dated August 5, 1997,  between Flents Products Co.,
     Inc. (a Delaware corporation) and W. Thomas Davies

8    Employment  Agreement,  dated August 5, 1997,  between Flents Products Co.,
     Inc. (a Delaware corporation) and James E. Dunn

9    Convertible Value and Registration Rights Agreement,  dated August 5, 1997,
     among PTI Holding Inc.,  W. Thomas  Davies,  James E. Dunn,  Stuart M. Low,
     Doris L. Hirsch,  Peter C. Kohn, Robert A. Low, Lester C. Migdal,  and Mary
     Lou Secchi





<PAGE>


                            SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

Dated:  August 20, 1997

                         PTI HOLDING INC.


                         By/s/ Meredith W. Birrittella
                            Meredith W. Birrittella,
                            Chief Executive Officer


<PAGE>


                            SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

Dated:  August 20, 1997

                         PTI HOLDING INC.


                         By
                             Meredith W. Birrittella,
                             Chief Executive Officer

<PAGE>


                            EXHIBIT 1

                   AGREEMENT AND PLAN OF MERGER

     AGREEMENT AND PLAN OF MERGER (the "Agreement"),  dated as of July 25, 1997,
by and among PTI HOLDING  INC.,  a Delaware  corporation,  having an address c/o
Protective    Technologies    International,    Inc.,    One    River    Street,
Hastings-on-Hudson,  New York  10706  ("PTI"),  FLENTS  PRODUCTS  CO.,  INC.,  a
Delaware corporation and a wholly-owned  subsidiary of PTI, having an address at
c/o Akabas & Cohen,  488 Madison Avenue,  New York, NY 10022 ("Merger Sub"), and
FLENTS PRODUCTS CO., INC., a New York  corporation  having an address at 258 Dr.
Martin  Luther  King  Drive,   Norwalk,   Connecticut  06854  ("Flents"  or  the
"Company").

     WHEREAS,  Merger  Sub  is a  wholly-owned  subsidiary  of  PTI  and  has an
authorized  capital stock  consisting  of 200 shares of common stock,  par value
$.01 per share  (the  "Merger  Sub  Stock"),  of which 100 shares are issued and
outstanding and owned by PTI;

     WHEREAS,  the respective  Boards of Directors of PTI, Merger Sub and Flents
have each  approved  the  acquisition  of Flents by PTI  pursuant to a merger of
Flents into Merger Sub (the  "Merger") in accordance  with Section 368 (a)(1)(A)
of the  Internal  Revenue  Code  of  1986,  as  amended  (the  "Code"),  and the
provisions of this Agreement,  with the result that 77,756  aggregate  shares of
common  stock,  par value $.02 per share,  of Flents (the  "Flents  Shares" or a
"Flents  Share")  shall be canceled  in exchange  for  $4,912,085  (the  "Merger
Consideration")  consisting of $2,210,435 in cash (the "Cash Consideration") and
not less than 270,165 units  consisting  of 270,165  shares of common stock (the
"Merger  Stock"),  par value $.01 per share, of PTI (the "PTI Common Stock") and
convertible  value  rights (as  described in Section 3 herein),  which  together
shall  have a value of  $2,701,650  at $10 per unit,  subject to  adjustment  as
provided herein; and

     WHEREAS,  it is intended that the Merger will create economies of scale and
cross-marketing  benefits  that will  enhance  the value of PTI,  Merger Sub and
Flents in a consolidated group,

     NOW,  THEREFORE,  in consideration of the premises and the mutual covenants
herein contained, PTI, Merger Sub and Flents hereby agree as follows:

     Section 1. The Merger

     1.1.  Surviving  Corporation.  At the  Closing  (as  defined  in  Section 4
herein), in accordance with the Code and this Agreement,  Flents shall be merged
with and into Merger Sub, and the separate existence of Flents (except as may be
continued by operation of law) shall cease, and Merger Sub shall continue as the
surviving  corporation (Merger Sub hereinafter sometimes shall be referred to as
the "Surviving Corporation").

     1.2. Effect of the Merger. At the Effective Time  (hereinafter  defined) of
the  Merger,  in  addition  to any other  purposes  and  powers set forth in the
Certificate  of Merger (as  defined in Section  1.3(b)  herein),  the  Surviving
Corporation  shall  have  the  rights  and  powers  of  Merger  Sub  and  Flents
(collectively referred to as the "Constituent Corporations"). The assets of each
Constituent  Corporation,  including  any  legacies  that each  would  have been
capable of taking,  shall  transfer  to, vest in and  devolve on, the  Surviving
Corporation  without  further act or deed.  Confirmatory  deeds,  assignments or
similar  instruments  to evidence the transfer may be executed and  delivered at
any time in the name of Flents by its last acting officers or by the appropriate
officers of the Surviving Corporation. The Surviving Corporation shall be liable
for all the debts and  obligations  of  Flents.  An  existing  claim,  action or
proceeding  pending by or against Flents may be prosecuted to judgment as if the
Merger had not taken place,  or, on motion of the Surviving  corporation  or any
party,  the surviving  Corporation may be substituted as a party, and a judgment
against  Flents  shall  constitute  a lien  on  the  property  of the  surviving
corporation. The Merger shall not impair the rights of creditors or any liens on
the property of a Constituent Corporation.

     1.3. Consummation of the Merger.

          (a)  This  Agreement  has  been  submitted  to  and  approved  by  the
stockholders  of Flents and Merger Sub and the board of  directors  of PTI.  PTI
represents  that  it  is  authorized  to  enter  into  this  Agreement   without
shareholder approval.

          (b) On the date of the Closing,  the appropriate  parties hereto shall
execute  and file  with  the  State  Department  of the  State of New York  (the
"Department")  a Certificate  of Merger  substantially  in the form of Exhibit A
annexed  hereto  (the  "Certificate  of  Merger").  Merger  Sub shall  also file
appropriate documents in such other Jurisdictions as may be required by law.

     1.4. Charter;  By-Laws;  Directors and Officers. The Charter of Merger Sub,
as in effect immediately prior to the date and time when the Merger shall become
effective (the  "Effective  Time"),  shall be further amended as provided in the
Certificate of Merger, and, as so amended, shall be the Charter of the Surviving
Corporation.  The By-Laws of Merger Sub, as in effect  immediately  prior to the
Effective Time, shall be the By-Laws of the Surviving Corporation.  The officers
of Merger Sub shall be the officers of Surviving Corporation, in each case until
an officer's  successor is elected and  qualified or until an officer's  earlier
death,  resignation  or  removal.  The  directors  of  Merger  Sub  shall be the
directors of the surviving  corporation,  until their successors are elected and
qualified or until a director's earlier death, resignation or removal.

     1.5. Taking of Necessary Action;  Further Action.  Subject to the fiduciary
obligations of their respective  Boards of Directors and the terms hereof,  PTI,
Merger Sub and Flents shall each use its best efforts to take all such action as
may be necessary or appropriate in order to effectuate the Merger under New York
and  Delaware law as promptly as  possible.  If at any time after the  Effective
Time any further  action is  necessary or desirable to carry out the purposes of
this Agreement and to vest the Surviving  Corporation with full right, title and
possession to all assets, property, rights,  privileges,  powers, and franchises
of either of the Constituent Corporations, the officers of such corporations are
fully  authorized  in the name of their  corporation  or otherwise to take,  and
shall take, all such lawful and necessary action.

     Section 2. Status and Conversion of Securities.

     2.1. Conversion of Shares.

          (a)  Flents   Shares.   Each  Flents  Share  issued  and   outstanding
immediately  prior to the  Effective  Time  shall,  by virtue of the  Merger and
without  any action on the part of the holder  thereof,  be  converted  into the
right to receive a pro rata share of the Merger  Consideration,  which, based on
77,756 shares of the common stock of Flents outstanding, consists of, (i) $28.43
in cash, and (ii) 3.47 shares of PTI Common Stock and convertible  value rights,
as  described  in Section 3 herein,  subject to the  payment of  expenses to the
Exchange Agent. This conversion shall be subject to equitable  adjustment in the
event of any stock split, stock dividend,  reverse stock split, or other similar
proportional change in the number of shares of PTI Common Stock outstanding.  No
Flents Shares shall be deemed to be  outstanding or to have any right other than
those set forth in this Agreement after the Effective Time. The Merger Stock has
not been,  and will not be,  registered  under the  Securities  Act of 1933,  as
amended  (the "Act"),  or under any state  securities  laws,  except as shall be
provided in the Convertible Value and Registration Rights Agreement described in
Section 7.9 herein. The Merger Stock will constitute  restricted  securities and
may not be sold or disposed of by Flents or  stockholders  of Flents,  unless so
registered or an exemption from such registration is available,  as evidenced by
an opinion of counsel to the Surviving Corporation. Upon the request of a Flents
stockholder or his/her  successors or assigns  receiving PTI shares  pursuant to
this Agreement,  counsel to the surviving  corporation will promptly and without
charge  furnish an opinion in  respect  of the lawful  sale or  transfer  of the
Merger Stock to the extent such counsel believes that such shareholder's  Merger
Stock may be sold  pursuant to an effective  registration  under the Act or Rule
144 thereunder.

          (b) Merger Sub Stock.  Immediately  following the Effective Time, each
of the  outstanding  shares of Merger Sub Common Stock,  issued and  outstanding
immediately  prior to the Effective Time, shall remain  outstanding as shares of
the surviving Corporation, and no payment shall be made with respect thereto.

     2.2. Exchange.

          (a) Exchange Agent.  At Closing,  PTI and Merger Sub shall transfer to
Migdal,  Pollack,  Rosenkrantz  & Sherman,  as  exchange  agent  (the  "Exchange
Agent"),  in a liquidating  trust for the benefit of the  stockholders of Flents
("Flents stockholders"), the Merger Consideration. The Exchange Agent shall hold
the Merger consideration the cash portion of which shall be by certified or bank
check  or by  wire  transfer  of  good  funds  in  trust  on  behalf  of  Flents
stockholders pending the cancellation of the certificates  evidencing the Flents
Shares (the "Certificates"). Upon cancellation of the Certificates, the Exchange
Agent shall distribute the Merger  Consideration  to the Flents  stockholders as
promptly as practicable following the date of the Closing, subject to the escrow
created under Section 10.6 herein.  The investment  powers of the Exchange Agent
are to be limited to  investments  in obligations of or guaranteed by the United
States of America,  or temporary  investments in  certificates  of deposit or in
demand  or  time   deposits  in   commercial   banks  with   capital   exceeding
$1,000,000,000  (collectively  "Permitted  Investments").  Any income  earned on
Permitted  Investments  shall be  distributed  pro rata to  Flents  stockholders
entitled thereto.  The maturities of the Permitted  Investments shall be such as
to permit the Exchange Agent to make prompt payment of the Cash Consideration to
Flents stockholders  entitled thereto. The Exchange Agent shall be paid from the
Merger Consideration, except as provided under Section 14 herein.

          (b)  Exchange  Procedure.  At  or  before  the  closing,  each  Flents
stockholder  shall deliver to the Exchange Agent all of his or her Certificates,
endorsed in blank.  The Exchange Agent upon receipt of the Merger  Consideration
at the closing  shall cancel the  Certificates  and  thereafter  distribute  the
Merger  Consideration  including the  convertible  value  rights,  together with
interest  on the  cash  portion  of the  Consideration,  subject  to the  escrow
provisions  of  Section  10.6,  to  each of the  Flents  stockholders  upon  the
surrender of the  Certificates to the Exchange  Agent.  The Exchange Agent shall
send a notice to each holder of the  Certificates  informing  such holder of the
effectiveness of the Merger.  Until surrendered,  each such Certificate shall be
deemed  for all  purposes  to  evidence  only the right to receive  such  Merger
Consideration.

          (c) Transfer of Merger Consideration.  If the Merger Consideration (or
any portion  thereof) is to be  delivered  to a person  other than the person in
whose name the Certificates surrendered in exchange therefor are registered,  it
shall be a  condition  to the payment of the Merger  Consideration  that (i) the
Certificates  so  surrendered  shall be  properly  endorsed  or  accompanied  by
appropriate  stock powers and otherwise in proper form for  transfer,  (ii) such
transfer otherwise be proper, and (iii) that the person requesting such transfer
pay to the Exchange  Agent any transfer or other taxes  payable by reason of the
foregoing or establish to the satisfaction of the Exchange Agent that such taxes
have been paid or are not required to be paid.

          (d) Lost  Certificates.  In the event any Certificate  shall have been
lost,  stolen or destroyed,  the beneficial owner of such Certificate shall sign
and deliver to Merger Sub an  affidavit of loss in the form of Exhibit B annexed
hereto,  attesting to such loss, theft or destruction,  and indemnifying  Merger
Sub for all loss or damages incurred in connection  therewith,  and the Exchange
Agent  shall issue or cause to be issued in  exchange  for such lost,  stolen or
destroyed Certificate the Merger Consideration deliverable in respect thereof in
accordance  with this  Agreement.  When  authorizing  such  issue of the  Merger
Consideration  in exchange  therefor,  the Exchange Agent may, in its discretion
and as a condition precedent to the issuance thereof,  require the owner of such
lost, stolen or destroyed  Certificate to give the Exchange Agent a bond in such
sum as the Exchange Agent may direct as indemnity  against any claim that may be
made against the Exchange Agent with respect to the Certificate  alleged to have
been lost, stolen or destroyed.

     2.3.  Acquired  Assets.  Flents  represents  and warrants to Merger Sub and
acknowledges  and confirms that each such  representation  and warranty shall be
deemed to be material and that Merger Sub is relying  upon such  representations
and  warranties in connection  with the execution,  delivery and  performance of
this  Agreement,  any  investigation  made  by  Merger  Sub  or  on  its  behalf
notwithstanding,  except as otherwise  specifically  set forth herein and in the
Schedules  hereto:  Flents owns all of the  business,  properties  and assets of
Flents or used by Flents, real, personal or mixed, tangible or intangible, other
than the Excluded  Assets (as defined in Section 2.4 herein),  together with the
goodwill of Flents,  all as the same existed on November  30,  1996,  except for
those assets disposed of in the ordinary course of business consistent with past
practice in arms-length  transactions with unaffiliated parties (except salaries
and benefits to employees who are affiliated  individuals  consistent  with past
practice and other  payments  expressly  permitted  herein),  together  with any
additions thereto after such date,  (hereinafter  sometimes together referred to
as the "Acquired Assets") including without limitation, the following assets:

          (i) all machines,  equipment,  tools,  dies,  product tooling,  molds,
furniture,  fixtures,  trucks,  automobiles,  other vehicles,  office  supplies,
including  without  limitation  that property (A) described on the  Depreciation
Expense Report included herein as Schedule 2.3(i) hereto or otherwise  listed on
Schedule 2.3(i), (B) used or held for use on the date hereof or acquired for use
after the date  hereof by Flents;  or (C)  located at any  premises  operated by
Flents;

          (ii) all contracts,  promissory notes, leases of personal property and
agreements listed on Schedule 2.3(ii) hereto,  and all other contracts,  leases,
agreements, promissory notes and other evidences of indebtedness to Flents;

          (iii) all  intangible  assets and all rights,  interests and claims of
Flents in, to or under all intangible  assets used, held for use or acquired for
use by Flents  (including  without  limitation  the names "Flents" and all other
trademarks,  trade names or service marks under which Flents has  operated,  any
copyrighted or copyrightable material,  patents,  drawings,  designs,  formulas,
customers' records,  customer lists, supplier lists, employee records, choses in
action, claims,  computer software,  programming and applications used, held for
use or acquired for use by Flents,  together with any goodwill  associated  with
any of the foregoing);

          (iv) all  inventories,  raw materials  (including  inventories and raw
materials   on  order  but  not   received   as  of  the  Closing   Date),   and
work-in-progress, used, held for use or acquired for use by Flents;

          (v) all claims, demands, judgments, rights, choses in action, accounts
receivable,  bills and notes  receivable,  documents,  instruments,  credits and
deferred items,  arising in connection with Flents' business,  except that as to
all such assets,  Flents makes no representation  that valid defenses may not be
asserted  against  them,  but  Flents  is  unaware  of any  such  defenses  or a
reasonable  basis for any such defenses,  and accounts  receivable and bills and
notes  receivable  may be subject  to claims,  but Flents is unaware of any such
claims or a reasonable basis for any such claims;

          (vi) all supplies, marketing and sales literature
(including catalogs) that are related to Flents;

          (vii) all rights and interests under or pursuant to warranties  and/or
guaranties of suppliers of Flents relating to the Acquired Assets or Flents;

          (viii) all  licenses,  franchises,  permits,  privileges,  immunities,
approvals  and   authorizations   from  a   governmental   or  regulatory   body
("Governmental  Permits")  that are necessary to entitle Flents to own or lease,
operate  and use  its  assets  and to  conduct  its  business  substantially  as
historically  conducted by Flents, and, to the best knowledge of Flents,  Flents
is in compliance with Federal Food and Drug Administration  ("FDA") requirements
regarding  the  marketing of Seal-Rite and Silaflex 2 silicone ear plugs (except
Flents in the current year first elected to identify itself as a  "manufacturer"
in addition to its  identification  as a repacker and labeler,  which additional
identification Flents has provided on its annual registration application),  and
in  compliance  with the  labeling  requirements  of the  Federal  Environmental
Protection  Agency to  indicate  noise  reduction  in  decibels  for  anti-noise
products and in compliance with FDA registration requirements for Maxi-Mask dust
masks;

          (ix) all telephone,  telex, and telephone facsimile numbers,  computer
online addresses,  other communication media designations and directory listings
utilized in connection  with Flents'  business,  subject to the  confidentiality
provisions of the license  agreement with Wal-Mart  Stores,  Inc. with regard to
its software system known as Retail LinkTM;

          (x)  all cash, marketable securities and other liquid
assets; and

          (xi) all books, records and files of Flents for all
periods.

     2.4. Excluded Assets.  The Acquired Assets do not include
the assets (herein collectively referred to as the "Excluded
Assets") of Flents as follows:

          (a)  counterclaims and cross claims to the extent
relating to any liability against which Flents indemnities Merger
Sub hereunder;

          (b) insurance claims and rights under insurance policies to the extent
relating to any liability against which Flents indemnities Merger Sub hereunder;
and

          (c) rights under this Agreement,

in each case, to the extent not reflected as an asset on any
balance sheet of Flents.

     Section 3. Convertible Value Rights.

          (a) As of the  first  anniversary  of the  Effective  Time,  PTI  will
transfer  to each  Flents  stockholder  PTI Common  Stock  equal in value to the
product of (a) the  positive  difference  of $10.00 minus the greater of (i) the
average of the median  closing  sale prices of the PTI Common  Stock  during the
immediately  preceding  twenty (20)  consecutive  trading days,  and (ii) $6.00,
multiplied by (b) the number of shares of Merger Stock held  beneficially and of
record by such stockholder on such first  anniversary (the right to receive such
distribution shall be referred to as a "Convertible Value Right").

          (b) The value of any PTI  Common  Stock  shall be the  average  of the
median  closing  sale  prices of the PTI Common  Stock  during  the  immediately
preceding  twenty  (20)  consecutive  trading  days prior to its  issuance.  The
Convertible  Value Rights shall be subject to equitable  adjustment in the event
of any stock split,  stock dividend or reverse stock split resulting in a change
in the number of shares of PTI Common  Stock  outstanding  prior to the one year
anniversary  of the  Effective  Time.  During the 30 trading  days prior to such
one-year  anniversary,  the Flents  stockholders shall not engage in any trades,
directly or indirectly, in the securities of PTI.

     Section 4. Closing. Provided that the conditions in Sections 8 and 9 hereof
have been satisfied or waived,  the Merger  contemplated  by this Agreement (the
"Closing") shall, unless another date or place is agreed to in writing by Flents
and Merger  Sub,  take place at the  offices of Migdal  Pollack,  Rosenkrantz  &
Sherman on August 5, 1997, or earlier upon satisfaction of all the conditions in
Sections 8 and 9, (the "Closing Date"), provided, however, that such date may be
adjourned by a party  hereto if the other party hereto shall not have  satisfied
all of the  conditions  to be  satisfied  by such  other  party on or before the
Closing.

     Section 5. Representations and Warranties of Flents.  Flents represents and
warrants to Merger Sub as follows,  and acknowledges and confirms that each such
representation  and warranty  shall be deemed to be material and that Merger Sub
is relying upon such  representations  and  warranties  in  connection  with the
execution,  delivery and  performance  of this  Agreement,  notwithstanding  any
investigation made by, or on behalf of, Merger Sub. PTI acknowledges that it has
had an opportunity to ask questions  about the disclosures in this Agreement and
its  schedules  and  has  discussed   such   questions   with  Flents  to  PTI's
satisfaction. Flents' representations and warranties expressed in this Agreement
are  qualified  by the  specific  disclosures  made by Flents in  respect of its
purchases,  sales, inventory,  returns policy or any other matter concerning the
Breast  Comfort  Pack.  Flents makes no  representation  that its  accounting in
respect of the Breast  Comfort Pack are in accordance  with  generally  accepted
accounting principles. Where, however, Flents establishes to the satisfaction of
a court or arbitration tribunal that PTI or Merger Sub was apprised of a fact or
facts prior to Closing that do not appear on the Schedules  hereto,  then Flents
shall not be deemed to be in violation of its representations and warranties and
said fact or facts shall be treated as if they were  included  in the  Schedules
hereto, provided, however, Flents shall have the burden of establishing beyond a
reasonable doubt that Merger Sub was apprised of the fact or facts in question.

     5.1. Organization and Good Standing.

          (a) Flents is a corporation  duly organized,  validly  existing and in
good standing under the laws of the state of its  incorporation and is qualified
to transact  business and is in good  standing as a foreign  corporation  in the
jurisdictions  where it is required to qualify (such  jurisdictions with respect
to Flents being set forth in Schedule 5.1 hereto).

          (b) Flents has the power and authority  (corporate  and  otherwise) to
own,  lease and  operate  its  properties  and to carry on its  business  as now
conducted  and  as  conducted  during  the  periods  covered  by  the  Financial
Statements (as defined in Section 5.4 herein).

          (c) Flents has no subsidiaries or equity investments in any entity and
is not involved in a partnership  or joint  venture.  Flents is not owned by any
other entity, except for the Flents stockholders.

          (d)  Intentionally omitted.

          (e) Schedule 5.1(e) hereto sets forth documents  reflecting each bank,
savings and loan, trust company,  brokerage house or other financial institution
in which an account used by Flents is maintained on the date hereof.

     5.2. Consents, Authorizations and Binding Effect.

          (a) Flents may execute, deliver and perform this Agreement without the
necessity of obtaining any consent, approval,  authorization or waiver or giving
any notice or otherwise,  except for such consents,  approvals,  authorizations,
waivers and notices set forth on  contracts,  documents  and the lease listed in
the Schedules  hereto,  some of which may impose  obligations  on Flents where a
third party is entitled to give consent to an assignment,  or where a notice may
be  appropriate  to  inform  a third  party  of a  change  of  address,  such as
Medela/Prism Settlement Agreement. Merger Sub acknowledges that it has notice of
the terms of the documents  listed in the Schedules  hereto,  and the failure of
Flents to receive such consents, approvals,  authorizations or waivers shall not
constitute a  misrepresentation  or give rise to any claim on the part of Merger
Sub or PTI.

          (b) This Agreement has been duly authorized, executed and delivered by
Flents  and  constitutes  the legal,  valid and  binding  obligation  of Flents,
enforceable  in  accordance  with  its  terms.   The  execution,   delivery  and
performance of this Agreement will not:

          (i)  constitute a violation of the Certificate or
Articles of Incorporation or the ByLaws, as amended, of Flents;
or

          (ii) constitute a violation of any statute, judgment, order, decree or
regulation or rule of any court, governmental authority or arbitrator applicable
or relating to Flents, or the Acquired Assets; or

          (iii)  except  as set  forth in  Schedule  5.2(b)(iii),  result in the
acceleration  of any debt or other  obligation  of Flents or the creation of any
Lien (as defined in Section 5.5(a) herein) upon any of the Acquired Assets.

     5.3. Title to Shares.

     The Flents Shares are the only  securities of Flents issued or outstanding,
front and back copies of which have previously  been submitted to PTI,  together
with  the  names  and  the  number  of  Flents  Shares  owned  for  each  Flents
Stockholder.  Each of the record  stockholders of Flents has represented that he
or she has good and marketable  title to the Flents Shares free and clear of all
Liens,  and  Schedule  5.3 sets forth the names and the number of Flents  Shares
owned for each Flents Stockholder. Each of the record stockholders of Flents has
good and marketable  title to the Flents Shares free and clear of all Liens, and
the  cancellation  of the Flents Shares in the Merger shall be free and clear of
Liens. No subscription,  option,  warrant,  right, call,  contract,  commitment,
understanding, right of first refusal, right of first offer, or agreement (other
than this  Agreement)  relates  to the  Flents  Shares or any  capital  stock of
Flents,  or the  issuance,  sale or transfer  of such  Flents  Shares or capital
stock,  except as set forth in certificates issued to employees of Flents or set
forth in  agreements  with said  employees,  which are  listed in the  Schedules
hereto. The Flents Shares were acquired by the Flents stockholders in compliance
with all applicable laws, including federal and state securities laws. Flents is
not  required  by any  agreement,  arrangement  or  understanding  to issue  any
additional securities, except with respect to bonus shares that may be issued to
Davies, which are included in Schedule 5.3.

     5.4. Financial Statements and Financial Condition.

          (a) Flents has,  except as specifically  set forth herein,  maintained
its books of account in accordance with applicable  laws, rules and regulations,
and such books and records are and,  during the periods covered by the Financial
Statements (as described in Section 5.4(b) herein, the "Financial  Statements"),
were  maintained in such fashion as to accurately  reflect the  transactions  of
Flents and the income, expenses, assets and liabilities of Flents, including the
nature thereof and the  transactions  giving rise thereto to the extent that the
same would  ordinarily be reflected in such books and records.  The February 28,
1997 interim  financial  computer  printouts  described in Section 5.4(b) herein
(the "February  Printouts") were prepared from the books and records  maintained
by the Company,  which were  maintained  in a manner not  inconsistent  with the
prior periods.

          (b) Included in Schedule 5.4 are the reviewed balance sheets of Flents
as of November 30, 1995 and 1996, and the related reviewed  statements of income
and of cash flows for the fiscal  years then  ended,  reported  on by Schwartz &
Hofflich,  and the unaudited  unreviewed balance sheet of Flents as of February,
28, 1997 and the  related  statement  of income for the three  months then ended
(collectively,  all  documents  included in Schedule 5.4 shall be referred to as
the "Financial Statements").

          (c) The  Financial  Statements  have been  prepared  from the books of
account of Flents. The Financial Statements,  except for the February Printouts,
present  fairly the financial  position of Flents as of the  respective  date of
such  statements and the results of operations of Flents for the periods covered
thereby.  The February  Printouts were prepared on a basis  consistent with past
practice for the  preparation  of Flents'  financial  statements.  The Financial
Statements  reflect  all  necessary  adjustments  and  reserves  for  losses and
contingencies,  except as the same may relate to the Breast  Comfort Pack or are
otherwise disclosed to PTI herein.

          (d)  Flents  has  no  liabilities   (including,   without  limitation,
unasserted  claims,  matured or unmatured,  absolute,  contingent or otherwise),
except as  otherwise  set forth in this  Agreement,  that,  in  accordance  with
Flents' prior  practice are required to be reflected and are not  reflected,  or
are in excess of the amount  reflected,  in the  balance  sheet  included in the
February  Printouts  except (i) those  incurred  since the date of the  February
Printouts in the ordinary course of business,  consistent with past practice, in
arms-length  transactions  with  unrelated  parties,  and  which do not have and
cannot  reasonably be expected to have,  in the  aggregate,  a material  adverse
effect on the business,  financial condition or prospects of Flents (a "Material
Adverse  Effect")  and (ii) those  specifically  described  on  Schedule  5.4(d)
hereto. All liabilities reflected on the February Printouts were incurred in the
ordinary course of business,  consistent with past practice, except up to $7,000
of legal fees payable to Migdal, Pollack, Rosenkrantz & Sherman.

          (e) Since  November  30,  1996,  Flents has not  suffered any material
adverse change in its business,  operations,  financial  condition or prospects,
except as disclosed in Schedule 5.4(e).

     5.5. Title and Condition of Assets.

          (a) Flents has and will retain after Closing good and marketable title
to the Acquired Assets, free and clear of liens,  encumbrances,  claims of third
parties, security interests,  mortgages, pledges, agreements, options and rights
of others of any kind whatsoever,  whether or not filed,  recorded or perfected,
and including,  without  limitation,  any  conditional  sale or title  retention
agreement or lease in the nature  thereof or any financing  statements  filed in
any  jurisdiction  or any  agreement  to  give  any  such  financing  statements
(hereinafter collectively referred to as "Liens"), other than possible liens for
taxes of which Flents has not been advised or possible  mechanics  liens held by
firms providing services to Flents on Flents' property which liens have not been
asserted.

          (b) Schedule 2.3 (i) hereto  includes a  depreciation  expense  report
consisting of a correct list and a summary  description of all material tangible
personal  property in the nature of machinery and  equipment  owned or leased by
Flents and used or held for use in the Business.  Since November 30, 1996,  none
of the Acquired  Assets has been affected by any fire,  accident,  act of God or
any other  casualty that  materially  and adversely  impairs its function in the
business  of  Flents.  The  business  of  Flents  is  not  conducted  under  any
restriction imposed upon Flents (such as a consent decree, easement, judgment or
zoning variance),  but not imposed upon other similar businesses in the locality
where its business is located, except as disclosed in Schedule 5.5(b).

          (c) True and  correct  copies  of the  lease  identified  on  Schedule
2.3(ii) and all  amendments  thereto  have been  delivered  to PTI.  Such lease,
amendment  and  leasehold  interest  represent  valid and binding  rights and/or
obligations  of Flents,  are in full force and  effect  and are  enforceable  by
Flents  in  accordance  with  their  respective  terms.  Flents  has no  accrued
obligation  as lessee  thereunder or under any other lease that it has not fully
performed;  and Flents  has not  received  any notice of default  under any such
lease.  Flents enjoys  peaceful and undisturbed  possession  under all leases to
which it is a party as  lessee.  The  lease is not in  default  and no event has
occurred or is continuing  that,  with proper notice and/or the passage of time,
would constitute an event of default  thereunder.  Except for such lease, Flents
does not lease any real property.

          (d)  Flents does not own or have any equity interest in
any real property.

     5.6.  Inventories.  Except as set forth in Schedule 5.6, the inventories of
Flents  reflected on the  February  Printouts  and those  observed by PTI in the
review on June 2, 1997,  have been valued,  at the lower of cost or market value
in accordance with generally accepted  accounting  principles,  and the value of
obsolete materials and materials of below standard quality has been written down
as set forth in the  February  Printouts,  which has been  submitted to PTI, and
which PTI  acknowledges  to have received and examined;  and the  inventories of
Flents  contain no material  amount of obsolete  or damaged  items,  are of good
useable or  merchantable  quality,  and are  saleable or usable in the  ordinary
course of business at present levels of business  operation.  PTI and Merger Sub
shall be  entitled  to no  adjustment  in the  purchase  price on account of the
Breast Comfort Pack inventory or the depreciation of dies, plates and molds, nor
on account of any returns,  charge-offs or credits granted or claimed on account
of Breast  Comfort Pack goods  shipped in the ordinary  course of business.  The
Company has not materially increased its work-in-progress  and/or finished goods
inventory in the 12 months preceding the date hereof.

     5.7.  Receivables.  The trade accounts and other  receivables of Flents are
bona fide  receivables and arose out of arms-length  transactions,  are recorded
correctly on the books and records of Flents,  consistent  with prior  practice,
except as otherwise expressly noted herein or on the Schedules annexed hereto.

     5.8. Insurance.

          (a)  Schedule  5.8(a)  hereto sets forth (i) a list of all policies of
insurance maintained by Flents, and all programs of selfinsurance covering risks
or  contingencies  customarily  covered  by  insurance  in  connection  with the
business of Flents,  including  insurance  providing benefits for employees,  in
effect on the date hereof,  (ii) a description of the coverage of such policies;
and (iii) the annual premiums  therefor and the underwriter and expiration dates
thereof.

          (b) Flents has made all premium payments currently due (accounting for
all  installment  payments) on the policies listed on Schedule  5.8(a),  and all
such policies are in full force and effect in accordance  with their  respective
terms.  There are no  outstanding  claims or  liabilities,  whether  matured  or
unmatured,  fixed or  contingent,  under any medical  reimbursement  plan or any
other  plan,  policy  or  arrangement  under  which  Flents  acts or  acted as a
self-insured.

          (c)  Schedule  5.8(c)  sets  forth  all  claims  pending  and,  to the
knowledge of Flents,  threatened  under any of the casualty or liability  (other
than products liability) insurance policies or self insurance programs set forth
in  Schedule  5.8 (a),  and all claims  made  thereunder  during the three years
preceding the date hereof.

          (d) There are no claims  pending  and,  to the  knowledge  of  Flents,
threatened in writing under any of the errors and omissions,  product  liability
or similar  insurance  policies or selfinsurance  programs set forth in Schedule
5.8(a), and all material claims made thereunder during the three years preceding
the date hereof are described on Schedule 5.8(d).

     5.9. Litigation and Compliance.

          (a) Except for circumstances  described on Schedule 5.9(a),  there are
no actions,  suits,  claims or proceedings  or  governmental  or  administrative
investigations  pending  nor  has  Flents  received  any  written  communication
regarding any reasonable basis for any such action,  suit, claim,  proceeding or
investigation (i) by, against or otherwise  involving Flents,  or, in connection
with  their  relationship  with  Flents,  any of  Flents'  officers,  directors,
employees or agents,  or any of the Acquired  Assets or any asset or property of
others  leased  or used by  Flents  or (ii) that  questions  or  challenges  the
validity of this  Agreement or any action taken or to be taken  pursuant to this
Agreement.  Schedule  5.9(a)  also sets  forth all  lawsuits,  arbitrations  and
similar  proceedings  commenced  during  the five years  before the date  hereof
involving   allegations  of  product   liability   and/or  defective  design  or
manufacture  of any  product  of  Flents  manufactured,  distributed  or sold by
Flents.

          (b) Flents is in  substantial  compliance  with,  is not in default or
violation  in any  material  respect  under,  and has not been  charged  with or
received any notice at any time during the past five (5) years, except as may be
otherwise  expressly disclosed herein or in the Schedules annexed hereto, of any
violation by them of, any statute, law, ordinance,  regulation,  decree or order
applicable to Flents or the Acquired Assets.

          (c) None of Flents, or any of Flents' officers,  directors,  employees
or agents is subject to any judgment,  order or decree entered in any lawsuit or
proceeding,  in  connection  with  any  of  the  Acquired  Assets  or any of the
transactions contemplated under this Agreement.

          (d) Within the five years immediately prior to the date hereof, Flents
has  duly  filed  all  reports  and  returns  required  to be  filed  by it with
governmental  authorities and has obtained all material  Governmental Permits (a
complete  list of which  Governmental  Permits is set forth on  Schedule  5.9(d)
hereto) that are required.  Flents has fulfilled  all of its  obligations  under
such Governmental  Permits.  All of such Governmental  Permits are in full force
and effect,  no notice has been  received by Flents  during the past three years
questioning  the validity  thereof or declaring  any defect or default  relating
thereto.  To Flents' best  knowledge,  no event has occurred  that,  with notice
and/or the passage of time,  might result in a default or grounds for suspension
or cancellation under any of such Governmental Permits or might adversely affect
the validity  thereof,  and no proceedings for the suspension or cancellation of
any of them, and no investigation relating to any of them, is pending.

          (e) Flents has operated, and will through the Closing Date operate, in
material  compliance  with all laws,  rules,  statutes,  ordinances,  orders and
regulations,   including,   without  limitation,   those  applicable  under  the
Occupational  Safety  and  Health  Act of  1970,  as  amended  ("OSHA"),  or any
equivalent  state law.  Flents  has not  received  any  notice of any  violation
thereof within the five years immediately prior to the date hereof.

     5.10. Taxes.

          (a) Flents has, or on or before the Closing Date will have, duly filed
all tax reports and returns  required to be filed in respect of the  business of
Flents and the Acquired Assets as of such date. All such tax reports and returns
are or will be complete,  accurate and in compliance  with all relevant laws and
regulations  in all  material  respects,  and,  except as  described in Schedule
5.10(a) hereto, none has been audited by any governmental authority. Flents has,
or on or before the Closing  Date will have,  paid and  discharged  all federal,
state, local and foreign taxes, interest,  penalties or other payments required,
as the case  may be,  to be paid  and  then  currently  due as shown on such tax
reports and returns or otherwise,  including,  without limitation, taxes arising
out of the  operations and employees of Flents as of such date. To the knowledge
of  Flents,  no audit of Flents is planned or  threatened.  Flents has  withheld
proper and accurate  amounts from its  employees'  compensation  and either paid
such amounts to the appropriate  taxing authorities or set aside such amounts in
accounts for such purpose in substantial  compliance  with all  withholding  and
similar provisions of the Code and any other applicable law.

          (b) Flents has not received notice of any tax deficiency  outstanding,
proposed or assessed against it or the Acquired Assets, nor does Flents have any
knowledge  of any basis for any tax  deficiency  or  assessment,  nor has Flents
executed  any  waiver  of  any  statute  of  limitations  on the  assessment  or
collection of any tax. There are no tax liens upon,  pending  against or, to the
best knowledge of Flents, threatened against any Acquired Assets.

     5.11.  Intangible Assets.

          (a) Flents' right,  title and interest in the following property used,
held for use or  licensed  for use by Flents  (collectively,  the  "Intellectual
Property") is described in Schedule 5.11(a) annexed hereto:

          (i) all existing patents, patent applications,  trademarks,  trademark
     registrations,  applications for trademark  registrations,  trade names and
     copyrights owned by Flents or in which Flents has any proprietary interest;

          (ii) all computer software, programs, and applications owned, licensed
     by or used or held by Flents  other than  commercially  available  software
     subject only to a "shrinkwrap" agreement;

          (iii)  all  material  copyrightable  property  that  is  published  or
     distributed   (such  as  brochures  or  catalogs)  and  patentable   ideas,
     inventions, discoveries (on which patent applications have been prepared or
     filed or evaluated in writing) and designs used or held by Flents; and

          (iv) all material  trade  secrets  used or held by Flents,  including,
     without limitation, designs, inventions, discoveries, methods of production
     and formulas.

All  license,  sublicense  and  other  agreements  with  respect  to  any of the
foregoing  intellectual  property  rights as to which  Flents is a  licensor  or
licensee are listed on the other schedules hereto.

Except as specifically disclosed in the Schedules hereto, Flents owns the entire
right,  title and  interest in and to the  Intellectual  Property  described  in
Schedule  5.11(a) or included in the Acquired  Assets in the United  States free
and clear of Liens and Flents has  received  no written  communication  that the
Intellectual  Property  developed by Flents infringes the intellectual  property
rights of others, or contains libelous information.

          (b) No  material  Intellectual  Property  other than as  described  on
Schedule 5.11(a) is used or necessary in connection with the conduct of Flents.

     5.12.  Employees.  Schedule  5.12  hereto  contains  a list of all  persons
performing  employment services for Flents and a description of all compensation
arrangements  (including  without  limitation  salaries and bonus  compensation)
affecting  them,  including  all active  employees and all employees on leave of
absence, on workers'  compensation,  disability leave,  military leave,  lay-off
(with recall rights),  or on other approved leave of absence, as of February 28,
1997. Each such employee is active.

     5.13.     ERISA.

          (a) Included on Schedule 5.13 is a list of each employee  benefit plan
(within the meaning of Section 3(3) of the Employee  Retirement  Income Security
Act of 1974,  as amended  ("ERISA")),  written or oral  employment or consulting
agreement,   severance  pay  plan,   employee  relations  policy,   practice  or
arrangement,  agreements with respect to leased or temporary employees, vacation
plan or arrangement,  sick plan, stock purchase plan, stock option plan,  fringe
benefit  plan,  bonus  plan and any  deferred  compensation  agreement,  plan or
program  covering  any present or former  employee of Flents and which is, or at
any time was,  sponsored or maintained by (or to which  contributions are, were,
or at any time  were  required  to have  been,  made  by)  Flents  or any  other
organization  which is a member of a controlled group of  organizations  (within
the meaning of Sections 414 (b), (c), (m) or (o) of the Code) of which Flents is
a member  (the  "Controlled  Group").  Each and every  such  plan,  program  and
agreement  included on the list set forth  under  Schedule  5.13 is  hereinafter
referred to as an "Employee Benefit Plan".

          (b) A true,  correct and complete copy of each Employee  Benefit Plan,
as amended,  has been  delivered to the PTI.  With respect to each such Employee
Benefit Plan, Flents has previously  delivered to PTI true and correct copies of
the following  documents,  as applicable:  (i) the trust agreement,  as amended,
(ii) the most recent  summary  plan  description,  (iii) the most recent  annual
report (Form 5500 series),  (iv) the most recent actuarial report, (v) insurance
contracts,  (vi) policy  statements and (vii) the most recent  Internal  Revenue
Service   determination   letter.  The  information   supplied  to  the  pension
consultant,  a copy of which is annexed  hereto in  Schedule  5.13,  is true and
correct in all material respects.

          (c)  Except  as set  forth in  Schedule  5.13  attached  hereto,  each
"employee  pension benefit plan" (as defined in Section 3(2) of ERISA) listed in
Schedule 5.13 that is intended to be qualified  under Section 401 (a) of the IRS
Code ("Pension Plan"), pursuant to the national Internal Revenue Service ("IRS")
determination  letter,  is qualified.  Except as disclosed in Schedule  5.13(b),
with respect to any Pension  Plan:  (i) each Pension Plan has been  administered
and  operated  in all  material  respects in  accordance  with its terms and the
provisions of ERISA and the Code (including  regulations  issued thereunder) and
other  applicable  laws;  (ii) no  determination  letter  has  been  revoked  or
threatened to be revoked,  (iii) no Pension Plan has been amended in any respect
that could adversely affect its  qualification  or could  materially  affect the
cost of  maintaining  the Pension Plan;  and (iv) other than claims for benefits
arising  in the  ordinary  course of the  administration  and  operation  of any
Pension Plan, there are no claims, investigations, suits, audits or arbitrations
which are pending or, Flent's knowledge, threatened, against any Pension Plan or
any fiduciary of any Pension Plan.  Except as disclosed on Schedule  5.13,  with
respect to any Pension Plan: (i) neither such Pension Plan nor any person acting
as a fiduciary with respect to such Plan has engaged in a transaction prohibited
under  Section  406 or 407 of ERISA or  Section  4975 of the Code,  which  could
subject any Pension  Plan,  fiduciary  or Flents to any  material tax or Penalty
imposed by Section  4975 of the Code or  Section  502 of ERISA;  (ii) to Flents'
knowledge,  no person  acting as a fiduciary  with respect to a Pension Plan has
participated  in or is aware of a breach of fiduciary  duty which could  subject
any fiduciary to any material liability or penalty under ERISA; (iii) no Pension
Plan has incurred any accumulated funding deficiency (whether or not waived), as
that term is  defined in Section  302 of ERISA or Section  412 of the Code;  and
(iv) all  contributions  required to be made to each  Pension  Plan prior to the
Closing have been made on a timely basis.

          (d) Except as disclosed on Schedule 5.13, with respect to each Pension
Plan that is subject to Title IV of ERISA: (i) no reportable event under Section
4043 of ERISA has occurred  (other than a reportable  event for which the notice
requirement  has been waived by the PBGC);  (ii) all PBGC  premiums  due to date
have been paid;  (iii) the Company has not filed a notice of intent to terminate
any such  Pension  Plan and has not adopted any  amendment  to treat any Pension
Plan as  terminated;  and  (iv)  the  PBGC  has not  instituted  proceedings  to
terminate any such Pension Plan.

          (e) No Pension  Plan is a  multiemployer  plan,  within the meaning of
Section 3 (37) or 4001 (a) (3) of ERISA, or a multiple  employer plan within the
meaning  of  Sections  4063 and 4064 of ERISA,  and the  Company  has not had an
obligation to contribute to any  multi-employer or multiple employer plan during
the preceding six (6) years.

     5.14.     Labor Relations.

          (a) No employee of Flents has been, and no employee is,
covered by any collective bargaining agreement.

          (b) Flents has not  received  any written  notice of any unfair  labor
practice  complaint,  or any claim for  discrimination or harassment  related to
Flents,  within the five years immediately prior to the date hereof,  except for
the matter set forth in Schedule 5.9(a).

     5.15.     Contracts, Etc.

          (a) All contracts,  leases,  agreements,  licenses, and commitments to
which  Flents  is a party  or by  which  Flents  or any of its  assets  is bound
("Contracts") are listed on Schedule 2.3(ii), except for sales representative(s)
agreements that are terminable  without penalty or premium by the Company within
90 days or involve  payments  of less than  $5,000 per year,  provided  that all
contracts excluded under this exception do not in the aggregate involve payments
of greater than $100,000 per year.  Flents has not disclosed and is not required
to disclose consumer pricing letters of the type similar to the example included
in Schedule 2.3(ii)(H).

          (b) To the best of Flents knowledge,  all of the Contracts,  are valid
and in full  force and  effect  and  constitute  the  legal,  valid and  binding
obligations of Flents and the other parties  thereto,  and there are no existing
defaults  by  Flents  (except  as set  forth in  Schedule  5.9(a)),  or,  to the
knowledge  of Flents,  by any other  party  thereto,  no party has  accrued  any
entitlement  to  indemnification  under any of the Contracts  whether based on a
default or otherwise, and, to the knowledge of Flents, no event, act or omission
has occurred that (with or without notice, lapse of time and/or the happening or
occurrence  of any other event) would result in a material  default  thereunder.
None of the Contracts is being or has been proposed to be  renegotiated  (except
as  disclosed  in  Schedule  5.15(b)),  and no party under any of them is paying
liquidated damages in lieu of performance.

          (c) Flents has heretofore delivered to Merger Sub or its counsel true,
correct and complete copies of all of the Contracts.

     5.16.     Customers and Suppliers.

     (a) Except as disclosed in Schedule  5.17,  Flents is not aware of any loss
of any  business  from any  material  customer,  supplier  or  account or of the
interruption  of supply or loss of business with any of the suppliers of Flents.
PTI  acknowledges  having  received  the  schedule  and having  examined  it. No
adjustment  in the  purchase  price  shall  be made on  account  of any  loss of
business,  returns or unused boxes regarding the Breast Comfort Pack. Flents has
not received in writing any material  complaint  from, and is not engaged in any
material dispute with, any customer or supplier.

          (b) Set forth on Schedule 5.16(b) is a list of the names and addresses
of the ten  largest  customers  of the  consumer  accounts  and  the  industrial
accounts  of Flents and the dollar  volume of orders  shipped to each during the
fiscal years ended  November 30, 1995,  1996 and the three months ended February
28, 1996 and 1997.

          (c) Nothing has come to the attention of Flents that would  reasonably
lead it to believe that any of the customers  listed on Schedule  5.16(b) or any
supplier of Flents has  terminated  or will  terminate  or curtail its  business
relationship  with Flents or with the Surviving  Corporation  as a result of the
Closing.

          (d) Flents has not  experienced  any work  stoppage  resulting  from a
shortage of supply of any raw material during the three years  immediately prior
to the date hereof.

     5.17.  Absence of Certain Changes,  Etc. Since November 30, 1996, Flents is
not aware of any event or other development that has occurred that could cause a
material  loss or decline in sales of Flents  (except as  disclosed  in Schedule
5.17);  Flents has not  experienced  any  material  increase  in the cost of, or
difficulty in obtaining,  raw materials or components,  replacement parts or any
other supplies (except as disclosed in Schedule 5.17); no compensation  increase
for any employee  working for Flents outside of the ordinary course or in excess
of 9% on an annual  basis has been  granted or promised  (except as disclosed in
Schedule  5.17);  no new employees  have been  retained  (except as disclosed in
Schedule  5.17);  nothing has come to the attention of Flents that would lead it
to believe that any material  adverse  change in its business or  operations  or
prospects of the  business of Flents or in the  condition of any of the Acquired
Assets,  or the assets or properties of others leased or used in the business of
Flents has  occurred;  no  material  damage,  destruction  or loss to any of the
Acquired  Assets has occurred;  Flents has not entered into any  transaction  or
contract,  or amended any contract,  which might have a Material Adverse Effect;
Flents has not incurred any material  indebtedness for borrowed funds or entered
into any material  capitalized lease obligation (except as disclosed in Schedule
5.17);  Flents has not  canceled  any claim or right of material  value or sold,
leased,  transferred,  suffered any Lien to arise upon, or otherwise disposed of
any assets except in arms-length  transactions  with unrelated  parties for fair
consideration  in the  ordinary  course  of  business;  Flents  has not paid any
dividend or distributed any property in respect of its corporate stock except as
disclosed in the Financial  Statements  (except as disclosed in Schedule  5.17);
Flents has not taken any action that would if taken  between the date hereof and
the Closing Date constitute a breach of Section 7.2 hereof.

     5.18.     Environmental Matters.

          (a) The Company is not required to obtain any Governmental Permits for
discharges, pollution and other environmental matters (whether relating to land,
air, water,  noise. odor or other matters)  necessary to conduct the business of
Flents as it has been conducted.  To the Company's  knowledge,  no investigation
into  environmental  matters in connection with Flents or any real property used
by Flents has been conducted  during the past three years, or is currently being
conducted, by any governmental authority.

          (b) To the best  knowledge of Flents,  no facts,  events or conditions
existing  on the date  hereof  (including  without  limitation  the  generation,
treatment,  transport,  storage, emission, disposal, release or other placement,
deposit or  location  of any  substance)  interfere  with or  prevent  continued
compliance  by  Flents  with  any  statute,   law,   regulation,   ordinance  or
Governmental Permit relating to the manufacture,  processing, distribution, use,
treatment,  storage,  disposal,  transport  or  handling,  emission,  discharge,
release  or  threatened   release  into  the  environment,   of  any  pollutant,
contaminant,  hazardous  waste,  hazardous  substance,  toxic substance or toxic
waste.

          (c)  Flents is not aware of any  pollutants,  contaminants,  hazardous
wastes, hazardous substances, toxic substances, toxic wastes, petroleum products
or non-biodegradable  substances  ("Contaminants") produced, used or disposed of
by Flents,  except wax used to produce  earplugs which is not considered a toxic
substance and substantially all of which is used and incorporated into the final
products of Flents.

          (d) Flents has not received or produced any written reports or notices
of releases,  leakings,  injections,  dispersals,  leachings, or migrations of a
Contaminant, or any written notices of the generation of any hazardous waste, in
connection with Flents.

          (e) There has not  occurred  any leaks,  spills or  discharges  of any
Contaminant by Flents (i) onto the land of property on which Flents  conducts or
has  conducted  business,  or (ii)  into  any  waterway  or body of water or any
sewerage or septic  system that is part of,  adjacent to or  connected  with any
such property or (iii) otherwise in connection with the business of Flents,  and
there has not been any other  environmental  degradation,  damage,  pollution or
contamination  by Flents of any property on which either Flents  conducts or has
conducted business that might result in any material liability.

     5.19. Other Information. The Schedules annexed hereto and the documents and
information  with respect to Flents and the Acquired Assets that are required to
be supplied to Merger Sub pursuant to this  Agreement  or have been  supplied to
Merger  Sub at its  request  by  Flents  or on its  behalf  do not  contain  any
statement  that is false or misleading  with respect to a material  fact, and do
not omit to state a  material  fact  necessary  in order to make the  statements
therein under the circumstance in which they are made not false or misleading in
any material respect.

     5.20.  Investment  Intent.  Flents is  acquiring  the Merger  Stock for the
account of the Flents  Stockholders,  for investment only, and not with any view
to the sale or distribution thereof. Flents acknowledges that sale of the Merger
Stock by the Flents  Stockholders  is not registered  under the Act or under any
state securities law.


     Section 6. Representations and Warranties of Merger Sub. PTI and Merger Sub
represent  and  warrant to Flents as  follows,  and  acknowledge  that Flents is
relying  upon  such  representations  and  warranties  in  connection  with  the
execution,  delivery and  performance  of this  Agreement,  notwithstanding  any
investigation made by Flents or on its behalf:

     6.1. Authorizations and Binding Effect.

          (a)  Each  of  Merger  Sub and PTI is a  corporation  duly  organized,
validly  existing  and in good  standing  under  the  laws of the  state  of its
incorporation and is qualified to transact business and is in good standing as a
foreign corporation in the jurisdictions where it is required to qualify.

          (b) This  Agreement has been duly executed and delivered by Merger Sub
and PTI and  constitutes the legal,  valid and binding  obligation of Merger Sub
and PTI,  enforceable in accordance with its terms. The execution,  delivery and
performance of this Agreement does not and will not:

          (i) conflict with, result in the breach of, constitute a default (with
     or without  notice  and/or lapse of time) under,  result in being  declared
     void or voidable any  provision  of, or result in any right to terminate or
     cancel, any contract,  lease or agreement to which Merger Sub or PTI or any
     of their properties is bound;

          (ii) constitute a violation of any statute, judgment, order, decree or
     regulation  or rule of any  court,  governmental  authority  or  arbitrator
     applicable or relating to Merger Sub or PTI; or

          (iii)     result in the acceleration of any debt
     or other obligation of PTI or Merger Sub.

          (c) PTI and Merger Sub jointly and severally  acknowledge  that Flents
makes no representations or warranties except as set forth in this Agreement and
the attached schedules.

     6.2. Judgments.  Except as set forth in the PTI Reports
(hereinafter defined), no material judgments or Liens exist
against Merger Sub PTI or any of Merger Sub's or PTI's assets.

     6.3.  Litigation.  Except as  disclosed  in PTI's  Reports  (as  defined in
Section 6.4 herein),  or have come to PTI's  attention  subsequent  thereto,  no
material actions,  suits, claims,  proceedings or investigations (whether or not
purportedly on behalf of or against PTI), are pending or threatened  against PTI
at law or in equity,  including  without limit,  that relate to the transactions
contemplated  by this  Agreement  or that will  prohibit  PTI or Merger Sub from
performing the obligations to be performed by it hereunder.

     6.4. Other  Information.  PTI's annual  financial  statements for the years
1995 and 1996, recorded on PTI's Form 10-K for the year ended December 31, 1996,
and PTI's Form SB-2 dated  January 27, 1997,  as filed with the  Securities  and
Exchange Commission, and PTI's reports to stockholders  (collectively,  the "PTI
Reports") do not contain any statement that is false or misleading  with respect
to a material  fact, and do not omit to state a material fact necessary in order
to make the statements therein under the circumstance in which they are made not
false or  misleading  in any material  respect,  except as set forth on Schedule
6.4.

     6.5. Capitalization.  PTI represents and warrants that its annual report on
Form 10-K for 1996 fairly and accurately  discloses the  capitalization  of PTI.
Since   December   31,  1996  there  has  been  no  material   change  in  PTI's
capitalization,  except as set forth on Schedule 6.4 and that PTI has called for
redemption all of its issued and outstanding  Public  Redeemable  Warrants,  and
this representation will be true at the effective time.

     6.6  Environmental Representations.

          (a)  PTI is not  required  to  obtain  any  Governmental  Permits  for
discharges, pollution and other environmental matters (whether relating to land,
air, water,  noise. odor or other matters)  necessary to conduct the business of
PTI  as it has  been  conducted.  To  PTI's  knowledge,  no  investigation  into
environmental  matters in  connection  with PTI or any real property used by PTI
has been conducted during the past three years, or is currently being conducted,
by any  governmental  authority,  except as set forth in  Schedule  6.6  annexed
hereto.

          (b) To the best  knowledge  of PTI,  no facts,  events  or  conditions
existing  on the date  hereof  (including  without  limitation  the  generation,
treatment,  transport,  storage, emission, disposal, release or other placement,
deposit or  location  of any  substance)  interfere  with or  prevent  continued
compliance by PTI with any statute,  law, regulation,  ordinance or Governmental
Permit relating to the manufacture,  processing,  distribution,  use, treatment,
storage,  disposal,  transport  or  handling,  emission,  discharge,  release or
threatened  release  into  the  environment,  of  any  pollutant,   contaminant,
hazardous waste, hazardous substance, toxic substance or toxic waste.

          (c) PTI is not aware of any Contaminants produced, used or disposed of
by  PTI,  except  nonmaterial   amounts  from  ordinary   maintenance  of  PTI's
facilities.

          (d) PTI has not received or produced any written reports or notices of
releases,  leakings,  injections,  dispersals,  leachings,  or  migrations  of a
Contaminant, or any written notices of the generation of any hazardous waste, in
connection with PTI.

          (e) There has not  occurred  any leaks,  spills or  discharges  of any
Contaminant  by PTI (i) onto the land of property  on which PTI  conducts or has
conducted  business,  or (ii) into any waterway or body of water or any sewerage
or  septic  system  that is part  of,  adjacent  to or  connected  with any such
property or (iii)  otherwise in  connection  with the business of PTI, and there
has  not  been  any  other  environmental  degradation,   damage,  pollution  or
contamination  by PTI of any  property  on  which  either  PTI  conducts  or has
conducted business that might result in any material liability, except the PTI's
facility in Hastings-on-Hudson is part of a contaminated site that is undergoing
extensive environmental remediation.

     Section 7. Covenants.

     7.1. Access to Records and Properties of Flents.

          (a) Between the date of this  Agreement and the Closing  Date,  Flents
shall  give to Merger  Sub such  access to the  premises,  books and  records of
Flents, and such copies thereof,  as Merger Sub may from time to time reasonably
request.  Any  investigation  pursuant to this Section 7.1 shall be conducted in
such manner as not to interfere  unreasonably with the operation of the business
of  Flents.  Representatives  and  officers  of  Flents  shall be  available  to
representatives  of  Merger  Sub to have  questions  asked  of them  and to give
answers.

          (b) Merger Sub shall not  dispose of or destroy any  business  records
and personnel  records and files of Flents for periods prior to the Closing Date
for seven years,  and thereafter  shall not dispose of or destroy same,  without
first  offering  to  turn  over  possession  thereof  to  Stuart  M.  Low or his
successors,  executors,  administrators  or assigns ("Low") by written notice to
Low at least ninety (90) days prior to the proposed dates of such disposition or
destruction.  All records  retained by Merger Sub shall be so retained at Merger
Sub's expense.

          (c) To the extent  reasonably  required  by the  Flents  stockholders,
Merger Sub shall allow a Flents  stockholder and his or her agents access to all
business records and files (including  appropriate personnel records and medical
records)  of Flents  related to the  business  of Flents  that relate to periods
prior to the Closing Date, upon reasonable  advance notice during normal working
hours at any location where such records are stored, and the Flents stockholders
shall have the right,  at their own expense,  to make copies of any such records
and files,  provided,  however,  that any such access or copying shall be had or
done in such a  manner  so as not to  unreasonably  interfere  with  the  normal
conduct of the business of the Surviving Corporation.

          (d) After the Closing,  Merger Sub shall make  available to the Flents
stockholders, upon written request, personnel of Merger Sub to assist the Flents
stockholders  in locating and obtaining  records and files  maintained by Flents
for  periods  prior to the  Closing  Date,  and the  Flents  stockholders  shall
reimburse Merger Sub for the actual cost thereof.

     7.2.  Operation of the  Business.  From and after the date hereof until the
Closing Date, Flents shall:

          (a) Operate diligently and only in the usual,  ordinary manner and, to
the extent consistent with such operation,  (i) use its best efforts to preserve
its current business  organization intact, (ii) use its best efforts to preserve
its current  relationships  with employees,  customers,  suppliers and all other
persons having  business  dealings with them,  (iii) offer no discounts on goods
sold,  outside of the ordinary  course of business,  (iv)  maintain in force the
insurance  policies  referred  to in Section 5.8  hereof,  (v)  maintain in good
working order and repair all tangible  personal property and all improvements on
real  property (and all fixtures and systems  therein)  included in the Acquired
Assets,  ordinary  wear and tear  excepted;  and (vi) not  amend or  modify  its
certificate of incorporation or by-laws, except as may be required to effectuate
this Agreement.

          (b)  Maintain  Flents'  books,  accounts  and records in the usual and
ordinary manner,  and in a manner that fairly and correctly reflects the income,
expenses,  assets and  liabilities  of Flents on a basis  consistent  with prior
years.

          (c)  Comply  with all  Federal,  state,  local and other  governmental
(domestic or foreign) laws, statutes,  ordinances,  rules, regulations,  orders,
writs, injunctions,  decrees, awards or other requirements of any court or other
governmental  or other  authority  applicable  to Flents or its assets or to the
conduct of its business,  and use best efforts to perform all obligations  under
all contracts, agreements, licenses, permits and undertakings without default.

          (d) Make no modification or change in any existing right,  concession,
license,  lease,  contract,  commitment  or  agreement,  and no  sale  or  other
disposition of any right or privilege  accruing to them,  except in the ordinary
course of business  consistent  with past  practice,  and except as set forth in
other sections of this Agreement.

          (e)  Intentionally omitted.

          (f) Make no change in the compensation payable or to become payable to
any present or former director, employee,  salesman,  consultant or other agent,
except as required  by  existing  contracts  to which  Flents is bound;  make no
change in any existing,  and enter into no new, arrangement or contract relating
to  management,  executive  or  clerical  services or relating to the sharing of
administrative  or other overhead or any management or supervisory  fee,  except
for the hiring and firing of  clerical  employees  as may be  required  by sound
business  practice;  establish or make no bonus,  stock option,  profit sharing,
retirement  or other  similar  payment,  plan or  arrangement  or institute  any
increase therein,  except as otherwise provided herein or in the ordinary course
of the  administration  of  existing  incentive,  welfare,  retirement  or other
similar plans or arrangements  hereinabove  referred to; and enter into no union
contract  and no  employment  agreement;  and enter into no  agreement  with any
salesperson   or  sales   agent   or  any   franchise   agreement,   independent
dealer/distributor  agreement or other contract or  arrangement  with respect to
the performance of services for Flents,  except for agreements terminable within
six months or less as may be required by sound business practice.

          (g) Not sell,  lease or dispose  of, or allow any Lien to arise  upon,
any of the  Acquired  Assets and not acquire or commit to acquire  any  material
capital assets except for fair market price, in the ordinary course of business,
consistent with prior practice,  in arms-length  transactions  with unaffiliated
parties.

          (h) Not  pay,  satisfy  or  discharge  in any  other  way any  account
payable,  indebtedness,  claim or liability of any kind,  except for the current
payment of liabilities  reflected on the balance sheet of the February Printouts
at no more than the book amount  thereof and except for payments  for  inventory
and supplies and services at fair market value ordered in the ordinary course of
business  consistent  with prior  practice and payments for legal and accounting
services  in the  aggregate  amount of $50,000  incurred  or to be  incurred  in
connection with this transaction and the closing  contemplated  herein;  and not
delay or accelerate the payment of any account  payable or  indebtedness  beyond
the usual and customary  period therefor or the legal maturity  thereof,  except
insofar as insurance premiums have been made on the installment basis.

          (i) Not  delay or  accelerate  collection  of any  note or  receivable
beyond the usual and customary period therefor or the legal maturity thereof.

          (j) Not allow levels of raw materials, supplies,  work-in-process,  or
inventories to vary materially from the levels customarily maintained by Flents.

          (k) Not create,  incur or assume, or agree to create, incur or assume,
any indebtedness,  or enter into any capitalized  lease  obligation,  other than
those  incurred  in the usual and  ordinary  course of  business,  or subject to
Section  7.2(h)  above,  incurred  in  connection  with this  Agreement  and the
contemplated Closing.


          (l) Not enter into any contract  for the purchase of real  property or
exercise any option to extend or terminate  any lease of real  property,  except
for the lease extension disclosed in the schedules hereto.

          (m) Not declare or pay any dividend or distribute any asset in respect
of any security, whether as a distribution, repurchase, redemption or otherwise;
and not issue, sell, grant options,  warrants or rights to purchase or subscribe
to, or enter into any  arrangement  or contract  with respect to the issuance or
sale of any of its capital stock or any  securities or  obligations  convertible
into or  exchangeable  for any of its capital stock,  or make any changes in its
capital structure, in all cases, except as disclosed in Schedule 5.17 hereto.

          (n) Not lend any money or make any financial  accommodation except for
trade credit in the ordinary course of business, consistent with prior practice;
and not  organize  any  subsidiary,  acquire any capital  stock or other  equity
securities of any other corporation, or acquire any equity or ownership interest
in any business,  and not merge with,  liquidate into or otherwise  combine with
any other business, person or entity.

          (o) Not make any  agreement,  commitment  or  arrangement  to take any
action that is inconsistent  with the obligations  under, or prohibited by, this
Section 7.2.

     7.3. Competing Transactions.  Flents, PTI and Merger Sub shall not take any
action, directly or indirectly, to negotiate, cause, promote, authorize or agree
to any  transaction  competing  or  interfering  with  any  of the  transactions
contemplated by this Agreement.

     7.4. Best Efforts to Satisfy  Conditions.  Flents, PTI and Merger Sub shall
each use its best  efforts to cause the  conditions  to the  obligations  of the
other  party  to be  satisfied  to the  extent  that  the  satisfaction  of such
conditions  is in its  control,  including  obtaining  any  necessary  consents,
authorizations,  and  approvals.  Each of the parties  hereto shall refrain from
taking any action,  and shall  notify the other  parties  promptly of any event,
occurrence or circumstances,  that might render any of its  representations  and
warranties inaccurate as of the Closing Date.

     7.5.  Noncompete and Employment  Agreements.  W. Thomas Davies  ("Davies"),
James Dunn ("Dunn"),  and Low shall enter into noncompete agreements with Merger
Sub and PTI substantially in the form of Exhibits C1 and C2 annexed hereto.  Low
shall enter into a consulting  agreement  with Merger Sub  substantially  in the
form of Exhibit D annexed  hereto.  Davies and Dunn shall enter into  employment
agreements  with  Merger  Sub  substantially  in the form of  Exhibits  El and 2
annexed  hereto.  Flents shall have no liability  for a default by Davies and/or
Dunn in  complying  with  his/their  obligations  hereunder  to enter  into such
agreements with Merger Sub and PTI.

     7.6.  Transfer  Taxes.  The  Flents  stockholders  shall  pay  any  income,
recapture or similar tax that becomes  payable as a result of the payments  made
to the Flents stockholders hereunder.

     7.7.  Confidentiality.  All parties hereto shall keep in strict  confidence
all information pertaining to the business of Flents, Merger Sub and PTI as well
as the terms of the  transactions  contemplated  hereby,  except as the  parties
hereto  mutually  agree and except as  disclosure  shall be  required by law, in
which  case,  to the  extent  possible,  the  party  required  to make  any such
disclosure  shall provide  notice  thereof at least three business days prior to
such  disclosure  and shall work in good faith with the other parties  hereto to
make a mutually acceptable disclosure.  Each party shall use its best efforts to
prevent  its   employees,   officers,   directors,   shareholders,   agents  and
representatives  from divulging any such confidential  information or taking any
action that would be prohibited by such party hereunder.  The parties hereto may
disclose such information to their employees, agents, affiliates,  shareholders,
lenders and  professionals on a need-to-know  basis,  provided the party to whom
such information is disclosed agrees to keep such information confidential.

     7.8. Benefit of Contracts.

          (a) Flents shall use its best efforts, subject to this Section 7.8, to
secure all consents, approvals,  novations and authorizations from third parties
(including a government or  governmental  unit) as shall be required in order to
enable Flents to effect the transactions contemplated by this Agreement, and the
parties will otherwise use all reasonable  efforts to cause the  consummation of
the transactions contemplated hereby in accordance with the terms and conditions
hereof.

          (b) To the extent that the Merger  would result in a breach or a right
to terminate or any other right adverse to Flents, without the consent or waiver
of any third person  (including a government or  governmental  unit),  or if the
Merger  would  constitute a breach  thereof or a violation  of any law,  decree,
order,  regulation or other governmental  edict, Flents shall use all reasonable
efforts,  and PTI and  Merger Sub shall  cooperate  with  Flents,  to obtain all
necessary consents,  waivers and novations and to resolve the impediments and to
obtain any other consents, waivers and novations necessary to the Merger.

     7.9.  Convertible Value and Registration  Rights Agreement.  PTI will enter
into a convertible value and registration rights agreement, substantially in the
form of  Exhibit F annexed  hereto,  with each of the Flents  stockholders  upon
execution of such agreement by such Flents stockholder.

     7.10.  Continuity of Business  Enterprise.  It is the present  intention of
Merger  Sub to  continue  at least one  significant  historic  business  line of
Flents, or to use a significant portion of Flents' historic business assets in a
business,  in each case within the meaning of Treasury  Regulation S 1.368-1(d),
promulgated by the Treasury Department of the United States, and Merger Sub will
do so for at least one year after the Closing.

     Section 8. Conditions of Obligations of Merger Sub and PTI. The obligations
of Merger Sub and PTI to consummate  the Merger under this Agreement are subject
to the satisfaction of the following  conditions by or on behalf of Flents, each
of which may be waived by Merger Sub and PTI.  Any such waiver by Merger Sub and
PTI  shall  not  reduce  or  impair   Merger   Sub's  or  PTI's  right  to  seek
indemnification  hereunder in respect of the failure to meet the condition  that
shall have been waived.

     8.1. Representations and Warranties, Performance of Obligations.

          (a) The  representations and warranties of Flents set forth in Section
5 hereof and in all agreements, documents and instruments executed and delivered
pursuant  hereto or in connection  with the Closing shall be true and correct in
all respects at times commencing with the date of this Agreement and through the
Closing Date as though made on and as of the Closing Date.

          (b)  Flents  shall  have  performed  the  agreements  and  obligations
necessary to be performed by it under this Agreement  prior to the Closing Date.
Without limiting the generality of the foregoing, Flents shall have obtained all
consents,   waivers,  approvals  and  authorizations  or  have  made  reasonable
arrangements  in accordance  with Section 7.8 hereof,  except as may be required
under the Wal-Mart License Agreement described in Schedule 2.3(ii)(L), and shall
have given notices to third parties, and discharged in full any Liens of record,
necessary so that upon the Merger, the Surviving Corporation shall have good and
marketable  title to all of the Acquired Assets and all right,  title,  interest
and claims of Flents in, to,  relating to or arising  under the Acquired  Assets
free and clear of any Liens.

     8.2.  Certificates  of Merger.  Flents  shall have  delivered to Merger Sub
executed Certificates of Merger.

     8.3. Flents' Goodstanding.  Flents shall have provided to Merger Sub a copy
of a  long-form  goodstanding  certificate  for  Flents  from  the  state of its
incorporation,  and a good standing  certificate  from each state in which it is
authorized to do business,  together  with a copy of its charter and bylaws,  as
amended,  and  certified  copies of the  minutes of its board and  shareholder's
meeting (or, if applicable,  executed consent of its directors and shareholders)
approving  this  Agreement,  each of the  documents  referred  to herein and the
consummation  of  the  transactions   contemplated  hereby  in  form  reasonably
satisfactory to Merger Sub.

     8.4. Noncompete and Employment Agreements.  Low, Davies and Dunn shall each
have entered into the agreements described in Section 7.5 herein.

     8.5.  Pending  Matters.  No claim,  action,  suit,  investigation  or other
proceeding  shall be pending  before any court or  governmental  agency or by an
unaffiliated  third party which presents a substantial  risk of the restraint or
prohibition of the transactions  contemplated by this Agreement or the obtaining
of material damages in connection therewith.  If PTI or Merger Sub elects not to
close the Merger  because the  condition  in this  Section 8.5 is not met,  then
Flents shall have no  liability  whatsoever  to PTI or Merger Sub in  connection
with the failure to meet such condition.

     8.6. Due Diligence.  Flents shall have satisfied Merger Sub, or a designee,
as to the due diligence  investigation of the business  operations and financial
condition and all business  records,  accounting  records and files  relating to
Flents.  If PTI or  Merger  Sub  elects  not to close  the  Merger  because  the
condition  in this  Section 8.6 is not met,  then Flents shall have no liability
whatsoever  to PTI or Merger  Sub in  connection  with the  failure to meet such
condition.

     8.7. Other Matters. Flents shall have furnished, or caused to be furnished,
to  Merger  Sub,  in  form  and  substance  satisfactory  to  Merger  Sub,  such
certificates  and other evidence as Merger Sub may have reasonably  requested on
reasonable  notice as to the  satisfaction  of the conditions  contained in this
Section 8 and as to such other matters as Merger Sub may reasonably request.

     Section 9.  Conditions of Obligations of Flents.  The obligations of Flents
to consummate the Merger under this Agreement are subject to the satisfaction of
the  following  conditions  by or on behalf of Merger Sub,  each of which may be
waived by Flents.  Any such waiver by Flents shall not reduce or impair Flents's
right to seek  indemnification  hereunder  in respect of the failure to meet the
condition that shall have been waived.

     9.1. Representations and Warranties, Performance of Obligations.

          (a) The representations and warranties of PTI and Merger Sub set forth
in Section 6 hereof and in all agreements,  documents and  instruments  executed
and delivered  pursuant  hereto or in connection  with the Closing shall be true
and correct in all respects at times  commencing with the date of this Agreement
and ending with and on the Closing  Date as though made on and as of the Closing
Date.

     (b) Merger Sub and PTI shall have performed the agreements and  obligations
necessary  to be  performed  by them under this  Agreement  prior to the Closing
Date.

     9.2. Delivery of the Merger Consideration. PTI and/or Merger Sub shall have
delivered to the Exchange Agent the Merger Consideration.

     9.3. Merger Sub's Goodstanding.  Merger Sub shall have provided Flents with
a  copy  of  a  long-form   good-standing   certificate  of  the  state  of  its
incorporation,  and, at or promptly  after  Closing,  each state in which it has
authority to do business,  together  with a copy of its charter and by-laws,  as
amended,  and the minutes of its board and shareholder  meeting and those of PTI
(or, if applicable, executed consent of its directors) approving this Agreement,
each  of  the  documents   referred  to  herein  and  the  consummation  of  the
transactions contemplated hereby.

     9.4.  Pending  Matters.  No claim,  action,  suit,  investigation  or other
proceeding  involving  PTI or Merger  Sub shall be  pending  before any court or
governmental  agency  or  by  an  unaffiliated  third  party  which  presents  a
substantial   risk  of  the  restraint  or  prohibition   of  the   transactions
contemplated  by  this  Agreement  or  the  obtaining  of  material  damages  in
connection therewith.

     9.5. Other Matters.  PTI and Merger Sub shall have furnished,  or caused to
be furnished,  to Flents,  in form and substance  satisfactory  to Flents,  such
certificates  and other  evidence  as Flents may have  reasonably  requested  on
reasonable  notice as to the  satisfaction  of the conditions  contained in this
Section 9 and as to such other matters as Flents may reasonably request.

     9.6.  No Change.  There shall have been no  substantial  change in PTI's or
Merger  Sub's  business  that  would  have a  material  negative  impact  on its
financial  condition  or the outlook of its  business or the value of the shares
offered  for  exchange  in this  transaction,  PTI and Merger Sub shall not have
notice or knowledge,  written or oral, that it has lost or may lose any customer
or customers contributing  individually or collectively 25% or more to its gross
revenue, PTI and Merger Sub shall have maintained product liability insurance in
an amount  consistent  with prior practice and shall have provided  certificates
and other evidence of such insurance as Flents may have reasonably requested.

     Section 10. Survival of Representations and Warranties; Indemnifications.

     10.1.  Survival.  The  representations,  warranties and agreements  made in
Sections  5 and 6 hereof  and in the  Schedules  hereto by Merger  Sub,  PTI and
Flents  shall  remain  operative  and in full force as of the date made  through
February  28,  1999,  except  with  respect  to  Section  5.3,  as to which such
representations  and  warranties  shall  continue to survive for a period of the
applicable  statute of  limitations  for  breach of  contract,  as  appropriate,
regardless  of any  investigation  made by, or on behalf of,  any party.  Flents
stockholders  shall remain  liable for  misrepresentations  of Flents in Section
5.3,  pro rata to the extent of the Merger  Consideration  actually  received by
each such stockholder

     10.2. Indemnification by Flents Stockholders. The Flents stockholders (on a
non-recourse  basis and only up to the limits of the escrow described in Section
10.6 herein) shall defend,  hold harmless and indemnify  Merger Sub from any and
all losses, liabilities,  proceedings,  claims,  settlements,  judgments, fines,
assessments,  damages and expenses  (including  reasonable  attorneys'  fees and
investigation  and  litigation  expenses,  whether  arising out of a third party
claim or  relating  to  recovering  indemnifiable  damages)  (collectively,  the
"indemnifiable damages") that Merger Sub may suffer or incur in whole or in part
by reason of, or which may arise out of:

          (a)  the inaccuracy or breach of any of the
representations and warranties of Flents in this Agreement;

          (b)  the breach by Flents of any of the covenants or
warranties herein;

          (c)  liabilities  for  any  civil  or  criminal  penalties  (including
interest) or any payments in the nature  thereof,  imposed upon, or sought to be
imposed  upon  Flents  or  Merger  Sub (or  any of the  officers,  directors  or
shareholders   of  Merger  Sub),  on  account  of  any   fraudulent,   criminal,
intentional,  or willful act or omission,  or any such act or omission of Flents
or any of the directors, officers, employees or agents of Flents occurring prior
to the Closing Date;

          (d) any present or  potential  obligation  to  remediate or take other
action or any present or  potential  liability  (including  with respect to past
activities  occurring prior to the Closing Date), whether criminal or civil, and
whether to any governmental  entity or private party,  under, any statute,  law,
regulation,  ordinance  or  Governmental  Permit or  otherwise  relating  to the
manufacture,   processing,  distribution,  use,  treatment,  storage,  disposal,
transport or handling,  emission,  discharge, release or threatened release into
the  environment by Flents,  of any  pollutant,  contaminant,  hazardous  waste,
hazardous  substance,  toxic substance or toxic waste that are related to facts,
events,   circumstances  or  conditions   (including   without   limitation  the
generation,  treatment, transport, storage, emission, disposal, release or other
placement,  deposit or location of any  substance)  existing or  occurring on or
prior to the Closing Date;

          provided,  however,  except as expressly set forth herein,  any matter
accurately  disclosed in the Schedules  hereto shall not result in any liability
to Flents or the Flents stockholders, or any right to indemnification under this
Section 10.

     10.3.  Indemnification  by Surviving  Corp.  Surviving  Corp. and PTI shall
defend,  hold harmless and indemnify  the Flents  stockholders  from any and all
indemnifiable damages that the Flents stockholders may suffer or incur by reason
of: (a) the inaccuracy or breach of any of the representations and warranties of
Merger  Sub and PTI  herein;  (b) the breach by Merger Sub and PTI of any of the
covenants or warranties  herein;  and (c) any claim for payment of any liability
or performance of any obligation assumed by the Surviving Corporation,  provided
that, other than for a breach of Section 7.10, the Flents  stockholders shall be
deemed  to  have  suffered  no  indemnifiable  damages  so  long  as the  Flents
stockholders  receive shares of Merger Stock with a value greater than $6.00 per
share one (1) year from the date hereof.

     10.4.     Assumed Liabilities.  Surviving Corp. shall assume
on the Closing Date and, effective as of the Closing and
contingent upon the occurrence of the Closing, shall discharge in
accordance with its terms (subject to any defenses or claimed
offsets asserted in good faith against the obligee to whom such
liabilities, payments and obligations are owed), subject to any
contrary provision herein, the liabilities, set forth in this
Section 10.4:

          (a) the  accrued  liabilities  of Flents to the  extent of the  amount
thereof  correctly  stated  on  the  balance  sheet  included  in  the  February
Printouts, to the extent not paid, performed,  satisfied, discharged or released
prior to the Effective Time;

          (b)  liabilities of Flents  incurred on or prior to the Effective Time
and  subsequent to the date of the February  Printouts  incurred in the ordinary
course of business in arms-length  transactions  with unrelated  parties if such
liabilities  are  consistent  with past  practices  of Flents and not  expressly
prohibited hereunder, to the extent not paid, performed,  satisfied,  discharged
or released prior to the Effective Time;

          (c)  the continuing obligations arising or continuing
subsequent to the Effective Time under the contracts:

          (i)  listed on Schedule 2.3(ii) hereto; or

          (ii) entered into or made by Flents in the ordinary course of business
     consistent with past practices of Flents on commercially  reasonable  terms
     and which,  pursuant to Section 5.15 hereof,  are not material enough to be
     listed on Schedule 2.3(ii) hereto or shall have been entered into after the
     date hereof in accordance with Section 7.2;

          (d)  liabilities  of Flents  resulting  from  facts and  circumstances
occurring and arising after the Effective Time.

     10.5.     Notice and Right to Defend Third Party Claims and
Perform Remediation.

          (a) Promptly  upon receipt of notice of any third party claim,  demand
or assessment or the  commencement of any suit,  action or proceeding in respect
of which indemnity may be sought on account of an indemnity  agreement contained
in this Section 10, the party seeking  indemnification  (the "Indemnitee") shall
notify in writing,  within sufficient time to respond to such claim or answer or
otherwise plead in such action,  the party from whom  indemnification  is sought
(the "Indemnitor") thereof;  provided,  however, that failure or delay to supply
such  notice  shall not relieve  Indemnitor  of its  indemnification  obligation
hereunder  except to the extent that  Indemnitor is actually  prejudiced by such
failure or delay.

          (b) In case any  claim,  demand or  assessment  is  asserted  or suit,
action or proceeding  commenced  against an Indemnitee  (collectively a "Claim")
and it notifies the Indemnitor of the  commencement  thereof,  if the Indemnitor
acknowledges  its  indemnification  obligations  therefor  hereunder,  then, the
Indemnitor shall be entitled to participate therein,  and, to the extent that it
may wish,  to assume the defense,  conduct or settlement  thereof,  with counsel
satisfactory  to the Indemnitee  whose consent to the selection of counsel shall
not unreasonably be withheld. After notice from the Indemnitor to the Indemnitee
of its election so to assume the defense,  conduct or  settlement  thereof,  the
Indemnitor shall not be liable to the Indemnitee for any legal or other expenses
subsequently incurred by the Indemnitee in connection with the defense,  conduct
or  settlement  thereof;  provided,  however,  that  if the  Indemnitee  has any
separate  defense from those of the  Indemnitor,  the Indemnitee  shall have the
right to be  represented  by its own counsel at the  Indemnitor's  expense.  The
Indemnitee  shall have the right in any event to participate in any such defense
with its own counsel at its own expense.  The Indemnitee will cooperate with the
Indemnitor  in  connection  with any such  Claim and make  personnel,  books and
records  relevant  to the Claim  available  to the  Indemnitor  at  Indemnitor's
expense.  In the event that the  Indemnitor  fails timely to defend,  contest or
otherwise protect against any such Claim, the Indemnitee shall have the right to
defend,  contest  or  otherwise  protect  against  the  same  and may  make  any
compromise  or  settlement  thereof and recover the entire cost thereof from the
Indemnitor,   including,   without  limitation,   reasonable   attorneys'  fees,
disbursements  and all amounts paid as a result of such Claim or  compromise  or
settlement thereof.

          (c) Anything in this Agreement to the contrary notwithstanding,  prior
to finally  settling any such Claim, the Indemnitor shall give to the Indemnitee
prompt  notice of its  intention  to settle same and the terms of such  proposed
settlement  and  acknowledging  its  indemnification   responsibility   therefor
hereunder.  If the Indemnitee shall object to such proposed settlement within 10
days,  then the Indemnitee  shall  thereafter,  at its sole expense,  assume the
control and defense of such claim suit, action,  investigation or proceeding and
in such event the liability of the Indemnitor shall be limited to the amount for
which the same could have been  settled as  proposed by the  Indemnitor.  If the
Indemnitee  does not object to the terms of the proposed  settlement  within the
aforesaid 10-day period,  then the Indemnitor shall have the right to consummate
such proposed  settlement upon the terms set forth in the aforesaid  notice.  If
Indemnitor  acknowledges in writing its obligation to indemnify  Indemnitee with
respect  to a Claim,  then  Indemnitee  shall  not  settle  such  Claim  without
Indemnitor's prior written consent.

     10.6.  Payment of Amounts  Due.  The  amount of any  indemnifiable  damages
conceded or  determined to be due from Flents to Merger Sub not in excess of the
amount in the escrow account described below,  pursuant to any of the provisions
of this  Section  10,  shall be paid from the  escrow to  Merger  Sub  within 20
business  days  from the date so  conceded  or  determined.  The  amount  of any
indemnifiable damages conceded or determined to be due from PTI or Merger Sub to
Flents,  pursuant to any of the  provisions of this Section 10, shall be paid to
the Exchange Agent by Merger Sub or PTI within 20 business days from the date so
conceded or determined.  The Flents stockholders shall not be required to pay to
Merger Sub or PTI under this Section 10.6, other than for fraud or wilful breach
any  amounts,  except as  specifically  provided  in this  Section 10. The final
40,000 shares of Merger Stock shall be held in escrow  jointly by Lester Migdal,
Esq. and Robert Low,  Esq.,  or the survivor,  as escrow agent,  pursuant to the
Escrow  Agreement in the form attached  hereto,  to satisfy  obligations  of the
Flents  stockholders  under the  indemnification  provisions  of this Section 10
until February 28, 1999 and thereafter, if a claim is brought under this Section
10 during the period  through  February 28, 1999, in which case the Escrow Agent
shall retain an amount  necessary  to satisfy such claim until final  resolution
thereof.  In satisfaction  of claims of Merger Sub and PTI, the Units,  prior to
the date payment has been set on the  Convertible  Value Rights included in such
Units on the first  anniversary  of the Closing Date,  shall have a value of the
greater  of $10.00 or the  Market  Value of PTI  shares  based  upon the  median
closing sale price of PTI shares on the 20 trading days  preceding  the delivery
of the shares by the Exchange Agent in satisfaction of the claim.

     10.7  Basket  for  Claims.  PTI and  Merger  Sub  shall  have no  right  to
indemnification  until  their  aggregate  claims  under  this  Section 10 exceed
$25,000,  and then may only  claim for  indemnification  of amounts in excess of
such  $25,000;  provided,  however,  that this  Section  10.7 shall not apply to
claims  based on knowing  misrepresentations  or to claims under  Sections  5.3,
5.4(d),  5.7 (except as relate to amounts disputed by the Customer) and 5.10 and
to a breach of Sections 7.2(h), (m) or (n) or 14.


     Section 11.  Termination and Liquidated  Damages.  Promptly after any party
becomes aware that any of the conditions  precedent to such party's  Closing has
not been, and is likely not to be,  fulfilled,  such party (the "Delayed Party")
shall notify the other party (the  "Delaying  Party"),  and the  Delaying  Party
shall have the right by written  notice to the Delayed Party to adjourn the date
for Closing, for up to 30 business days, to satisfy such condition precedent. If
all such  conditions to the Delayed Party's  obligations are not satisfied,  the
Delayed Party may either (i) waive any such condition and proceed to Closing, in
which case the Delayed Party shall be entitled to a credit or debit, as the case
may be, to the Cash  Consideration  equal to the  reasonable  estimated  cost to
satisfy such condition  (other than the failure of the  conditions  contained in
Sections  8.4, 8.5 and 9.4 herein by action of third  parties),  but without any
other  liability  on the part of the  Delaying  Party,  or (ii)  terminate  this
Agreement,  in which case (other than the failure of the conditions contained in
Sections  8.4, 8.5 and 9.4 herein by action of third  parties) the Delayed Party
shall  be  reimbursed  by the  Delaying  Party  for the  Delayed  Party's  costs
reasonably  incurred in connection with the  investigation  of the Delayed Party
and the consummation of the transaction  contemplated by this Agreement, and the
parties hereto shall have no further liability or obligation hereunder.

     Section 12. Further Actions.  From time to time,  prior to the Closing,  as
and when requested by Merger Sub, on reasonable notice, Flents shall execute and
deliver  such  documents  and  instruments  and shall take such further or other
actions as Merger Sub may reasonably  deem necessary to carry out the intent and
purposes of this Agreement,  to convey,  transfer,  assign and deliver to Merger
Sub, and its  successors and assigns,  the Flents Shares,  and to vest in Flents
all right,  title and interest in and to Acquired Assets free and clear of Liens
except as described in Schedule 5.5 (or to evidence any of the foregoing) and to
consummate and give effect to the other transactions contemplated hereby. If, as
a result of a request  of Merger  Sub under  this  Section  12 for  delivery  of
documents or the transfer of Flents' shares prior to Closing,  taxes of any kind
are imposed on Flents or its  stockholders  that would not have been imposed had
they been  delivered at the  Closing,  then,  at the  Closing,  Merger Sub shall
reimburse Flents or its stockholders the amount of such tax.

     Section 13.  Broker's Fees.  Each of Flents,  PTI and Merger Sub represents
that it has not used or  retained  any broker or finder in  connection  with the
transactions  contemplated  hereby,  other than the Woodbridge Group,  Inc., the
fees of which shall be paid by Merger Sub.

     Section 14. Expenses. Except as otherwise specifically provided herein, the
stockholders  of Flents  and  Merger Sub shall each bear their and its own legal
fees and other costs and expenses with respect to the negotiation, execution and
the  delivery  of  this  Agreement  and  the  consummation  of the  transactions
hereunder,  and the  Acquired  Assets  shall not be reduced or  impaired  by the
payment or accrual of any such costs and expenses of Flents; provided,  however,
Flents shall pay for transaction  expenses with regard to the Merger,  including
legal and  accounting  fees up to an amount of $50,000 plus up to $7,000 accrued
as an expense on the balance sheet included in the February  Printouts,  without
adjustment,  and amounts, if any, in excess of $50,000 plus such unpaid accruals
on the balance sheet included in the February  Printouts  shall be adjusted by a
reduction, dollar for dollar, in the cash portion of the Merger Consideration.

     Section 15. Entire Agreement. This Agreement,  which includes the Schedules
and Exhibits hereto and the other documents, agreements and instruments executed
and delivered  pursuant to or in connection  with this  Agreement,  contains the
entire  agreement  among  Flents,  Merger  Sub  and  PTI  with  respect  to  the
transactions   contemplated   by  this   Agreement  and   supersedes  all  prior
arrangements or understandings with respect thereto, whether written or oral.

     Section 16.  Construction.

          (a) The  descriptive  headings of this  Agreement are for  convenience
only and  shall not  control  or  affect  the  meaning  or  construction  of any
provision of this Agreement.

          (b) Except as otherwise  expressly  set forth in this  Agreement,  any
representation or warranty made to the knowledge of any parties hereto, or as to
what any such party is aware of, or  statements of similar  purport,  shall mean
that such party has made a reasonable and diligent investigation of the facts in
connection  therewith and is making such  representation  or warranty based upon
the results of such investigation.

          (c) Each of the parties to this Agreement participated in the drafting
of this  Agreement and the  interpretation  of any  ambiguity  contained in this
Agreement will not be affected by the claim that a particular  party drafted any
provision hereof.

          (d) Any pronoun  herein shall include all genders and/or the plural or
singular as appropriate from the context.

     Section 17. Notices. All notices or other communications which are required
or  permitted  hereunder  shall be in  writing  and  sufficient  when  delivered
personally  or  telecopied  by  facsimile  and  confirmed  orally  or by  return
facsimile, or three (3) business days after mailing with an affidavit of mailing
produced upon request, or the next business day if sent by nationally recognized
overnight courier providing for a return receipt,  in each case postage prepaid,
addressed as follows:

          If to PTI or Merger Sub:
          c/o Protective Technologies International, Inc.
          One River Street
          Hastings-on-Hudson, NY 10706
          Attn: Mr. Meredith W. Birrittella
          Facsimile: (914) 478-8298

          with a copy to:
          Akabas & Cohen
          488 Madison Ave.
          New York, New York 10022
          Attn: Seth A. Akabas, Esq.
          Facsimile: (212) 308-8582

          If to Flents:
          Flents Products Co., Inc.
          258 Dr. Martin Luther King Drive
          Norwalk, CT 06954
          Attn: Mr. Stuart M. Low
          Facsimile: (203) 854-9322

          with a copy to:
          Migdal, Pollack, Rosenkrantz & Sherman
          41 East 57th Street
          New York, NY 10022
          Attn: Lester C. Migdal, Esq.
          Facsimile: (212) 759-5422

          If to the Exchange Agent or the Flents stockholders:
          Migdal, Pollack, Rosenkrantz & Sherman
          41 East 57th Street
          New York, NY 10022
          Attn: Lester C. Migdal, Esq.
          Facsimile: (212) 759-5422

Any  party  may  by  notice   change  the  address  to  which  notice  or  other
communications  to it are to be delivered or mailed,  effective 10 business days
after receipt.

     Section  18.  Governing  Law.  This  Agreement  shall  be  governed  by and
construed in  accordance  with the laws of the State of New York  applicable  to
contracts  entered  into,  executed  and to be  performed  wholly in such state,
except for its conflict of laws provisions.

     Section 19. Assignability. This Agreement shall not be assignable otherwise
than by operation of law by any party hereto  without the prior written  consent
of the other parties,  and any purported  assignment  without such prior written
consent  shall be void,  except that Merger Sub may assign this  Agreement  to a
corporation controlling, controlled by or under common control with Merger Sub.

     Section 20. Waivers and Amendments.  Any waiver of any term or condition of
this Agreement, or any amendment or supplementation of this Agreement,  shall be
effective  only if in writing  executed by the party  against  whom such waiver,
amendment or  supplementation is sought to be charged. A waiver of any breach or
failure to enforce any of the terms or conditions of this Agreement shall not in
any way affect, limit or waive a party's rights hereunder at any time to enforce
strict compliance thereafter with every term or condition of this Agreement.

     Section 21. Third Party Rights.  Any other  provision of this  Agreement to
the contrary  notwithstanding,  this Agreement shall not create benefits for any
third party,  including,  without limitation,  any employees of Flents or Merger
Sub, provided, however, that Merger Sub shall assume all Assumed Liabilities (as
defined in Section  10.4),  including the  obligations  to Low,  Davies and Dunn
disclosed or created in this Agreement.

     Section 22. Illegalities. In the event that any provision contained in this
Agreement  shall be determined to be invalid,  illegal or  unenforceable  in any
respect for any reason,  the validity,  legality and  enforceability of any such
provision in every other respect and the remaining  provisions of this Agreement
shall not, at the election of the party for whose benefit the provision  exists,
be in any way impaired.

     Section 23.  Counterparts.  This Agreement may be executed
in multiple counterparts all of which taken together shall
constitute one and the same instrument.

     Section 24.  Severability.  Any term or provision of this Agreement that is
invalid or unenforceable  in any situation in any jurisdiction  shall not affect
the validity or  enforceability  of the remaining terms and provisions hereof or
the validity or  enforceability of the offending terms or provision in any other
situation or in any other jurisdiction.

     Section  25.  Press  Release  and  Public  Announcement.  No  party to this
Agreement  shall issue any press release or public  statement or make any public
announcement  relating to the subject matter of this Agreement without the prior
written  approval of the other parties;  provided,  however.  that any party may
make any public  disclosures it believes in good faith is required by applicable
law  or  any  listing  or  trading  agreement   concerning  its  publicly-traded
securities in which case the disclosing  party shall use its reasonable  efforts
to advise the other party at least three days prior to making the disclosure.

     Section 26. Arbitration. Any controversy, dispute or claim arising under or
relating to the provisions of this Agreement,  or the breach  thereof,  shall be
determined  by  arbitration  in New  York,  New  York  in  accordance  with  the
Commercial  Arbitration Rules of the American  Arbitration  Association  ("AAA")
then in effect,  except  that the  arbitrator  shall be required to set forth in
reasonable  detail  the basis  for his  determination  as well as the  method of
calculating  any  monetary  award.  However,  where the parties  hereto agree on
alternate dispute resolution  proceedings,  utilization of the facilities of the
AAA shall  not be  required.  The  decision  and  award in any such  arbitration
proceeding  shall be binding and final on the  parties,  and  judgment  upon the
award  rendered by the  arbitrator(s)  may be entered in any court of  competent
jurisdiction.
           [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

<PAGE>


     IN WITNESS  WHEREOF,  each of the undersigned  corporations has caused this
Agreement to be executed by its duly authorized officer, and each individual has
signed this Agreement, as of the date first above written.

FLENTS PRODUCTS CO., INC.          PTI HOLDING INC.
(a New York corporation)


By: /s/ W. Thomas Davies           By:/s/ Meredith W. Birrittella
Name: W. Thomas Davies             Name: Meredith W. Birrittella
Title: President                   Title: Chief Executive Officer


FLENTS PRODUCTS CO., INC.
(a Delaware corporation)



By: /s/ Meredith W. Birrittella
Name: Meredith W. Birrittella
Title: Secretary

Agreed as to Sections 7.5, 7.9 and 8.4:


 /s/ W. Thomas Davies
W. THOMAS DAVIES




 /s/ James Dunn
JAMES DUNN




 /s/ Stuart M. Low
STUART M. LOW

Agreed to as to Sections 2.2:


MIGDAL, POLLACK, ROSENKRANTZ & SHERMAN, as Exchange Agent


By: /s/ Lester C. Migdal
Name: Lester C. Migdal
Title: Partner

<PAGE>


         LIST OF EXHIBITS, SCHEDULES AND OTHER DOCUMENTS

Exhibits

A:   Certificates of Merger
B:   Affidavit of Loss
C1:  Noncompete Agreement Form w/ S. Low
C2:  Noncompete Agreement Form w/ W.T. Davies and J. Dunn
D:   Consulting Agreement Form
E1:  Employment Agreement Form w/ W.T. Davies
E2:  Employment Agreement Form w/ J. Dunn
F:   Convertible Value and Registration Rights Agreement Form


Schedules

2.3(i):   tangible personal property
   (ii):  contracts, agreements, etc.
5.1:      foreign jurisdictions
5.1(e):   bank accounts
5.2(b)(iii):   acceleration of debt
5.3:      capitalization/shareholders
5.4(b):   financial statements
5.4(d):   additional liabilities
5.4(e):   material adverse changes since 11/30/96
5.5(b):   business restrictions
5.6:      inventory
5.8(a):   list of insurance policies
5.8(c):   pending and threatened casualty or liability claims
5.8(d):   insurance claims
5.9(a):   claims, lawsuits, proceedings
5.9(d)    government permits
5.10(a):  taxes
5.11(a):  intangible assets
5.11(a)(1):    royalties and limits of intellectual property
rights
5.12:     employees, compensation and status
5.13:     employee benefit plans
5.15(b):  contract renegotiation
5.16(b):  lists of customers
5.17:     changes since 11/30/96
6.4:      changes since PTI Reports
6.6:      environmental investigations


Closing Documents

Flents' long-form good standing certificate Flents' certificate as to compliance
with closing conditions Flents' secretary's  certificate as to charter,  Bylaws,
Board resolutions and shareholder resolutions

PTI's  long-form good standing  certificate  PTI's  certificate as to compliance
with closing conditions PTI's secretary's certificate as to charter, Bylaws, and
Board resolutions Merger Sub's long-form good standing  certificate Merger Sub's
certificate as to compliance with closing  conditions  Merger Sub's  secretary's
certificate as to charter, Bylaws, and Board resolutions

<PAGE>


                            EXHIBIT 2

            AMENDMENT TO AGREEMENT AND PLAN OF MERGER


     THIS AMENDMENT,  dated as of the date of Closing,  by and among the parties
to the AGREEMENT AND PLAN OF MERGER (the "Agreement"), dated as of July 25, 1997
and the stockholders of Flents,


                      W I T N E S S E T H :


     WHEREAS,  PTI Holding Inc.  ("PTI"),  Flents Products Co., Inc., a Delaware
corporation   ("Merger  Sub"),  and  Flents  Products  Co.,  Inc.,  a  New  York
corporation ("Flents") have entered into the Agreement; and

     WHEREAS,  Flents paid $75,000 of legal and accounting expenses in excess of
the  $50,000 of such  expenses  stated in Section  7.2(h) of the  Agreement,  in
connection with the sale of the business,  and the parties hereto wish to adjust
the Cash Consideration accordingly,

     NOW,  THEREFORE,  in consideration of the premises and the mutual covenants
herein contained,  PTI, Merger Sub, Flents and the stockholders of Flents hereby
agree as follows:

     This Amendment modifies the Agreement as set forth herein. Each capitalized
term used and not defined  herein  shall have the meaning  ascribed to it in the
Agreement.

     The date of the Merger for financial accounting and for income tax purposes
shall be deemed to be May 31, 1997.

     The second clause of the preamble to the  Agreement,  is modified to change
the Merger  Consideration to consist of $4,837,085 and the Cash Consideration to
consist of $2,135,435.

     The amount stated in Section 7(h) of the  agreement,  previously  stated as
$50,000, is modified to read $125,000.

      Except as amended hereby, the Agreement remains unmodified, unamended, and
in full force and effect.

     This Agreement may be executed in multiple  counterparts all of which taken
together shall constitute one and the same instrument.



<PAGE>


     IN WITNESS  WHEREOF,  each of the undersigned  corporations has caused this
Agreement to be executed by its duly authorized officer, and each individual has
signed this Agreement, as of the date first above written.

FLENTS PRODUCTS CO., INC.          PTI HOLDING INC.
(a New York corporation)


By:   /s/ W. Thomas Davies                     By:   /s/ Meredith W. Birrittella
       W. Thomas Davies                        Meredith W. Birrittella
       President                               Chief Executive Officer


FLENTS PRODUCTS CO., INC.
(a Delaware corporation)


By:  /s/ Meredith W. Birrittella
       Meredith W. Birrittella
       Secretary


   /s/ W. Thomas Davies                  /s/ James E. Dunn
W. THOMAS DAVIES                         JAMES E. DUNN



 /s/ Stuart M. Low                            /s/ Robert A. Low
STUART M. LOW                                  ROBERT A. LOW



 /s/ Doris L. Hirsch                          /s/ Lester C. Migdal
DORIS L. HIRSCH                             LESTER C. MIGDAL


 /s/ Peter C. Kohn                             /s/ Mary Lou Secchi
PETER C. KOHN                                     MARY LOU SECCHI

<PAGE>


                            EXHIBIT 3

                      CERTIFICATE OF MERGER
      OF FLENTS PRODUCTS CO., INC., A NEW YORK CORPORATION,
      INTO FLENTS PRODUCTS CO., INC., A DELAWARE CORPORATION


The undersigned corporations do hereby certify in accordance with Section 252 of
the General Corporation Law of the State of Delaware (the "Law"):

     FIRST:  The  names of the  constituent  corporations  and  their  states of
incorporation are as follows:
     FLENTS PRODUCTS CO., INC., a New York corporation ("Flents")

     FLENTS PRODUCTS CO., INC., a Delaware corporation ("New Flents")

     SECOND: The proposed merger has been approved, adopted, certified, executed
and  acknowledged by Flents in accordance with the laws of the State of New York
and by New Flents in accordance with Section 252 of the Law.

     THIRD: The name of the surviving  corporation is Flents Products Co., Inc.,
a Delaware corporation.

     FOURTH:  The  Certificate  of  Incorporation  of New  Flents  shall  be the
Certificate of Incorporation of the surviving  entity.  No changes shall be made
to the  certificate  of  incorporation  of the  surviving  corporation  upon the
effective date of the merger.

     FIFTH:  A copy of the  Agreement and Plan of Merger (the "Plan") is on file
at the  principal  place of business of New Flents is 258 Dr. Martin Luther King
Drive,  Norwalk,  CT 06854. A copy of the Plan shall be furnished by New Flents,
upon request and at no cost, to any stockholder of either Flents or New Flents.

     SIXTH:    The authorized capital stock of Flents is as follows:

                                   Number                        Voting
     Class          Designation    Authorized     Outstanding   Par Value Rights
     Common    N/A       125,000   77,756               $.02      Full




<PAGE>


     SEVENTH:  This Certificate of Merger shall be effective on its filing date.

DATED: August 5, 1997

ATTEST:                       FLENTS PRODUCTS CO., INC., a
                              New York corporation



By:  /s/ Mary Lou Secchi                By:     /s/ W. Thomas Davies
     Mary Lou Secchi                             W. Thomas Davies
     Secretary                                   President


ATTEST:                       FLENTS PRODUCTS CO., INC., a
                              Delaware corporation




By:   /s/ Meredith W. Birrittella                 By:   /s/ W. Thomas Davies
     Meredith W. Birrittella                             W. Thomas Davies
     Secretary                                           President

<PAGE>


                      CERTIFICATE OF MERGER

                                OF

                    FLENTS PRODUCTS CO., INC.
                     (a New York corporation)

                               INTO

                    FLENTS PRODUCTS CO., INC.
                     (a Delaware corporation)


          UNDER SECTION 907 OF THE BUSINESS CORPORATION
             LAW OF THE STATE OF NEW YORK (the "BCL")

The undersigned,  W. Thomas Davies and Mary Lou Secchi,  being the President and
the  Secretary,   respectively,   of  Flents  Products  Co.,  Inc.,  a  domestic
corporation  duly  organized and existing under and by virtue of the laws of the
State of New York ("Flents"),  and W. Thomas Davies and Meredith W. Birrittella,
being the President and the  Secretary,  respectively,  of Flents  Products Co.,
Inc., a foreign  corporation  duly organized and existing under and by virtue of
the laws of the State of  Delaware  ("New  Flents"),  do hereby  certify and set
forth that an Agreement  and Plan of Merger (the "Plan") has been adopted by the
board of directors of each of said constituent corporation, and that:

     (1) The name of each constituent corporation is as follows:

Flents Products Co., Inc., a New York corporation

Flents Products Co., Inc., a Delaware corporation

     (2) The jurisdiction  and date of incorporation of the foreign  constituent
corporation, New Flents, is set forth below:

     Jurisdiction        Date of Incorporation
     Delaware              July 16, 1997

     (3) The name of the surviving  corporation is Flents  Products Co., Inc., a
Delaware corporation

     (4) The designation, number, and voting rights of the outstanding shares of
each class and series of Flents are as follows:

 Class    Designation    Number Authorized   Outstanding         Voting Rights
 Common    N/A           125,000             77,756              Full


     The  designation,  number,  and voting rights of the outstanding  shares of
each class and series of New Flents are as follows:

Class    Designation    Number Authorized   Outstanding         Voting Rights
Common    N/A           200                 100                 Full

     (5) The  effective  date of the merger of Flents  and New  Flents  into New
Flents shall be upon the filing of this Certificate by the Department of State.

     (6) The manner in which the Plan was authorized by each of the  constituent
corporations is set forth below:

     With respect to the constituent domestic corporation,  Flents, the Plan was
unanimously approved and adopted by the Board of Directors on July 15, 1997, and
authorized and approved in a meeting of the holders of the outstanding shares of
such corporation on July 15, 1997 in accordance with the applicable  statutes of
the State of New York. With respect to the constituent foreign corporation,  New
Flents, the Plan was unanimously  approved and adopted by the Board of Directors
on July 16, 1997, and authorized and approved by the unanimous  written  consent
of the holders of the outstanding  shares of such  corporation on July 16, 1997,
in accordance with the applicable  statues of its jurisdiction of incorporation.
The  merger  of Flents  with and into New  Flents  is  permitted  by the laws of
Delaware and is in compliance therewith.

     (7) The date when the certificate of  incorporation of New Flents was filed
by the Department of State of Delaware was the 16th day of July, 1997.

     An application of authority to do business in the State of New York has not
been filed by New  Flents.  New Flents  shall do no business in the state of New
York until such an application of authority has been filed.

     (8) The date when the original  certificate of  incorporation of Flents was
filed by the Department of State of New York was the 4th day of November, 1935.

     (9) New Flents may be served  with  process in the State of New York in any
action or special  proceeding for the enforcement of any liability or obligation
of any domestic corporation or of any foreign  corporation,  previously amenable
to suit in the State of New York,  which is a  constituent  corporation  in this
merger.

     (10) Subject to the  provisions of Section 623 of the BCL, New Flents shall
promptly pay to the  shareholders  of the constituent  domestic  corporation the
amount,  if any, to which they shall be entitled under the provisions of the BCL
relating to the rights of shareholders to receive payment for their shares.

     (11) The secretary of state is hereby designated as agent upon whom process
against Flents Products Co., Inc., a Delaware corporation,  may be served in the
manner set forth in  paragraph  (b) of Section  306 of the BCL, in any action or
special  proceeding.  The  secretary  of state  shall mail a copy of any process
against  Flents  Products  Co.,  Inc., a Delaware  corporation,  served upon the
secretary of state to Flents Products Co., Inc., c/o Akabas & Cohen, 488 Madison
Avenue, New York, NY 10022.

     IN  WITNESS  WHEREOF,   the  undersigned  have  executed  and  signed  this
certificate, under penalties of perjury, as of this 5th day of August, 1997.


FLENTS PRODUCTS CO., INC.,                   FLENTS PRODUCTS CO., INC.,
a New York corporation                            a Delaware corporation


By:    /s/ W. Thomas Davies                  By:    /s/ W. Thomas Davies
      W. Thomas Davies, President                    W. Thomas Davies, President



By:     /s/ Mary Lou Secchi                By:     /s/ Meredith W. Birrittella
      Mary Lou Secchi, Secretary              Meredith W. Birrittella, Secretary

<PAGE>


                            EXHIBIT 4

                     NONCOMPETITION AGREEMENT

     AGREEMENT  dated as of  August 5,  1997,  by and  among  Stuart M. Low,  an
individual, having an address at 29 Grove Hill Road, Guilford, CT 06437 ("Low"),
PTI Holding  Inc., a Delaware  corporation,  having an office at c/o  Protective
Technologies International Inc., One River Street, Hastings-on-Hudson,  NY 10706
("PTI"),  and Flents Products Co., Inc., a Delaware corporation having an office
at 258 Dr. Martin Luther King Drive,  Norwalk, CT 06854 (the "Company") (PTI and
the Company,  together  with other  corporate  affiliates,  shall be referred to
herein as the "PTI Companies").

                      W I T N E S S E T H :

     WHEREAS,  PTI,  the  Company  and Flents  Products  Co.,  Inc.,  a New York
corporation,  ("Old  Flents")  have entered into a Agreement  and Plan of Merger
dated as of July 25,1997, (the "Merger Agreement") pursuant to which the Company
shall acquire from the  shareholders of Old Flents all of the outstanding  stock
of Old Flents in exchange for cash and common stock of PTI and the Company shall
assume the operations of Old Flents, as described in the Merger Agreement; and

     WHEREAS,  pursuant to the Merger Agreement, the Company shall retain Low as
a consultant to the Company; and

     WHEREAS, in order to preserve for the Company the goodwill of Old Flents to
be acquired by the Company pursuant to the Merger Agreement,  and Low has agreed
not to compete with the Company, as described more fully herein,

     NOW,  THEREFORE,  in consideration of the premises and the mutual covenants
herein contained, the adequacy and sufficiency of which are hereby acknowledged,
the parties hereto agree hereby as follows:

     Section 1.  Restrictions.  (a) The parties hereto confirm that Low is aware
of  important  business  information  (i) relating to the  products,  processes,
designs  and/or  systems used by Old Flents and (ii)  relating to the  customers
(including, without limitation,  customer lists, call lists, prices and all data
about  customers)  and  employees,  consultants,   independent  contractors  and
suppliers of Old Flents,  which together  constitutes the substantial portion of
the goodwill of Old Flents  acquired by the Company under the Merger  Agreement.
The parties  hereto further  confirm that it is reasonably  necessary to protect
and maintain Flents' goodwill, which the Company acquired pursuant to the Merger
Agreement,  and to prevent  the  usurpation  by Low (or any Person  (hereinafter
defined)  employing Low at a later date) of all or any portion of such goodwill,
which was purchased by the Company,  that Low agrees,  and  accordingly  he does
agree,  that he will not directly or indirectly,  for or on behalf of himself or
any Person (hereinafter defined) at any time for a period of five years from the
date hereof:

     (i) employ or  otherwise  obtain  services  from,  or solicit or  otherwise
     attempt to employ or otherwise  obtain  services from, or assist any Person
     in employing or otherwise  obtaining  services from or attempting to employ
     or otherwise  obtain  services from, any person who is then, or at any time
     during the  preceding  twelve  months shall have been,  in the employ of or
     otherwise retained by Old Flents; or

     (ii)  solicit any  individual  who was a customer of Old Flents at any time
     during  the two years  prior to the date  hereof to supply  any  product or
     service  that was  supplied  by Old  Flents  or shall  hereafter  have been
     supplied by the PTI Companies, or to reduce, or cease to receive, the level
     of products or services  that such  customer  had been  receiving  from Old
     Flents  or that  such  customer  shall  have  been  receiving  from the PTI
     Companies; or

     (iii)  open or  operate  any  business  or assist in any way,  directly  or
     indirectly (as consultant, broker, officer, director, employee, independent
     contractor, financier, investor, or otherwise), any other Person in opening
     or  operating  any business  that  provides any product or service that was
     supplied by Old Flents at any time prior to the date hereof; or

     (iv) at any time negotiate for or enter into an agreement, understanding or
     arrangement, or otherwise cause or authorize any Person, to take any of the
     actions prohibited by clauses (i) through (iii) above.

As used  herein,  the term  "Person"  means  any  person,  corporation,  limited
liability company, partnership or other entity.

          (b) Low  acknowledges  that he has been informed that it is the policy
of the PTI Companies to maintain as secret and  confidential all information (i)
relating to the products, pro-

cesses,  designs  and/or  systems used by the PTI Companies and (ii) relating to
the customers (including, without limitation, customer lists, call lists, prices
and  all  data  about   customers)  and  employees,   consultants,   independent
contractors and suppliers of the PTI Companies (all such  information  hereafter
referred to as "Confidential  Information").  Low further acknowledges that such
Confidential  Information has been acquired  pursuant to the Merger Agreement or
assembled by the PTI Companies at great cost to the PTI  Companies,  through the
expenditure  of extensive  resources of the PTI Companies over a long period and
is of great value to the PTI Companies.  The parties  hereto  recognize that the
services to be  performed by Low under a  consulting  agreement  dated as of the
date hereof,  are special and unique,  and that by reason of his  involvement in
Old Flents and his  rendering  services  to the PTI  Companies,  he has and will
acquire Confidential  Information as aforesaid.  The parties hereto confirm that
it is  reasonably  necessary  to protect the PTI  Companies'  goodwill  that Low
agrees,  and accordingly he does agree, that he will not, directly or indirectly
(except  where  authorized  by  either  of the  Board  of  Directors  of the PTI
Companies, for the benefit of either of the PTI Companies),  for or on behalf of
Low or any Person,  at any time:  (i)  divulge to any Person  other than the PTI
Companies  (hereinafter  referred to collectively as a "third party"), or use or
cause to authorize any third parties to use, any such Confidential  Information,
or any other  information  regarded  as  confidential  and  valuable  by the PTI
Companies that he knows or should know is regarded as confidential  and valuable
by the  PTI  Companies  (whether  or not  any of the  foregoing  information  is
actually  novel or unique or is actually  known to others and whether or not the
Confidential  Information  is  labeled  as  confidential  or  secret);  or  (ii)
negotiate for or enter into any arrangement, contract or commitment to do any of
the foregoing prohibited acts.

     Section  2.  Injunctive   Relief.  Low  acknowledges  that  any  breach  or
threatened breach by him of any provision of this Agreement will, because of the
unique nature of the  transaction  which will take place  pursuant to the Merger
Agreement,  cause  irreparable  harm  to the PTI  Companies  and  leave  the PTI
Companies  without  any  adequate  remedy  at law  and  shall  entitle  the  PTI
Companies,  in  addition  to any  other  legal  remedies  available  to the  PTI
Companies,  including  offset  for  damages  of any  amounts  owing from the PTI
Companies to Low, to apply to any court of competent jurisdiction to enjoin such
breach or threatened  breach without the need to specifically  prove irreparable
harm or the inadequacy of legal remedies.

     Section 3.  Acknowledgement  of  Reasonableness.  Low and the PTI Companies
each  acknowledges  that the type and periods of restriction  imposed herein are
fair and reasonable  and are  reasonably  required for the protection of the PTI
Companies  and the goodwill  associated  with the business of Old Flents and are
given  as an  integral  part  of the  acquisition  by the PTI  Companies  of the
business and goodwill of Old Flents.

     Section 4. Severability. The parties hereto understand and intend that: (a)
each  restriction  agreed to by Low hereinabove  shall be construed as separable
and divisible from every other restriction;  (b) the unenforceability,  in whole
or in part, of any such restriction in any one or more jurisdictions,  shall not
affect the enforceability of the remaining  restrictions in such jurisdiction or
jurisdictions or the  enforceability  of any restriction in other  jurisdictions
and this Agreement shall be construed in such jurisdiction in all respects as if
such invalid or  unenforceable  provisions were omitted;  and (c) one or more or
all  of  such  restrictions  may  be  enforced  in  whole  or  in  part  as  the
circumstances warrant.

     Section 5. Entire  Agreement.  This Agreement,  together with the documents
referred to herein and in the Merger  Agreement,  contains the entire  agreement
among  the   parties   hereto  and   supersedes   all  prior   arrangements   or
understandings.

     Section 6. Construction. The descriptive headings of this Agreement are for
convenience  only and shall not control or affect the meaning or construction of
any  provision  of  this  Agreement.  Each  of the  parties  to  this  Agreement
participated  in the drafting of this  Agreement and the  interpretation  of any
ambiguity  contained in this  Agreement will not be affected by the claim that a
particular party drafted any provision hereof.  Any pronoun herein shall include
all genders and/or the plural or singular as appropriate from the context.

     Section 7. Notices.  All notices or other  communications that are required
or permitted  hereunder  shall be in writing and  sufficient  when  delivered in
accordance with the notice provisions under the Merger Agreement.

     Section 8. Governing Law. This Agreement shall be governed by and construed
in  accordance  with the laws of the State of New York  applicable  to contracts
entered into, executed and to be performed wholly in such state.

     Section 9. Assignability.  This Agreement shall not be assignable otherwise
than by operation of law by any party hereto  without the prior written  consent
of the other parties,  and any purported  assignment  without such prior written
consent shall be void,  except that the PTI Companies may assign this  Agreement
to an  affiliate  or an entity  purchasing  all,  or  substantially  all, of its
assets.

     Section 10. Waivers and Amendments.  Any waiver of any term or condition of
this Agreement, or any amendment or supplementation of this Agreement,  shall be
effective  only if in writing  executed by the party  against  whom such waiver,
amendment or  supplementation is sought to be charged. A waiver of any breach or
failure to enforce any of the terms or conditions of this Agreement shall not in
any way affect, limit or waive a party's rights hereunder at any time to enforce
strict compliance thereafter with every term or condition of this Agreement.

     Section 11. Illegalities. In the event that any provision contained in this
Agreement  shall be determined to be invalid,  illegal or  unenforceable  in any
respect for any reason,  the validity,  legality and  enforceability of any such
provision in every other respect and the remaining  provisions of this Agreement
shall not, at the election of the party for whose benefit the provision  exists,
be in any way impaired,  and in lieu of such provision determined to be invalid,
illegal or  unenforceable  a new provision  shall be  automatically  and without
further action of the parties hereto  substituted that is as similar as possible
to such invalid, illegal or unenforceable provision to accomplish the intent and
purpose thereof and still be valid, legal and enforceable. More particularly, if
any  provision  hereof  is  determined  by any  court or other  tribunal  having
jurisdiction  thereof  to be  unenforceable  because  of the  duration  or scope
thereof, then the duration or scope of such provision shall be automatically and
without  further  action of the parties hereto reduced to the extent that in the
judgment  of such  court or other  tribunal  would be  necessary  to  render  it
enforceable.



<PAGE>


     Section  12.  Counterparts.  This  Agreement  may be  executed  in multiple
counterparts  all of which  taken  together  shall  constitute  one and the same
instrument.

     IN WITNESS  WHEREOF,  each of the undersigned  corporations has caused this
Agreement to be executed by its duly  authorized  officer,  and Low has executed
this Agreement as of the date first above written.

PTI HOLDING INC.                        FLENTS PRODUCTS CO., INC., a
                                        Delaware corporation




By:  /s/ Meredith W. Birrittella              By:  /s/ W. Thomas Davies
     Meredith W. Birrittella                     W. Thomas Davies
     Chief Executive Officer                      President





  /s/ Stuart M. Low
STUART M. LOW

<PAGE>


                            EXHIBIT 5


                     NONCOMPETITION AGREEMENT

     AGREEMENT  dated as of August 5, 1997,  by and among W. Thomas  Davies,  an
individual,  having  an  address  at 27  Quaker  Ridge  Road,  Bethel,  CT 06801
("Davies"),  James E. Dunn,  an  individual,  having an address at 88  Hillcrest
Avenue,  Hawthorne,  NJ 07506  ("Dunn"),  (Davies  and Dunn shall be referred to
collectively herein as the "Flents stockholders"),  PTI Holding Inc., a Delaware
corporation, having an address c/o Protective Technologies International,  Inc.,
One River Street, Hastings-on-Hudson, NY 10706 ("PTI"), and Flents Products Co.,
Inc.,  a Delaware  corporation  having an address  c/o  Protective  Technologies
International,  Inc.,  One  River  Street,  Hastings-on-Hudson,  NY  10706  (the
"Company") (PTI and the Company, together with other corporate affiliates, shall
be referred to herein as the "PTI Companies").

                      W I T N E S S E T H :

     WHEREAS,  PTI,  the  Company  and Flents  Products  Co.,  Inc.,  a New York
corporation,  ("Flents")  have entered into a Agreement and Plan of Merger dated
as of July 25,  1997 (the  "Merger  Agreement"),  pursuant  to which the Company
shall acquire from the  shareholders of Flents all of the  outstanding  stock of
Flents in exchange for cash and common stock of PTI and the Company shall assume
the operations of Flents, as described in the Merger Agreement; and

     WHEREAS,  pursuant to the Merger Agreement, the Company shall employ Davies
and Dunn as executives of the Company; and

     WHEREAS,  in order to preserve for the Company the goodwill of Flents to be
acquired  by the  Company  pursuant  to the  Merger  Agreement,  and the  Flents
stockholders  have agreed not to compete  with the Company,  as  described  more
fully herein,

     NOW,  THEREFORE,  in consideration of the premises and the mutual covenants
herein contained, the adequacy and sufficiency of which are hereby acknowledged,
the parties hereto agree hereby as follows:

     Section 1.  Restrictions.  (a) The parties  hereto  confirm that the Flents
stockholders  are each aware of important  business  information (i) relating to
the products, processes, designs and/or systems used by Flents and (ii) relating
to the customers  (including,  without  limitation,  customer lists, call lists,
prices and all data about  customers)  and employees,  consultants,  independent
contractors and suppliers of Flents,  which together constitutes the substantial
portion of the  goodwill  of Flents  acquired  by the  Company  under the Merger
Agreement. The parties hereto further confirm that it is reasonably necessary to
protect and maintain Flent's  goodwill,  which the Company acquired  pursuant to
the  Merger  Agreement,  and to  prevent  the  usurpation  by any of the  Flents
stockholders (or any Person  (hereinafter  defined)  employing any of the Flents
stockholders at a later date) of all or any portion of such goodwill,  which was
purchased by the Company,  that Flents  stockholders each agree, and accordingly
each of the  Flents  stockholders  does  agree,  that he will  not  directly  or
indirectly,  for or on behalf of himself or any Person (hereinafter  defined) at
any time for a period of four year,  in the case of Davies,  and five years,  in
the case of Dunn, from the date hereof:

     (i) employ or  otherwise  obtain  services  from,  or solicit or  otherwise
     attempt to employ or otherwise  obtain  services from, or assist any Person
     in employing or otherwise  obtaining  services from or attempting to employ
     or otherwise  obtain  services from, any person who is then, or at any time
     during the  preceding  twelve  months shall have been,  in the employ of or
     otherwise retained by Flents; or

     (ii) solicit any individual who was a customer of Flents at any time during
     the two years  prior to the date  hereof to supply  any  product or service
     that was supplied by Flents or shall  hereafter  have been  supplied by the
     PTI Companies,  or to reduce, or cease to receive, the level of products or
     services  that such  customer had been  receiving  from Flents or that such
     customer shall have been receiving from the PTI Companies; or

     (iii)  open or  operate  any  business  or assist in any way,  directly  or
     indirectly (as consultant, broker, officer, director, employee, independent
     contractor, financier, investor, or otherwise), any other Person in opening
     or  operating  any business  that  provides any product or service that was
     supplied by Flents at any time prior to the date hereof; or

     (iv) at any time negotiate for or enter into an agreement, understanding or
     arrangement, or otherwise cause or authorize any Person, to take any of the
     actions prohibited by clauses (i) through (iii) above.

As used  herein,  the term  "Person"  means  any  person,  corporation,  limited
liability company, partnership or other entity.

     (b) Each of Flents stockholders acknowledges that he has been informed that
it is the policy of the PTI Companies to maintain as secret and confidential all
information (i) relating to the products, processes, designs and/or systems used
by the PTI  Companies and (ii)  relating to the  customers  (including,  without
limitation, customer lists, call lists, prices and all data about customers) and
employees,  consultants,  independent  contractors  and  suppliers  of  the  PTI
Companies  (all  such  information   hereafter   referred  to  as  "Confidential
Information").  Each of the Flents stockholders  further  acknowledges that such
Confidential  Information has been acquired  pursuant to the Merger Agreement or
assembled by the PTI Companies at great cost to the PTI  Companies,  through the
expenditure  of extensive  resources of the PTI Companies over a long period and
is of great value to the PTI Companies.  The parties  hereto  recognize that the
services to be performed by Davies and Dunn under employment agreements dated as
of the date hereof, and by Low under a consulting agreement dated as of the date
hereof,  are  special  and unique,  and that by reason of their  involvement  in
Flents and their  rendering  services  to the PTI  Companies,  each has and will
acquire Confidential  Information as aforesaid.  The parties hereto confirm that
it is reasonably  necessary to protect the PTI Companies'  goodwill that each of
the Flents  stockholders  agree, and accordingly each of the Flents stockholders
does agree, that he will not, directly or indirectly (except where authorized by
either of the Board of Directors of the PTI Companies, for the benefit of either
of the PTI Companies), for or on behalf of any of the Flents stockholders or any
Person,  at any time:  (i)  divulge to any Person  other than the PTI  Companies
(hereinafter  referred to collectively  as a "third party"),  or use or cause to
authorize any third parties to use, any such  Confidential  Information,  or any
other  information  regarded as confiden-tial  and valuable by the PTI Companies
that he knows or should know is regarded as confidential and valuable by the PTI
Companies (whether or not any of the foregoing  information is actually novel or
unique  or is  actually  known to others  and  whether  or not the  Confidential
Information  is labeled as  confidential  or secret);  or (ii)  negotiate for or
enter into any  arrangement,  contract or  commitment to do any of the foregoing
prohibited acts.

     Section 2. Injunctive Relief. Each of the Flents stockholders  acknowledges
that any breach or threatened  breach by him of any provision of this  Agreement
will,  because of the  unique  nature of the  transaction  which will take place
pursuant to the Merger  Agreement,  cause  irreparable harm to the PTI Companies
and leave the PTI Companies without any adequate remedy at law and shall entitle
the PTI Companies,  in addition to any other legal remedies available to the PTI
Companies,  including  offset  for  damages  of any  amounts  owing from the PTI
Companies to any of the Flents stockholders,  to apply to any court of competent
jurisdiction  to enjoin such  breach or  threatened  breach  without the need to
specifically  prove  irreparable  harm or the inadequacy of legal remedies or to
post a bond in connection therewith.

     Section 3.  Acknowledgement of Reasonableness.  The Flents stockholders and
the PTI Companies  each  acknowledges  that the type and periods of  restriction
imposed  herein are fair and  reasonable  and are  reasonably  required  for the
protection of the PTI Companies and the goodwill associated with the business of
Flents and are given as an integral part of the acquisition by the PTI Companies
of the business and goodwill of Flents.

     Section 4. Severability. The parties hereto understand and intend that: (a)
each restriction agreed to by each of the Flents stockholders  hereinabove shall
be construed as separable and divisible  from every other  restriction;  (b) the
unenforceability,  in whole or in part,  of any such  restriction  in any one or
more  jurisdictions,  shall  not  affect  the  enforceability  of the  remaining
restrictions in such jurisdiction or jurisdictions or the  enforceability of any
restriction in other jurisdictions and this Agreement shall be construed in such
jurisdiction in all respects as if such invalid or unenforceable provisions were
omitted;  and (c) one or more or all of such  restrictions  may be  enforced  in
whole or in part as the circumstances warrant.

     Section 5. Entire  Agreement.  This Agreement,  together with the documents
referred to herein and in the Merger  Agreement,  contains the entire  agreement
among  the   parties   hereto  and   supersedes   all  prior   arrangements   or
understandings.

     Section 6. Construction. The descriptive headings of this Agreement are for
convenience  only and shall not control or affect the meaning or construction of
any  provision  of  this  Agreement.  Each  of the  parties  to  this  Agreement
participated  in the drafting of this  Agreement and the  interpretation  of any
ambiguity  contained in this  Agreement will not be affected by the claim that a
particular party drafted any provision hereof.  Any pronoun herein shall include
all genders and/or the plural or singular as appropriate from the context.

     Section 7. Notices.  All notices or other  communications that are required
or permitted  hereunder  shall be in writing and  sufficient  when  delivered in
accordance with the notice provisions under the Merger Agreement.

     Section 8. Governing Law. This Agreement shall be governed by and construed
in  accordance  with the laws of the State of New York  applicable  to contracts
entered into, executed and to be performed wholly in such state.

     Section 9. Assignability.  This Agreement shall not be assignable otherwise
than by operation of law by any party hereto  without the prior written  consent
of the other parties,  and any purported  assignment  without such prior written
consent shall be void,  except that the PTI Companies may assign this  Agreement
to an  affiliate  or an entity  purchasing  all,  or  substantially  all, of its
assets.

     Section 10. Waivers and Amendments.  Any waiver of any term or condition of
this Agreement, or any amendment or supplementation of this Agreement,  shall be
effective  only if in writing  executed by the party  against  whom such waiver,
amendment or  supplementation is sought to be charged. A waiver of any breach or
failure to enforce any of the terms or conditions of this Agreement shall not in
any way affect, limit or waive a party's rights hereunder at any time to enforce
strict compliance thereafter with every term or condition of this Agreement.

     Section 11. Illegalities. In the event that any provision contained in this
Agreement  shall be determined to be invalid,  illegal or  unenforceable  in any
respect for any reason,  the validity,  legality and  enforceability of any such
provision in every other respect and the remaining  provisions of this Agreement
shall not, at the election of the party for whose benefit the provision  exists,
be in any way impaired,  and in lieu of such provision determined to be invalid,
illegal or  unenforceable  a new provision  shall be  automatically  and without
further action of the parties hereto  substituted that is as similar as possible
to such invalid, illegal or unenforceable provision to accomplish the intent and
purpose thereof and still be valid, legal and enforceable. More particularly, if
any  provision  hereof  is  determined  by any  court or other  tribunal  having
jurisdiction  thereof  to be  unenforceable  because  of the  duration  or scope
thereof, then the duration or scope of such provision shall be automatically and
without  further  action of the parties hereto reduced to the extent that in the
judgment  of such  court or other  tribunal  would be  necessary  to  render  it
enforceable.



<PAGE>


     Section  12.  Counterparts.  This  Agreement  may be  executed  in multiple
counterparts  all of which  taken  together  shall  constitute  one and the same
instrument.

     IN WITNESS  WHEREOF,  each of the undersigned  corporations has caused this
Agreement to be executed by its duly authorized officer,  and each of Davies and
Dunn has executed this Agreement as of the date first above written.

PTI HOLDING INC.                   FLENTS PRODUCTS CO., INC., a
                                   Delaware corporation



By:   /s/ Meredith W. Birrittella              By:   /s/ Meredith W. Birrittella
      Meredith W. Birrittella                        Meredith W. Birrittella
      Chief Executive Officer                           Secretary



 /s/ W. Thomas Davies
W. THOMAS DAVIES




 /s/ James E. Dunn
JAMES E. DUNN

<PAGE>


                            EXHIBIT 6

                       CONSULTING AGREEMENT

     AGREEMENT  dated as of August 5, 1997 between Flents  Products Co., Inc., a
Delaware  corporation,  having an office c/o 258 Dr.  Martin  Luther King Drive,
Norwalk,  CT 06854 ("the  Company")  and Stuart M. Low, an  individual,  with an
address at 29 Grove Hill Road, Guilford, CT 06437 (the "Consultant").

                      W I T N E S S E T H :

     WHEREAS, PTI Holdings Inc., a Delaware corporation ("PTI"), the Company and
Flents Products Co., Inc., a New York corporation,  ("Flents") have entered into
a Merger Agreement dated as of July 25, 1997, (the "Merger Agreement")  pursuant
to which the Company shall  purchase all of the  outstanding  stock of Flents in
exchange  for cash and  common  stock of PTI and the  Company  shall  assume the
operations of Flents, as described in the Merger Agreement; and


     WHEREAS,  the Company  desires to retain the  Consultant and the Consultant
desires to provide his services to the Company, as more fully described herein,

     NOW,  THEREFORE,  in consideration of the premises and the mutual covenants
herein contained, the adequacy and sufficiency of which are hereby acknowledged,
the parties hereto agree hereby as follows:

     1. Retention.  The Company hereby retains the Consultant and the Consultant
hereby accepts such engagement,  subject to the terms and conditions hereinafter
set forth.

     2. Term. The term  hereunder  shall be ten (10) years from the date hereof,
unless terminated earlier in accordance with the terms hereof.

     3.   Duties.

          (a) The  Consultant  shall be  available to the Company for his advice
and expertise and upon  reasonable  notice from time to time the Company  shall,
when  seeking the advice and  expertise  of the  Consultant,  put the matters on
which it seeks  his  advice  in  writing  and  provide  him with  such  relevant
information  as he may require in order to opine.  The  Consultant  may elect to
provide such advice orally or in writing, by telephone,  by mail or in person at
the offices of the Company and the  Consultant  agrees the Company shall provide
appropriate transportation at its expense. In any event, the Consultant will not
be obliged, except for the first three calendar months after the date hereof, to
respond to requests from the Company for the  Consultant's  advice and expertise
on more than four occasions in any one calendar month.

          (b) The Consultant shall serve the Company loyally,  faithfully and to
the best of his  abilities,  but shall not be required  devote his full  working
time to the  performance  of his duties  hereunder,  provided that the will not,
during the term hereof, engage in any business activity that interferes with the
performance of his obligations under this Agreement.

     4.   Compensation and Benefits.

          (a) In  consideration of the services to be rendered by the Consultant
under  Section  3  herein,  the  Company  shall  pay to the  Consultant  $12,000
annually, payable in equal monthly installments,  subject to Sections 4(b), 4(c)
and 7 and remainder of this Section 4(a) herein and shall provide to him, at the
Company's expense, (i) the medical benefits provided to senior management to the
extent set forth in Section 4(b) below, or (ii) such medical  benefits as may be
agreed upon by the Company and the Consultant, or (iii) such medical benefits as
the Consultant  specifies,  provided that PTI shall pay for such benefits at its
own cost up to the cost of clause  4(a)(i)  above  and shall pay any  additional
cost by reducing the  Consultant's  cash  compensation,  if  available,  and the
Consultant shall himself pay any remaining cost.

      Each monthly  payment shall be made without  regard to the extent,  or the
absence, of services rendered by the Consultant, provided that the Consultant is
not in  material  breach of the terms of this  Agreement,  and in  addition  the
Company shall reimburse the Consultant for reasonable  out-of-pocket expenses in
connection with his duties, to the extent approved in advance by the Company.

          (b)  The  Consultant  shall  receive  health  insurance,  as  is  made
available to senior  management-level  employees  of the Company,  for the first
four (4) years of the term  hereof.  Upon the  fourth  anniversary  hereof,  the
Consultant may elect, in writing, to remain on the Company's health plan, but in
such  instance,  the cost to the Company of the  Consultant's  health  insurance
coverage shall be deducted from the Consultant's compensation hereunder. In such
case, if the cost to the Company of the Consultant's  health insurance  coverage
is greater than the Consultant's  compensation  hereunder,  the Consultant shall
pay such difference to the Company.

          (c) On and after the fourth anniversary hereof, or in the event of his
death before the fourth  anniversary  hereof,  the  Consultant  or his widow may
elect in writing to remain on the  Company's  health plan,  or such other health
plan as the parties  hereto have agreed upon,  for as long as the  Consultant or
his widow shall bear the cost to the Company for such health insurance.  As long
as  consulting  fees are due to the  Consultant  after  the  fourth  anniversary
hereof, the Company shall withhold from its payments to the Consultant an amount
equal to the health plan costs.  The  Consultant  hereby  acknowledges  that the
Company in no way guarantees that Consultant or his widow shall qualify for such
health  insurance  and the  Company's  health  insurance  provider,  and not the
Company, may make the final decision on eligibility of health plan participants.
This Section 4(c) shall survive termination hereof.

     5.   Covenants.

          (a) The  Consultant  agrees  that all work  produced by him under this
Agreement  or otherwise  for the Company  shall be deemed to be a "work made for
hire" as defined in the federal  Copyright  Act,  Title 17 of the United  States
Code. Without further consideration,  the Consultant hereby irrevocably assigns,
transfers and sets over to the Company,  its successors and assigns,  all of the
Consultant's  right,  title  and  interest  in and to any and all  developments,
processes,  discoveries,  technologies and creations and all  copyrightable  and
patentable  works,  materials  and  ideas  (collectively  "Inventions")  and any
improvement  to any  Invention,  whether  or not  patentable,  copyrightable  or
legally  protectible  or  recognized  as forms of  property,  and whether or not
completed or used in practice,  together with all  information and data relating
thereto  (hereinafter   "Proprietary   Information")   (including  all  designs,
drawings, prints, patterns, sketches, ideas, inventions,  improvements, writings
and other works of  authorship,  theses,  books,  computer  programs,  lectures,
illustrations,  photographs,  scientific and mathematical models, prints and any
other subject matter that is or may become legally  protectible or recognized as
a form  of  property)  that  have  been  conceived,  made or  suggested,  or may
hereafter be conceived, made or suggested, either by the Consultant or by others
with the assistance or other  participation  of the  Consultant,  and (i) on the
Company's  premises  or during  the  Employee's  usual  working  hours,  or (ii)
otherwise  related  to the  business  of the  Company  or any  affiliate  of the
Company.

          (b) The Consultant shall disclose  promptly to the Company any and all
Inventions and Proprietary Information when conceived or made by the Consultant,
and report  promptly to the Company all  information of which the Consultant may
become  aware  during the term of  employment  with the  Company  that may be of
benefit  to the  Company.  During the period of his  employment  hereunder,  the
Consultant shall also disclose promptly to the Board of Directors of the Company
all material Inventions relating to the business,  products,  or projects of the
Company  and/or  involving  the  use of the  Company's  time,  materials  and/or
facilities.

          (c)  Upon  request  by the  Company,  the  Consultant  shall,  without
compensation other than the Consultant's  usual and customary salary,  bonus and
benefits hereunder, execute all such assignments and other documents and perform
all such  acts  necessary  to enable  the  Company  to obtain or uphold  for its
benefit  patents or  copyrights  for, and other rights to, such  Inventions  and
Proprietary  Information relating thereto,  which shall be owned by the Company,
whether or not the Consultant is the inventor thereof.

     6.   Disability and Death.

          (a) If the  Consultant  shall have been  unable  fully to perform  his
duties  hereunder  due to  disability  for any 60 days  during any  twelve  (12)
consecutive months, as determined in good faith by the Board of Directors,  then
the Company may  terminate  the  Consultant's  engagement  hereunder  by written
notice to the  Consultant  or his legal  guardian,  effective  immediately  upon
delivery of such notice.

          (b) If the Consultant shall die during the term of this Agreement, the
Consultant's   engagement   hereunder  shall  terminate   immediately  upon  the
Consultant's death.

     7.  Termination  of  Employment.  The Company may at any time terminate the
Consultant's  engagement hereunder by written notice to the Consultant effective
immediately upon delivery of such notice if:

          (i)  the Consultant shall commit any act whether or not involving the
     Company that constitutes a felony in the jurisdiction involved; or

          (ii)  the Consultant engages in repeated substance abuse; or

          (iii) the Board of  Directors,  after due  inquiry and  providing  the
     Consultant with a reasonable opportunity to be heard, shall have determined
     in good faith that the Consultant has committed wilful malfeasance or gross
     misconduct in his  performance  hereunder,  or any material act of fraud or
     dishonesty against the Company.

     8.   Non-Disclosure of Confidential
          Information and Non-Competition.

          (a) The Consultant  acknowledges  that he has been informed that it is
the policy of the Company to maintain as secret and confidential all information
(i)  relating to the  products,  processes,  technologies,  inventions,  designs
and/or systems used by the Company and (ii) relating to the suppliers, customers
and  employees of the Company  (all such  information  hereafter  referred to as
"Confidential  Information"),  and the Consultant further acknowledges that such
Confidential  Information  is of great value to the Company.  The parties hereto
recognize  that the services to be performed by the  Consultant  are special and
unique,  and that by reason of his  employment  by the Company,  he has and will
acquire Confidential  Information as aforesaid.  The parties hereto confirm that
it is reasonably necessary to protect the Company's goodwill that the Consultant
agree,  and accordingly the Consultant does agree,  that he will not directly or
indirectly (except where authorized by the Board of Directors of the Company for
the  benefit  of the  Company),  for  or on  behalf  of  himself  or any  Person
(hereinafter defined):

               (i) at any time during his  employment by the Company or after he
          ceases to be employed  by the  Company for any reason,  divulge to any
          Person other than the Company (hereinafter referred to collectively as
          a "third  party"),  or use or cause to authorize  any third parties to
          use,  any such  Confidential  Information,  or any  other  information
          regarded as confidential  and valuable by the Company that he knows or
          should know is regarded as  confidential  and  valuable by the Company
          (whether or not any of the foregoing  information is actually novel or
          unique  or is  actually  known  to  others  and  whether  or  not  the
          Confidential Information is labelled as confidential); or

               (ii) at any time during his  employment  by the Company and for a
          period of one year after he ceases to be  employed  by the Company for
          any reason, act as or be an officer, director, stockholder, consultant
          or advisor, partner or employee of, or render any service for, or have
          any  profit-sharing  or other  interest  in, or lend money or make any
          other  financial  accommodation  for or on behalf of, or undertake any
          business  transaction  with, any Person that engages in or is planning
          or preparing to engage in either direct  competition  with the Company
          or  any  corporate  affiliate  of the  Company,  or  the  business  of
          providing,  in any state where the Company or any corporate  affiliate
          sells products or performs services, the same products and/or services
          as those  provided by the Company or any corporate  affiliate,  except
          that he may hold  securities  that are part of a publicly traded class
          of  securities  (not in excess of 5% of the  outstanding  total of any
          class  of  such  securities)  in  competitive  concerns  so long as he
          discloses such holding to the Company; or

               (iii) at any time during his  employment by the Company and for a
          period of one year after he ceases to be  employed  by the Company for
          any reason,  engage in or plan or prepare to engage in (A) competition
          with the Company or any  corporate  affiliate  or (B) the  business of
          providing,  in any state where the Company or any corporate  affiliate
          sells products or performs services, the same products and/or services
          as those provided by the Company or any corporate affiliate; or

               (iv) at any time during his  employment  by the Company and for a
          period of two years  after he ceases to be employed by the Company for
          any reason, (A) attempt in any manner to solicit, or instruct,  assist
          or provide any services in connection with the solicitation,  from any
          Person that is, or shall have been after the date hereof,  a client of
          the Company or PTI International, Inc. or any affiliate of the Company
          (a  "Client")  (except  on behalf of the  Company),  or  persuade,  or
          attempt in any manner to persuade,  any Client to cease doing business
          or to  reduce  the  amount  of  business  that  any  such  Client  has
          customarily  done  or  contemplates  doing  with  the  Company  or any
          affiliate  of the  Company,  or (B)  serve  as an  officer,  director,
          employee,  agent or consultant of, or otherwise render services to, or
          become or remain a creditor or equity  interest  holder in, any Person
          that  accepts  business  competitive  with the business of the Company
          from any such  Client,  whether or not the  relationship  between  the
          Company and such Client was originally established in whole or in part
          through the efforts of the Consultant; or

               (v) at any time  during his  employment  by the Company and for a
          period of two years  after he ceases to be employed by the Company for
          any reason,  employ or otherwise  obtain  services from, or solicit or
          otherwise  attempt to employ or otherwise  obtain  services  from,  or
          assist any Person in employing or otherwise  obtaining  services from,
          or attempting to employ or otherwise  obtain services from, any person
          who is then, or at any time during the  preceding  twelve months shall
          have been,  in the employ of or  retained  by the  Company  and/or its
          affiliates; or

               (vi) at any time  during his  employment  by the  Company and the
          applicable period  thereafter  specified in each of the clauses above,
          negotiate   for  or  enter  into  an   agreement,   understanding   or
          arrangement,  or otherwise cause or authorize any Person,  to take any
          of the actions prohibited by such clause.

As used  herein,  the term  "Person"  means  any  person,  corporation,  limited
liability company,  partnership or other entity and the term "Client" shall mean
(i) anyone who is then a client of the  Company or any of its  affiliates,  (ii)
anyone who was a client of the  Company at any time during the  two-year  period
immediately  preceding the alleged prohibited conduct, and (iii) any prospective
client that shall have placed a purchase order with the Company.  The expiration
or termination  for any reason of the  restrictive  covenants  contained in this
Section 8(a) shall not in any manner modify, terminate or impair the restrictive
covenants  contained  in the Non-  Competition  Agreement  dated the date hereof
between the Consultant and the Company.

          (b) The Consultant shall, upon the expiration of his employment by the
Company  for  any  reason,  forthwith  deliver  up to the  Company  any  and all
drawings,  notebooks, keys and other documents and materials, or copies thereof,
in his  possession  or  under  his  control  that  relate  to  any  Confidential
Information,  including any of same that relate to any Invention relating to the
business of the Company or any  affiliate  of the Company  described  in Section
5(a),  or that are  otherwise  the property of the  Company.  This Section 8 and
Section  5(c)  shall  survive  any  expiration  or  other  termination  of  this
Agreement.

          (c) The Consultant  agrees that any breach or threatened breach by him
of any  provision  of this Section 8 will,  because of the unique  nature of the
Consultant's  services  and the  Confidential  Information  entrusted  to him as
aforesaid,  cause irreparable harm to the Company and shall entitle the Company,
in addition to any other legal  remedies  available to it, to apply to any court
of competent  jurisdiction to enjoin such breach or threatened  breach,  without
the need to show irreparable injury or to post any bond, which are hereby waived
by  the  Consultant.   The  parties  hereto  understand  and  intend  that  each
restriction  agreed  to by the  Consultant  hereinabove  shall be  construed  as
separable and divisible from every other restriction,  and the unenforceability,
in whole or in part, of any such  restriction,  in any  jurisdiction,  shall not
affect the  enforceability  of such restriction in any other  jurisdiction or of
the remaining  restrictions in any jurisdiction,  and that one or more or all of
such  restrictions  may be  enforced  in whole  or in part as the  circumstances
warrant.  The Consultant  further  acknowledges that the Company is relying upon
such covenants as an inducement to provide the Consultant with employment and in
connection  therewith  to permit  the  Consultant  to have  continued  access to
Confidential Information.

     9. Entire Agreement. This Agreement, together with the Merger Agreement and
the  documents  and  instruments  referred  to  therein,   contains  the  entire
understanding  of the  parties  with  respect to the subject  matter  hereof and
supersedes any prior agreement  between the parties.  No change,  termination or
attempted  waiver of any of the  provisions  hereof  shall be binding  unless in
writing and signed by the party  against whom the same is sought to be enforced.
No action by either party shall be deemed a waiver of any right  hereunder,  and
no waiver of any right at any time shall  operate as a waiver of any other right
or as a waiver of such right at any other time.

     10. Successors and Assigns.  This Agreement shall be binding upon and shall
inure to the benefit of the respective heirs, legal representatives,  successors
and  assigns  of the  parties  hereto,  except  that this  agreement  may not be
assigned by the Consultant.

     11. Governing Law. All matters  concerning the validity and  interpretation
of and  performance  under this  Agreement  shall be governed by the laws of the
State of New York.
     12.  Designations  and Notices.  Whenever notice is required to be given by
any party hereunder, such notice shall be deemed sufficient if given pursuant to
the terms of the Merger Agreement.

     13.  Severability.  The  invalidity or  unenforceability  of any particular
provision  of this  Agreement  in any  jurisdiction  shall not  affect the other
provisions hereof or such provision in other  jurisdictions,  and this Agreement
shall be  construed in such  jurisdiction  in all respects as if such invalid or
unenforceable  provisions  were omitted.  Furthermore,  in lieu of such illegal,
invalid,  or unenforceable  provision in such jurisdiction  there shall be added
automatically  as a part of this  Agreement a  provision  as similar in terms to
such  illegal,  invalid,  or  unenforceable  provision as may be possible and be
legal, valid and enforceable.

     14. Construction.  Throughout this Agreement,  each pronoun shall be deemed
to include the masculine,  the feminine and the neuter, the singular and plural,
and vice versa,  where such meanings would be  appropriate.  The headings herein
are inserted only as a matter of convenience  and reference,  and they in no way
define,  limit or  describe  the scope of this  Agreement  or the  intent of any
provisions thereof.

     15. Further  Assurances.  Each party shall execute such other documents and
instruments  as  shall  be  requested  by the  other  party  in  order  fully to
accomplish the purposes of this Agreement.

     16.  Counterparts.  This  Agreement  may  be  executed  in  any  number  of
counterparts,  all of which taken  together  shall  constitute  one and the same
instrument.


     IN WITNESS  WHEREOF the  Consultant  has executed  this  Agreement  and the
Company has caused this Agreement to be executed by its duly authorized  officer
as of the date first above written.

                              FLENTS PRODUCTS CO., INC.




/s/ Stuart M. Low                          By:   /s/ W. Thomas Davies
STUART M. LOW                                     W. Thomas Davies, President

<PAGE>


                            EXHIBIT 7
                       EMPLOYMENT AGREEMENT

     EMPLOYMENT  AGREEMENT  dated as of August 5, 1997 between W. Thomas Davies,
an individual,  having an address at 27 Quaker Ridge Road, Bethel, CT 06801 (the
"Executive")  and Flents  Products Co., Inc., a Delaware  corporation  having an
office at One River Street, Hastings-on-Hudson, NY 10706 (the "Company").

                      W I T N E S S E T H :

     WHEREAS,  PTI Holding Inc., a Delaware corporation ("PTI"), the Company and
Flents Products Co., Inc., a New York corporation,  ("Flents") have entered into
a Merger Agreement dated as of July 25, 1997, (the "Merger Agreement")  pursuant
to which the  Company is  acquiring  all of the  outstanding  stock of Flents in
exchange  for cash and  common  stock of PTI and the  Company  shall  assume the
operations of Flents, as described in the Merger Agreement; and

     WHEREAS,  pursuant to the Merger  Agreement,  the Company  shall employ the
Executive to serve as its President, as more fully described herein,

     NOW,  THEREFORE,  in consideration of the premises and the mutual covenants
herein contained, the adequacy and sufficiency of which are hereby acknowledged,
the parties hereto agree hereby as follows:

     1.  Employment.  The Company hereby employs the Executive as its President,
and the  Executive  hereby  accepts  such  employment,  subject to the terms and
conditions  hereinafter  set forth,  under the direction of the Chief  Executive
Officer and the Board of Directors of the Company.

     2. Term. The term of the Executive's  employment  hereunder shall be deemed
to have commenced on June 1, 1997, and shall continue thereafter for a period of
four (4) years, unless terminated earlier in accordance with the terms hereof.

     3.   Duties.

          (a) The duties of the Executive  shall be  predominantly  executive in
nature.  The Executive  shall serve the Company  loyally,  faithfully and to the
best of his  abilities and shall devote his full working time and efforts to the
performance of his duties hereunder. The Executive shall be available for travel
as the needs of the business of the Company require.

          (b) The  Executive  agrees  that he will not,  during the term of this
Agreement,  engage in any business activity that interferes with the performance
of his obligations under this Agreement.

     4.   Compensation and Benefits.

          (a) In  consideration  of the services to be rendered by the Executive
hereunder,  the Company shall pay to the  Executive,  and he shall accept,  base
salary  payable  biweekly or monthly in accordance  with the Company's  standard
practices,  at an annual rate of not less than $180,000 plus $12,500.  Increases
to the  Executive's  base salary  shall be  determined  annually by the Board of
Directors  of the  Company.  Within  30  days  of  the  closing  of  the  merger
contemplated  under the Merger  Agreement (the  "Closing"),  the Executive shall
receive an amount equal to the difference between his base salary paid by Flents
from June 1, 1997 through the Closing and his base salary payable hereunder. The
Executive  hereby  acknowledges  that he is due no  additional  compensation  by
Flents, except as provided herein.

          (b)  The  Executive  shall  receive  health  insurance  equal  to such
benefits as are made  available  to  management-level  employees  of PTI. If the
Executive chooses to be included on his spouse's health insurance plan, then the
Company  shall pay the  Executive  the amount it would have paid to include  the
Executive on the Company's health plan. The Executive shall be included on PTI's
401(k) pension plan,  when and if such plan is adopted by PTI for all employees.
On or about  September  1,  1997 and  annually  thereafter,  the  Company  shall
reimburse the Executive for his costs in maintaining a life insurance  policy on
the life of the  Executive up to an amount not to exceed  $1,000  annually.  The
Executive  shall  receive  the  number  of  paid  vacation/personal/  sick  days
indicated  on Exhibit B annexed  hereto,  based on October  15, 1984 as the date
hired,  which  days may be taken at any time,  subject  to the  Company's  prior
approval, which shall not be unreasonably withheld or delayed.

          (c) The Executive  shall  receive  long-term  disability  insurance of
disability  benefits under the Company's  disability plan, which shall generally
have the following  provisions:  60% of his base salary, as described in Section
4(a) herein  commencing  180 days after the onset of the  disability,  provided,
however,  that such payment shall not exceed $5,000  monthly.  On condition that
the  Executive  is an  employee  of the  Company  at the  time of the  onset  of
disability,  such  benefit  will  continue  for the period of time  indicated on
Exhibit C  annexed  hereto,  based on the  Executive's  age when the  disability
began.  The Company  shall  reimburse  the  Executive  annually in the amount of
$1,082.00 for his cost to obtain additional disability coverage.

          (d) The Executive  shall receive  $8,400 per year as a cash  allowance
for a car or other related expenses.

          (e) The Executive shall receive, upon vesting,  options to purchase an
aggregate of 40,000  shares of common stock of PTI.  Such options  shall vest at
the rate of 10,000  per year on the last  calendar  day of each  year  beginning
December 31, 1997 and  concluding  on December 31,  2000,  unless the  Executive
voluntarily  resigns or this  Agreement is terminated  under Section 6 hereof or
the Executive is  terminated  for cause under Section 7 herein prior to the date
of vesting.  The exercise  price of the options to purchase  10,000 shares which
will vest on December 31, 1997 shall be $9.00 per share,  the exercise  price of
the options to purchase 10,000 shares which will vest on December 31, 1998 shall
be $10.00 per share, the exercise price of the options to purchase 10,000 shares
which will vest on December 31, 1999 shall be $11.00 per share, and the exercise
price of the options to purchase  10,000  shares which will vest on December 31,
2000  shall  be  $12.00  per  share.  In the  event of a stock  dividend,  stock
split-up,  reverse stock split or share  combination  after the  effective  date
hereof,  the Board of  Directors of PTI shall make a  proportionate  increase or
decrease in the number of shares and option  price,  as shall give proper effect
to such  event.  The  Options  shall  be in the form of the  Company's  standard
employee  stock option as set forth on Exhibit A hereto and shall have a term of
5 years from the date of vesting.

          (f) In addition to the options  described in Section 4(e) herein,  the
Executive shall receive  additional  options  (unless the Executive  voluntarily
resigns or this Agreement is terminated  under Section 6 hereof or the Executive
is  terminated  for cause under  Section 7 herein prior to the date of vesting),
based on net revenues and income from operations of the Company as follows:

               (i)  For  the  Combined  Period  (as  hereinafter  defined),  the
          Executive  shall  receive  options to purchase an  aggregate  of 5,000
          shares of common stock of PTI at an exercise price of $10.00 per share
          if the combined Net Revenues  (hereinafter  defined) exceed $6,400,000
          for Flents for the period  beginning  December  1, 1996 and ending May
          31,  1997  and for the  Company  beginning  June 1,  1997  and  ending
          November  30,  1997  (collectively,  the  "Combined  Period")  and the
          Company has Income from Operations  (hereinafter  defined) of 12.9% of
          Net Revenues or greater for the Combined  Period,  provided,  however,
          that such options shall be reduced equitably by an amount equal to any
          cash or other  compensation  received as a bonus (except for the bonus
          received  as a  Christmas  bonus,  regularly  given the  employees  of
          Flents)  for the fiscal  year  ending  November  30,  1997 paid to the
          Executive by Flents.

               (ii) For the fiscal year ending  December 31, 1998, the Executive
          shall  receive  options to purchase an  aggregate  of 5,000  shares of
          common  stock of PTI at an  exercise  price of $11.00 per share if the
          Company's Net Revenues exceed  $7,000,000 for such fiscal year and the
          Company  has an Income  from  Operations  of 12.9% of Net  Revenues or
          greater.

               (iii) For the fiscal year ending December 31, 1999, the Executive
          shall  receive  options to purchase an  aggregate  of 5,000  shares of
          common  stock of PTI at an  exercise  price of $12.00 per share if the
          Company's Net Revenues exceed  $7,700,000 for such fiscal year and the
          Company  has an Income  from  Operations  of 12.9% of Net  Revenues or
          greater.

               (iv) For the fiscal year ending  December 31, 2000, the Executive
          shall  receive  options to purchase an  aggregate  of 5,000  shares of
          common  stock of PTI at an  exercise  price of $13.00 per share if the
          Company's Net Revenues exceed  $8,500,000 for such fiscal year and the
          Company  has an Income  from  Operations  of 12.9% of Net  Revenues or
          greater.

"Net  Revenues"  shall equal gross  revenues  less returns,  refunds,  bad debt,
cooperative  advertising,  slotting charges, sales allowances and other credits.
"Income from  Operations"  shall be defined as that term is defined by generally
accepted accounting  principles,  consistently  applied. Net Revenues and Income
from Operations shall be determined  finally by the certified public accountants
regularly  retained by the Company.  The options  described in this Section 4(f)
shall be in the same form as the  options  described  in Section  4(e) and shall
vest  retroactively as of the last day of each year if the target is achieved as
indicated on the Company's financial statements for such year.

          (g)  Notwithstanding  any provision of this Agreement to the contrary,
if the Executive's employment shall terminate for any reason prior to the end of
the term hereof, other than those reason listed in Section 7 herein, the Company
shall  pay  to  the  Executive,  or  the  principal  beneficiary  named  in  the
Executive's  life insurance policy within 30 days after the date of termination,
$1,041.67  for each of the  complete  months then  remaining in the term of this
Agreement.

     5.   Covenants.

          (a) The  Executive  agrees  that all work  produced  by him under this
Agreement  or otherwise  for the Company  shall be deemed to be a "work made for
hire" as defined in the federal  Copyright  Act,  Title 17 of the United  States
Code. Without further  consideration,  the Executive hereby irrevocably assigns,
transfers and sets over to the Company,  its successors and assigns,  all of the
Executive's  right,  title  and  interest  in and to any and  all  developments,
processes,  discoveries,  technologies and creations and all  copyrightable  and
patentable  works,  materials  and  ideas  (collectively  "Inventions")  and any
improvement  to any  Invention,  whether  or not  patentable,  copyrightable  or
legally  protectible  or  recognized  as forms of  property,  and whether or not
completed or used in practice,  together with all  information and data relating
thereto  (hereinafter   "Proprietary   Information")   (including  all  designs,
drawings, prints, patterns, sketches, ideas, inventions,  improvements, writings
and other works of  authorship,  theses,  books,  computer  programs,  lectures,
illustrations,  photographs,  scientific and mathematical models, prints and any
other subject matter that is or may become legally  protectible or recognized as
a form  of  property)  that  have  been  conceived,  made or  suggested,  or may
hereafter be conceived, made or suggested,  either by the Executive or by others
with the  assistance or other  participation  of the  Executive,  and (i) on the
Company's  premises  or during  the  Employee's  usual  working  hours,  or (ii)
otherwise  related  to the  business  of the  Company  or any  affiliate  of the
Company.

          (b) The Executive  shall disclose  promptly to the Company any and all
Inventions and Proprietary  Information when conceived or made by the Executive,
and report  promptly to the Company all  information  of which the Executive may
become  aware  during the term of  employment  with the  Company  that may be of
benefit  to the  Company.  During the period of his  employment  hereunder,  the
Executive shall also disclose  promptly to the Board of Directors of the Company
all material Inventions relating to the business,  products,  or projects of the
Company  and/or  involving  the  use of the  Company's  time,  materials  and/or
facilities.

          (c)  Upon  request  by  the  Company,  the  Executive  shall,  without
compensation  other than the Executive's usual and customary  salary,  bonus and
benefits hereunder, execute all such assignments and other documents and perform
all such  acts  necessary  to enable  the  Company  to obtain or uphold  for its
benefit  patents or  copyrights  for, and other rights to, such  Inventions  and
Proprietary  Information relating thereto,  which shall be owned by the Company,
whether or not the Executive is the inventor thereof.

     6.   Disability and Death.

          (a)  If the  Executive,  due  to  physical  or  mental  disability  or
incapacity, shall have been unable fully to perform his duties hereunder for any
180 days during any twelve (12) consecutive  months, as determined in good faith
by the Board of Directors, then the Company may terminate this Agreement and the
Executive's employment hereunder by written notice to the Executive or his legal
guardian, effective immediately upon delivery of such notice.

          (b) If the Executive shall die during the term of this Agreement, this
Agreement and the Executive's  employment hereunder shall terminate  immediately
upon the Executive's death.

     7.  Termination  of  Employment  For  Cause.  The  Company  may at any time
terminate this  Agreement and the  Executive's  employment  hereunder by written
notice to the Executive effective immediately upon delivery of such notice if:

          (a)  the Executive shall commit any act whether or not involving the
     Company that constitutes a felony in the jurisdiction involved; or

          (b)  the Executive engages in repeated substance abuse; or

          (c) the  Board of  Directors,  after due  inquiry  and  providing  the
     Executive with a reasonable  opportunity to be heard, shall have determined
     in good faith that the  Executive  committed  wilful  malfeasance  or gross
     misconduct in his  performance  hereunder,  or any material act of fraud or
     dishonesty against the Company; or

          (d) the Executive shall have committed a material breach of this 
Agreement; or

          (e) the Executive  shall have refused to obey a directive of the Board
     of Directors  to perform an act that the  Executive is or should be able to
     perform and that is not illegal or unethical for 30 days after receipt of a
     written directive to perform such act.

     8.   Non-Disclosure of Confidential
          Information and Non-Competition.

          (a) The  Executive  acknowledges  that he has been informed that it is
the policy of the Company to maintain as secret and confidential all information
(i)  relating to the  products,  processes,  technologies,  inventions,  designs
and/or systems used by the Company and (ii) relating to the suppliers, customers
and  employees of the Company  (all such  information  hereafter  referred to as
"Confidential  Information"),  and the Executive further  acknowledges that such
Confidential  Information  is of great value to the Company.  The parties hereto
recognize  that the services to be performed  by the  Executive  are special and
unique,  and that by reason of his  employment  by the Company,  he has and will
acquire Confidential  Information as aforesaid.  The parties hereto confirm that
it is reasonably  necessary to protect the Company's goodwill that the Executive
agree,  and accordingly  the Executive does agree,  that he will not directly or
indirectly (except where authorized by the Board of Directors of the Company for
the  benefit  of the  Company),  for  or on  behalf  of  himself  or any  Person
(hereinafter defined):

               (i) at any time  during his  employment  by the  Company or for a
          period of five (5) years after he ceases to be employed by the Company
          for  any  reason,  divulge  to  any  Person  other  than  the  Company
          (hereinafter  referred to collectively as a "third party"),  or use or
          cause to authorize  any third  parties to use,  any such  Confidential
          Information,  or any other  information  regarded as confidential  and
          valuable  by the  Company  that he knows or should know is regarded as
          confidential  and  valuable by the Company  (whether or not any of the
          foregoing information is actually novel or unique or is actually known
          to others and whether or not the Confidential  Information is labelled
          as confidential); or

               (ii) at any time during his  employment  by the Company and for a
          period of one year after he ceases to be  employed  by the Company for
          any reason, act as or be an officer, director, stockholder, consultant
          or advisor, partner or employee of, or render any service for, or have
          any  profit-sharing  or other  interest  in, or lend money or make any
          other  financial  accommodation  for or on behalf of, or undertake any
          business  transaction  with, any Person that engages in or is planning
          or preparing to engage in either direct  competition  with the Company
          or  any  corporate  affiliate  of the  Company,  or  the  business  of
          providing,  in any state where the Company or any corporate  affiliate
          sells products or performs services, the same products and/or services
          as those  provided by the Company or any corporate  affiliate,  except
          that he may hold  securities  that are part of a publicly traded class
          of  securities  (not in excess of 5% of the  outstanding  total of any
          class  of  such  securities)  in  competitive  concerns  so long as he
          discloses such holding to the Company; or

               (iii) at any time during his  employment by the Company and for a
          period of one year after he ceases to be  employed  by the Company for
          any reason,  engage in or plan or prepare to engage in (A) competition
          with the Company or any  corporate  affiliate  or (B) the  business of
          providing,  in any state where the Company or any corporate  affiliate
          sells products or performs services, the same products and/or services
          as those provided by the Company or any corporate affiliate; or

               (iv) at any time during his  employment  by the Company and for a
          period of two years  after he ceases to be employed by the Company for
          any reason, (A) attempt in any manner to solicit, or instruct,  assist
          or provide any services in connection with the solicitation,  from any
          Person that is, or shall have been after the date hereof,  a client of
          the Company or Protective Technologies International Inc. or any other
          affiliate  of the  Company  (a  "Client")  (except  on  behalf  of the
          Company),  or  persuade,  or attempt in any  manner to  persuade,  any
          Client to cease  doing  business  or to reduce the amount of  business
          that any such Client has customarily  done or contemplates  doing with
          the  Company  or any  affiliate  of the  Company,  or (B)  serve as an
          officer,  director,  employee,  agent or  consultant  of, or otherwise
          render  services to, or become or remain a creditor or equity interest
          holder in, any  Person  that  accepts  business  competitive  with the
          business  of the  Company  from any such  Client,  whether  or not the
          relationship  between  the  Company  and such  Client  was  originally
          established  in whole or in part through the efforts of the Executive;
          or

               (v) at any time  during his  employment  by the Company and for a
          period of two years  after he ceases to be employed by the Company for
          any reason,  employ or otherwise  obtain  services from, or solicit or
          otherwise  attempt to employ or otherwise  obtain  services  from,  or
          assist any Person in employing or otherwise  obtaining  services from,
          or attempting to employ or otherwise  obtain services from, any person
          who is then, or at any time during the  preceding  twelve months shall
          have been,  in the employ of or  retained  by the  Company  and/or its
          affiliates; or

               (vi) at any time  during his  employment  by the  Company and the
          applicable period  thereafter  specified in each of the clauses above,
          negotiate   for  or  enter  into  an   agreement,   understanding   or
          arrangement,  or otherwise cause or authorize any Person,  to take any
          of the actions prohibited by such clause.

As used  herein,  the term  "Person"  means  any  person,  corporation,  limited
liability company,  partnership or other entity and the term "Client" shall mean
(i) anyone who is then a client of the  Company or any of its  affiliates,  (ii)
anyone who was a client of the  Company at any time during the  two-year  period
immediately  preceding the alleged prohibited conduct, and (iii) any prospective
client that shall have placed a purchase order with the Company.  The expiration
or termination  for any reason of the  restrictive  covenants  contained in this
Section 8(a) shall not in any manner modify, terminate or impair the restrictive
covenants  contained  in the  Non-Competition  Agreement  dated the date  hereof
between the Executive and the Company.

          (b) The Executive shall,  upon the expiration of his employment by the
Company  for  any  reason,  forthwith  deliver  up to the  Company  any  and all
drawings,  notebooks, keys and other documents and materials, or copies thereof,
in his  possession  or  under  his  control  that  relate  to  any  Confidential
Information,  including any of same that relate to any Invention relating to the
business of the Company or any  affiliate  of the Company  described  in Section
5(a),  or that are  otherwise  the  property of the Company.  In  addition,  the
Executive shall delete all copies on magnetic disk, computer hard drive or other
electronic or digital  medium in his  possession  and shall supply a certificate
signed by him confirming the  destruction of all such files.  This Section 8 and
Section  5(c)  shall  survive  any  expiration  or  other  termination  of  this
Agreement.

          (c) The Executive  agrees that any breach or threatened  breach by him
of any  provision  of this Section 8 will,  because of the unique  nature of the
Executive's  services  and  the  Confidential  Information  entrusted  to him as
aforesaid,  cause irreparable harm to the Company and shall entitle the Company,
in addition to any other legal  remedies  available to it, to apply to any court
of competent  jurisdiction to enjoin such breach or threatened  breach,  without
the need to show irreparable injury or to post any bond, which are hereby waived
by the Executive. The parties hereto understand and intend that each restriction
agreed to by the  Executive  hereinabove  shall be construed  as  separable  and
divisible from every other restriction, and the unenforceability, in whole or in
part,  of any such  restriction,  in any  jurisdiction,  shall  not  affect  the
enforceability of such restriction in any other jurisdiction or of the remaining
restrictions  in any  jurisdiction,  and  that  one  or  more  or  all  of  such
restrictions may be enforced in whole or in part as the  circumstances  warrant.
The  Executive  further  acknowledges  that the  Company  is  relying  upon such
covenants as an  inducement  to provide the  Executive  with  employment  and in
connection  therewith  to  permit  the  Executive  to have  continued  access to
Confidential Information.

     9. Entire Agreement. This Agreement, together with the Merger Agreement and
the  documents  and  instruments  referred  to  therein,   contains  the  entire
understanding  of the  parties  with  respect to the subject  matter  hereof and
supersedes  any  prior  agreement  between  the  parties,   including,   without
limitation,  the  employment  agreement  dated  November  25,  1995  between the
Executive and Flents, containing a stay-put incentive. No change, termination or
attempted  waiver of any of the  provisions  hereof  shall be binding  unless in
writing and signed by the party  against whom the same is sought to be enforced;
provided,  however,  that the Executive's  compensation  may be increased at any
time by the  Company  without in any way  affecting  any of the other  terms and
conditions of this  Agreement,  which in all other respects shall remain in full
force and  effect.  No action  by either  party  shall be deemed a waiver of any
right  hereunder,  and no  waiver of any right at any time  shall  operate  as a
waiver of any other right or as a waiver of such right at any other time.

     10. Successors and Assigns.  This Agreement shall be binding upon and shall
inure to the benefit of the respective heirs, legal representatives,  successors
and  assigns  of the  parties  hereto,  except  that this  agreement  may not be
assigned by the  Executive,  or by the  Company  except to an  affiliate  of the
Company,  in  which  case  the  Company  shall  remain  liable  for  all  of its
obligations hereunder.

     11. Governing Law. All matters  concerning the validity and  interpretation
of and  performance  under this  Agreement  shall be governed by the laws of the
State of New York, except with respect to its conflict of laws provisions.

     12.  Designations  and Notices.  Whenever notice is required to be given by
any party hereunder, such notice shall be deemed sufficient if given pursuant to
the terms of the Merger Agreement.

     13.  Severability.  The  invalidity or  unenforceability  of any particular
provision  of this  Agreement  in any  jurisdiction  shall not  affect the other
provisions hereof or such provision in other  jurisdictions,  and this Agreement
shall be  construed in such  jurisdiction  in all respects as if such invalid or
unenforceable  provisions  were omitted.  Furthermore,  in lieu of such illegal,
invalid,  or unenforceable  provision in such jurisdiction  there shall be added
automatically  as a part of this  Agreement a  provision  as similar in terms to
such  illegal,  invalid,  or  unenforceable  provision as may be possible and be
legal, valid and enforceable.

     14. Construction.  Throughout this Agreement,  each pronoun shall be deemed
to include the masculine,  the feminine and the neuter, the singular and plural,
and vice versa,  where such meanings would be  appropriate.  The headings herein
are inserted only as a matter of convenience  and reference,  and they in no way
define,  limit or  describe  the scope of this  Agreement  or the  intent of any
provisions thereof.

     15. Further  Assurances.  Each party shall execute such other documents and
instruments  as  shall  be  requested  by the  other  party  in  order  fully to
accomplish the purposes of this Agreement.

     16.  Counterparts.  This  Agreement  may  be  executed  in  any  number  of
counterparts,  all of which taken  together  shall  constitute  one and the same
instrument.

     IN WITNESS  WHEREOF,  the  Executive  has executed  this  Agreement and the
Company has caused this Agreement to be executed by its duly authorized  officer
as of the date first above written.

                                   FLENTS PRODUCTS CO., INC.




  /s/ W. Thomas Davies            By:   /s/ Meredith W. Birrittella
W. THOMAS DAVIES                        Meredith W.Birrittella, Secretary


Agreed to as to Sections 4(b), (e) and (f):

PTI HOLDING INC.




By:  /s/ Meredith W. Birrittella
     Meredith W. Birrittella
     Chief Executive Officer

<PAGE>


                     EXHIBIT A to EXHIBIT 7

                 INCENTIVE STOCK OPTION AGREEMENT

          AGREEMENT   dated  ,  1997  between  PTI  Holding   Inc.,  a  Delaware
corporation (the "Company"), and W. Thomas Davies, an individual with an address
at 27 Quaker Ridge Road, Bethel, CT 06801 (the "Optionee").

                      W I T N E S S E T H :

          WHEREAS,  the Company  desires,  in connection with the services to be
rendered by the Optionee in  connection  with his  employment at an affiliate of
the  Company,  to provide the Optionee  with an  opportunity  to acquire  Common
Stock,  par value $.01 per share ("Common  Stock"),  of the Company on favorable
terms and thereby increase his proprietary  interest in the progress and success
of the business of the Company and its affiliates; and

          WHEREAS,  on 1997 (the "Date of Grant")  the  Company  authorized  the
grant to the  Optionee of an option  intended to be an  incentive  stock  option
("Incentive  Stock  Option") as defined in Section 422 of the  Internal  Revenue
Code of 1986, as amended (the "Code"),  to purchase shares of the authorized but
unissued  Common  Stock,  pursuant to the  Company's  1994 Joint  Incentive  and
Non-Qualified Stock Option Plan (the "Plan"),  upon the terms and conditions set
forth in this Agreement;

          NOW, THEREFORE, in consideration of the premises, the mutual covenants
herein set forth and other good and valuable consideration,  the Company and the
Optionee hereby agree as follows:

          1. Confirmation of Grant of Option. Pursuant to a determination by the
Board of Directors of the Company made by unanimous  written consent on the Date
of  Grant,  the  Company,  subject  to the  terms  of  this  Agreement,  and the
performance  by  Optionee  of  Optionee's  obligations  in  accordance  with the
Optionee's  employment  hereby  confirms  that the  Optionee  has  been  granted
effective  1997,  as a matter  of  separate  inducement  and  agreement,  and in
addition to and not in lieu of other  compensation  for  services,  the right to
purchase  (hereinafter  referred to as the "Option") a maximum  aggregate of ( )
shares (the "Shares") of Common Stock of the Company on the terms and conditions
set forth, subject to adjustment as provided in Section 9 hereof.

     2. Vesting of Option. The Option shall vest as follows: on .

     3. Purchase Price. The purchase price of the shares of Common Stock covered
by the Option will be $ per share,  subject to adjustment as provided in Section
9 hereof.

          4.  Exercise of Option.

               (a) The  Option  shall  become  exercisable  as and to the extent
vested in accordance with Section 2.

               (b) The Option may be  exercised  in integral  multiples of 1,000
shares subject to the Option by notice and payment to the Company as provided in
Sections 11 and 16 hereof.

          5.  Term of Option.

               (a) The term of the  Option  shall be a period  of five (5) years
from the date such  Option  vested,  as  provided  for in Section 2,  subject to
earlier termination or cancellation as provided herein.

               (b) The  holder  of the  Option  will  not  have  any  rights  to
dividends  or any other  rights of a  stockholder  with respect to any shares of
Common Stock subject to the Option until such shares have been issued to him (as
evidenced by the appropriate  entry on the books of a duly  authorized  transfer
agent of the Company)  provided  that the date of issuance  shall not be earlier
than the  Closing  Date (as  hereinafter  defined)  with  respect to such shares
pursuant to Section 11 hereof, upon purchase of such shares upon exercise of the
Option.

          6. Non-transferability of Option. The Option shall not be transferable
otherwise  than by will,  or by the laws of descent  and  distribution,  and the
Option may be exercised  during the lifetime of the Optionee  only by him.  More
particularly,  but without limiting the generality of the foregoing,  the Option
may not be  assigned,  transferred  or  otherwise  disposed  of, or  pledged  or
hypothecated  in any way (whether by operation of law or  otherwise),  and shall
not be  subject to  execution,  attachment  or other  process.  Any  assignment,
transfer,  pledge,  hypothecation  or other  disposition of the Option attempted
contrary  to the  provisions  of  this  Agreement,  or any  levy  of  execution,
attachment or other process  attempted  upon the Option,  shall be null and void
and without  effect.  Any  attempt to make such  assignment,  transfer,  pledge,
hypothecation  or other  disposition  of the Option or any  attempt to make such
levy of  execution,  attachment  or other  process  shall  cause  the  Option to
terminate  immediately  upon the  happening  of any such  event if the  Board of
Directors of the Company, at any time, should, in its sole discretion, so elect,
by written  notice to the Optionee or to the person or persons then  entitled to
exercise the Option under the provisions  hereof;  provided,  however,  that any
such termination of the Option under the foregoing  provisions of this section 6
will not  prejudice  any rights or remedies that the Company or any affiliate or
subsidiary thereof may have under this Agreement or otherwise.

          7.  Exercise upon Cessation of Employment.

                    (a) If the  Optionee  ceases  to  serve  as an  employee  or
director of the Company or any affiliate or subsidiary  thereof by reason of his
discharge  for cause,  as  determined in good faith by the Board of Directors of
the Company, or by reason of the voluntary resignation of the Optionee, then the
Option shall forthwith terminate. If, however, the Optionee for any other reason
(except  disability or death) ceases to serve,  then the Option may,  subject to
the provisions of Section 6 hereof, be exercised to the same extent the Optionee
would have been  entitled  under  Section 2 hereof to exercise the Option on the
day immediately  preceding the date of such cessation,  at any time within three
months  after  such  cessation,  at the end of which  period  the  Option  shall
terminate.  In any event the Option may not be exercised after the expiration of
the term provided in Section 5 hereof.

                    (b) The Option shall not be affected by any change of duties
of the  Optionee so long as he  continues to serve as an employee or director of
the Company or any affiliated corporation or subsidiary thereof. If the Optionee
is granted a temporary leave of absence,  such leave of absence will be deemed a
continuation  of his  service to the  Company  or any  affiliate  or  subsidiary
thereof for the purposes of this Agreement only if and so long as the Company in
its sole discretion consents thereto. Retirement, whether or not pursuant to any
retirement  or  pension  plan of the  Company  or any  affiliate  or  subsidiary
thereof,  shall be deemed to be a cessation of service with written  consent for
all purposes of this Agreement.

                    (c) Any termination of this Option by reason of cessation of
service,  whether under this Section 7 or Section 8, shall be without  prejudice
to any rights or remedies  that the  Company or any  affiliated  corporation  or
subsidiary thereof may have against the Optionee hereunder or otherwise.

          8.  Exercise upon Death or Disability.

                    (a) If the Optionee  dies while he is serving as an employee
or director  of the  Company or any  affiliated  corporation  or any  subsidiary
thereof or within three months after he has ceased such service  (provided  such
cessation was not due to the  Optionee's  having  resigned  voluntarily  or been
discharged  for  cause),  during  which  period he would have been  entitled  to
exercise the Option under the  provisions  of Section 7 hereof,  the Option may,
subject to the  provisions  of Section 6 hereof,  be exercised to the extent the
Optionee  would have been entitled under Section 2 hereof to exercise the Option
on the day preceding the date of his death,  by the estate of the Optionee or by
the person or persons  (including  the estate of any such  person or persons who
have  died)  who  acquire  the  right to  exercise  the  Option  by  bequest  or
inheritance at any time within the period ending one year after the death of the
Optionee,  at the end of which period the Option shall  terminate.  In any event
the Option may not be exercised  after the  expiration  of the term  provided in
Section 5 hereof.

                    (b) If the  service of the  Optionee  for the Company or any
affiliated  corporation  or any  subsidiary  thereof is  terminated by reason of
"disability",  the Option may, subject to the provisions of Section 6 hereof, be
exercised to the extent the Optionee  would have been  entitled  under Section 2
hereof to exercise the Option on the day preceding the date of his "disability,"
at any time  within the period  ending  one year after the  "disability"  of the
Optionee,  at the end of which period the Option shall  terminate.  In any event
the Option may not be exercised  after the  expiration  of the term  provided in
Section 5 hereof.

                    (c) A temporary disability may in the sole discretion of the
Board of Directors or the Committee,  as the case may be, be deemed hereunder to
be a  continuation  of service for the Company or any  affiliate  or  subsidiary
thereof  if such  disability  lasts  less  than 90  days,  or,  in the case of a
disability  longer  than  90  days,  if  the  Company  in  its  sole  discretion
contractually  guarantees  the  Optionee's  right to return to work  after  such
disability.

          9.  Adjustments.  In the event of a stock  dividend,  stock  split-up,
share combination, exchange of shares, re-capitalization, merger, consolidation,
acquisition or disposition of property or shares,  reorganization,  liquidation,
stock sale or option grant below market price or the exercise  price hereof,  or
other  similar  changes or  transactions  of or by the Company after the Date of
Grant,  the Board of Directors of the Company shall make (or shall  undertake to
have the Board of Directors of any corporation that merges with, or acquires the
assets of, the Company  make) such  adjustment  of the number or class of shares
then covered by the Option, or of the option price, or both, as it shall, in its
sole discretion, deem appropriate to give proper effect to such event; provided,
however,  that  no  such  adjustment  shall  be  made  so  as  to  constitute  a
modification,  extension or renewal of the Option  within the meaning of Section
424(h) of the Code.

          10.  Registration.  The  shares of Common  Stock  subject  hereto  and
issuable upon the exercise hereof may not be registered under the Securities Act
of 1933, as amended (the "Act"), and, if required upon the request of counsel to
the  Company,  the Optionee  shall give a  representation  as to his  investment
intent and other matters with respect to such shares prior to their  issuance as
set forth in Section 11 hereof.

          11.  Method of Exercise of Option.

               (a) Subject to the terms and  conditions of this  Agreement,  the
Option shall be  exercisable  by notice and payment to the Company in accordance
with the procedure prescribed herein. Each notice shall:

(i)  state the  election  to  exercise  the  Option  and the number of shares in
     respect of which it is being exercised;

(ii) contain a  representation  and agreement as to investment  intent and other
     matters, if required by counsel to the Company with respect to such shares,
     in form satisfactory to counsel for the Company; and

(iii)be signed by the person or persons  entitled to exercise the Option and, if
     the  Option is being  exercised  by any  person or  persons  other than the
     Optionee, be accompanied by proof,  satisfactory to counsel of the Company,
     of the right of such person or persons to exercise the Option.

               (b) Upon receipt of such notice,  the Company shall  specify,  by
written notice to the Optionee, a date and time (such date and time being herein
called the "Closing  Date") and place for payment of the full purchase  price of
such shares.  The closing date shall not be more than fifteen days from the date
the notice of exercise is received by the Company  unless another date is agreed
upon by the  Company and the  Optionee or is required  upon advise of counsel of
the Company in order to meet the requirements of Section 12 hereof.

               (c) Payment of the purchase  price of any shares of Common Stock,
in respect of which the Option shall be exercised, shall be made by the Optionee
at a place  specified by the Company on or before the Closing Date by delivering
to the Company a certified or bank  cashier's  check payable to the order of the
Company.  The Option shall be deemed to have been  exercised with respect to any
particular shares of Common Stock, if, and only if, the preceding  provisions of
this Section 11 and the provisions of Section 12 hereof shall have been complied
with,  in which event the Option  shall be deemed to have been  exercised on the
Closing Date.  Anything in this agreement to the contrary  notwithstanding,  any
notice of exercise  given pursuant to the provisions of this Section 11 shall be
void and of no effect if all the preceding provisions of this Section 11 and the
provisions of Section 12 shall not have been complied with.  The  certificate or
certificates  for  shares  of  Common  Stock as to  which  the  Option  shall be
exercised shall be registered in the name of the Optionee or, if the Optionee so
requests in the notice exercising the Option, shall be registered in the name of
the Optionee and another person jointly,  with right of survivorship,  and shall
be delivered on the Closing Date to the Optionee at the place  specified for the
closing,  but only upon compliance with all of the provisions of this Agreement.
If the Optionee  fails to accept  delivery of and pay for all or any part of the
number of shares specified in such notice upon tender or delivery thereof on the
Closing date, his right to exercise the Option with respect to such  undelivered
shares may be terminated in the sole discretion of the Board of Directors of the
Company. The Option may be exercised only with respect to full shares.


          12.  Approval of Counsel.  The exercise of the Option and the issuance
and  delivery of shares of Common  Stock  pursuant  thereto  shall be subject to
approval by the Company's counsel of all legal matters in connection  therewith,
including  compliance  with  the  requirements  of the  Act and  the  rules  and
regulations  thereunder,  and the  requirements  of any stock exchange or market
upon which the Common Stock may then be listed.

          13.  Resale of Common Stock.

               (a) Upon any sale or transfer of the Common Stock  purchased upon
exercise of the Option,  unless such shares are  registered  under the Act,  the
Optionee shall deliver to the Company an opinion of counsel  satisfactory to the
Company to the  effect  that such  common  stock may be sold  without  violating
Section 5 of said Act.

               (b) Unless registered under the Act, the Common Stock issued upon
exercise of the Option  shall bear the  following  legend if required by counsel
for the Company:

                 THE    SHARES  EVIDENCED BY THIS  CERTIFICATE  MAY NOT BE SOLD,
                        TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED
                        OF UNLESS  THEY HAVE  FIRST  BEEN  REGISTERED  UNDER THE
                        SECURITIES  ACT OF 1933, AS AMENDED,  OR UNLESS,  IN THE
                        OPINION OF COUNSEL FOR THE COMPANY, SUCH REGISTRATION IS
                        NOT REQUIRED.

          14.  Reservation of Shares.  The Company shall at all times during the
term of the Option reserve and keep available such number of shares of the class
of stock  then  subject  to the  Option as will be  sufficient  to  satisfy  the
requirements of this Agreement.

          15.   Limitation  of  Action.   The  Optionee  and  the  Company  each
acknowledge  that every  right of action  accruing to him or it, as the case may
be, and arising out of or in connection with this Agreement  against the Company
or an  affiliated  corporation  or subsidiary  thereof,  on the one hand, or the
Optionee,  on the other hand,  shall,  irrespective of the place where an action
may be brought,  cease and be barred by the  expiration  of three years from the
date of the act or omission in respect of which such right of action arises.

          16.  Notices.  Each  notice  relating  to this  Agreement  shall be in
writing and  delivered  in person or by  certified or  registered  mail,  return
receipt  requested,  or  by  nationally  recognized  overnight  courier  service
providing for a signed return receipt, to the proper address. All notices to the
Company  shall be  addressed  to it at 1 River  Street,  Hastings-on-Hudson,  NY
10706.  All notices to the  Optionee  shall be  addressed to the Optionee at the
Optionee's  address above specified.  Anyone to whom a notice may be given under
this  Agreement may designate a new address by notice to that effect,  effective
upon actual receipt thereof.

          17.  Benefits of Agreement.  This Agreement shall inure to the benefit
of and be binding upon each successor and assign of the Company. All obligations
imposed  upon the  Optionee  and all rights  granted to the  Company  under this
Agreement shall be binding upon the Optionee's heirs, legal  representatives and
successors.

          18. Severability. In the event that any one or more provisions of this
Agreement  shall be deemed to be illegal or  unenforceable,  such  illegality or
unenforceability  shall  not  affect  the  validity  and  enforceability  of the
remaining legal and enforceable provisions hereof, which shall be constructed as
if such illegal or unenforceable provision or provisions had not been inserted.

          19.  Plan Governs Conflicts.

               (a) In the event of a conflict between the provisions of the Plan
and the Provisions of this Agreement,  the provisions of the Plan,  specifically
provisions  governing  incentive  stock  options,   shall  in  all  respects  be
controlling.

               (b) It is the intent of the  Company  that the  Options  shall be
treated as  incentive  stock  options  as set forth in Section  422 of the Code.
Compliance by the Optionee  with the various  provisions of Section 422 entitles
the  Optionee  to tax  treatment  upon the  exercise  of Options as set forth in
Section 421 of the Code. If any provision of this Agreement does not comply with
the  requirements  of Section 422 as then  applicable to any  transaction,  such
provision  will be construed or deemed to be amended to the extent  necessary to
conform to the applicable  requirements of Section 422 so that the Optionee will
be entitled to tax treatment in accordance with Section 421 of the Code.

          20.  Governing Law.  This Agreement will be construed and governed in
accordance with the laws of the State of New York.
          21.  No  Implied  Employment  Agreement.  Neither  the  Plan  nor this
Agreement  shall be construed as giving the Optionee any right to be employed by
the Company or any of its  subsidiaries  or affiliates or interfering in any way
with the right of the  Company or any of its  subsidiaries  or  affiliates  from
terminating the employment of the Optionee.



          IN WITNESS  WHEREOF,  the parties hereto have caused this Agreement to
be executed as of the date and year first above written.


                         PTI HOLDING INC.



                         By:
                               Meredith Birrittella, President





                             Name: W. THOMAS DAVIES

<PAGE>



                      EXHIBIT B to EXHIBIT 7

                       Vacation Eligibility

Length of Service                       Vacation Days
Less than five years                       10 days
Five years to ten years                    15 days

Thereafter,  accrue one additional day of vacation for each  additional  year of
service, to a maximum of twenty-five vacation days.



<PAGE>



                      EXHIBIT C to EXHIBIT 7

                    Disability Benefit Period

Executive's Age When
Disability Begins                       Maximum Benefit Period
younger than 60                         to age 65
60                                 five years
61                                 four years
62                                 42 months
63                                 36 months
64                                 30 months
65                                 24 months
66                                 21 months
67                                 18 months
68                                 15 months
age 69 and over                    12 months

<PAGE>


                            EXHIBIT 8

                       EMPLOYMENT AGREEMENT

     EMPLOYMENT  AGREEMENT  dated as of August 5, 1997 between James E. Dunn, an
individual,  having an address at 88 Hillcrest Avenue,  Hawthorne, NJ 07506 (the
"Executive")  and Flents  Products Co., Inc., a Delaware  corporation  having an
office at One River Street, Hastings-on-Hudson, NY 10706 (the "Company").

                      W I T N E S S E T H :

     WHEREAS,  PTI Holding Inc., a Delaware corporation ("PTI"), the Company and
Flents Products Co., Inc., a New York corporation,  ("Flents") have entered into
a Merger Agreement dated as of July 25, 1997 (the "Merger  Agreement")  pursuant
to which the  Company is  acquiring  all of the  outstanding  stock of Flents in
exchange  for cash and  common  stock of PTI and the  Company  shall  assume the
operations of Flents, as described in the Merger Agreement; and

     WHEREAS,  pursuant to the Merger  Agreement,  the Company  shall employ the
Executive  to serve as its Vice  President  of Sales,  as more  fully  described
herein,

     NOW,  THEREFORE,  in consideration of the premises and the mutual covenants
herein contained, the adequacy and sufficiency of which are hereby acknowledged,
the parties hereto agree hereby as follows:

     1.  Employment.  The  Company  hereby  employs  the  Executive  as its Vice
President of Sales, and the Executive hereby accepts such employment, subject to
the terms and conditions hereinafter set forth, under the direction of the Chief
Executive Officer and the Board of Directors of the Company.

     2. Term. The term of the Executive's  employment  hereunder shall be deemed
to have commenced on June 1, 1997, and shall continue thereafter for a period of
five (5) years, unless terminated earlier in accordance with the terms hereof.

     3.   Duties.

          (a) The duties of the Executive  shall be  predominantly  executive in
nature.  The Executive  shall serve the Company  loyally,  faithfully and to the
best of his  abilities and shall devote his full working time and efforts to the
performance of his duties hereunder. The Executive shall be available for travel
as the needs of the business of the Company require.

          (b) The  Executive  agrees  that he will not,  during the term of this
Agreement,  engage in any business activity that interferes with the performance
of his obligations under this Agreement.

     4.   Compensation and Benefits.

          (a) In  consideration  of the services to be rendered by the Executive
hereunder,  the Company shall pay to the  Executive,  and he shall accept,  base
salary  payable  biweekly or monthly in accordance  with the Company's  standard
practices, of not less than $108,000 annually. Increases to the Executive's base
salary  shall be  determined  annually by the Board of Directors of the Company.
The  Executive's  year-end  bonus shall be  determined  annually by the Board of
Directors of the Company, in accordance with Section 4(e) herein. Within 30 days
of the  closing  of the merger  contemplated  under the  Merger  Agreement  (the
"Closing"),  the  Executive  shall  receive  an amount  equal to the  difference
between his base salary paid by Flents from June 1, 1997 through the Closing and
his base salary payable hereunder.  The Executive hereby acknowledges that he is
due no additional compensation by Flents, except as provided herein.

          (b) The  Executive  shall  receive  health  insurance,  equal  to such
benefits as are made  available  to  management-level  employees  of PTI. If the
Executive chooses to be included on his spouse's health insurance plan, then the
Company  shall pay the  Executive  the amount it would have paid to include  the
Executive on the Company's health plan. The Executive shall be included on PTI's
401(k) pension plan,  when and if such plan is adopted by PTI for all employees.
The Company shall  provide,  or, in the sole  discretion  of the Company,  shall
reimburse  the  Executive  for,  a term life  insurance  policy in the amount of
$125,000  on the  life of the  Executive,  with  the  Executive's  heirs  as the
beneficiaries  of such life insurance  policy up to an amount not to exceed $300
annually. The Executive shall receive the number of paid vacation/personal/ sick
days  indicated on Exhibit A annexed  hereto,  based on October 1, 1992,  as the
date hired,  which days may be taken at any time, subject to the Company's prior
approval, which shall not be unreasonably withheld or delayed.

          (c) The Executive  shall  receive  long-term  disability  insurance of
disability  benefits under the Company's  disability plan, which shall generally
have the following  provisions:  60% of his base annual salary,  as described in
Section  4(a)  herein  commencing  180 days  after the onset of the  disability,
provided,  however,  that such  payment  shall not  exceed  $5,000  monthly.  On
condition  that the  Executive  is an employee of the Company at the time of the
onset of disability, such benefit will continue for the period of time indicated
on Exhibit B annexed  hereto,  based on the  Executive's age when the disability
began.

          (d) The Executive  shall receive  $7,200 per year as a cash  allowance
for a car or other related expenses.

          (e) The  Executive  shall  receive a bonus at the end of the  Combined
Period (as  hereinafter  defined)  of 3% of the  increase in the  Company's  Net
Revenues  (hereinafter  defined) from  consumer  sales for Flents for the period
beginning December 1, 1996 and ending May 31, 1997 and for the Company beginning
June 1, 1997 and ending November 30, 1997 (collectively,  the "Combined Period")
above  $5,640,862,  which shall be determined  finally by the  certified  public
accountants  regularly retained by the Company. Such bonus shall be decreased by
the amount of cash or other  compensation  received by the Executive from Flents
as a bonus (except for the bonus received as a Christmas bonus,  regularly given
the employees of Flents) for the fiscal year ending  November 30, 1997.  Bonuses
for  subsequent  years of the term hereof  shall be  determined  by the Board of
Directors  of the  Company,  prior to the end of the  applicable  fiscal year by
setting  targets that  reasonably  could result in a bonus at least equal to the
dollar amount received by the Executive as a bonus for the Combined Period. "Net
Revenues"  shall  equal  gross  revenues  less  returns,   refunds,   bad  debt,
cooperative advertising, slotting charges, sales allowances and other credits.

     5.   Covenants.

          (a) The  Executive  agrees  that all work  produced  by him under this
Agreement  or otherwise  for the Company  shall be deemed to be a "work made for
hire" as defined in the federal  Copyright  Act,  Title 17 of the United  States
Code. Without further  consideration,  the Executive hereby irrevocably assigns,
transfers and sets over to the Company,  its successors and assigns,  all of the
Executive's  right,  title  and  interest  in and to any and  all  developments,
processes,  discoveries,  technologies and creations and all  copyrightable  and
patentable  works,  materials  and  ideas  (collectively  "Inventions")  and any
improvement  to any  Invention,  whether  or not  patentable,  copyrightable  or
legally  protectible  or  recognized  as forms of  property,  and whether or not
completed or used in practice,  together with all  information and data relating
thereto  (hereinafter   "Proprietary   Information")   (including  all  designs,
drawings, prints, patterns, sketches, ideas, inventions,  improvements, writings
and other works of  authorship,  theses,  books,  computer  programs,  lectures,
illustrations,  photographs,  scientific and mathematical models, prints and any
other subject matter that is or may become legally  protectible or recognized as
a form  of  property)  that  have  been  conceived,  made or  suggested,  or may
hereafter be conceived, made or suggested,  either by the Executive or by others
with the  assistance or other  participation  of the  Executive,  and (i) on the
Company's  premises  or during  the  Employee's  usual  working  hours,  or (ii)
otherwise  related  to the  business  of the  Company  or any  affiliate  of the
Company.

          (b) The Executive  shall disclose  promptly to the Company any and all
Inventions and Proprietary  Information when conceived or made by the Executive,
and report  promptly to the Company all  information  of which the Executive may
become  aware  during the term of  employment  with the  Company  that may be of
benefit  to the  Company.  During the period of his  employment  hereunder,  the
Executive shall also disclose  promptly to the Board of Directors of the Company
all material Inventions relating to the business,  products,  or projects of the
Company  and/or  involving  the  use of the  Company's  time,  materials  and/or
facilities.

          (c)  Upon  request  by  the  Company,  the  Executive  shall,  without
compensation  other than the Executive's usual and customary  salary,  bonus and
benefits hereunder, execute all such assignments and other documents and perform
all such  acts  necessary  to enable  the  Company  to obtain or uphold  for its
benefit  patents or  copyrights  for, and other rights to, such  Inventions  and
Proprietary  Information relating thereto,  which shall be owned by the Company,
whether or not the Executive is the inventor thereof.

     6.   Disability and Death.

          (a)  If the  Executive,  due  to  physical  or  mental  disability  or
incapacity, shall have been unable fully to perform his duties hereunder for any
180 days during any twelve (12) consecutive  months, as determined in good faith
by the Board of Directors, then the Company may terminate this Agreement and the
Executive's employment hereunder by written notice to the Executive or his legal
guardian, effective immediately upon delivery of such notice.

          (b) If the Executive shall die during the term of this Agreement, this
Agreement and the Executive's  employment hereunder shall terminate  immediately
upon the Executive's death.

     7.  Termination  of  Employment  For  Cause.  The  Company  may at any time
terminate this  Agreement and the  Executive's  employment  hereunder by written
notice to the Executive effective immediately upon delivery of such notice if:

          (a)  the Executive shall commit any act whether or not involving the
     Company that constitutes a felony in the jurisdiction involved; or

          (b)  the Executive engages in repeated substance abuse; or

          (c) the  Board of  Directors,  after due  inquiry  and  providing  the
     Executive with a reasonable  opportunity to be heard, shall have determined
     in good faith that the  Executive  committed  wilful  malfeasance  or gross
     misconduct in his  performance  hereunder,  or any material act of fraud or
     dishonesty against the Company; or

          (d)  the Executive shall have committed a material breach of this 
Agreement; or

          (e) the Executive  shall have refused to obey a directive of the Board
     of Directors  to perform an act that the  Executive is or should be able to
     perform and that is not illegal or unethical for 30 days after receipt of a
     written directive to perform such act.

     8.   Non-Disclosure of Confidential
          Information and Non-Competition.

          (a) The  Executive  acknowledges  that he has been informed that it is
the policy of the Company to maintain as secret and confidential all information
(i)  relating to the  products,  processes,  technologies,  inventions,  designs
and/or systems used by the Company and (ii) relating to the suppliers, customers
and  employees of the Company  (all such  information  hereafter  referred to as
"Confidential  Information"),  and the Executive further  acknowledges that such
Confidential  Information  is of great value to the Company.  The parties hereto
recognize  that the services to be performed  by the  Executive  are special and
unique,  and that by reason of his  employment  by the Company,  he has and will
acquire Confidential  Information as aforesaid.  The parties hereto confirm that
it is reasonably  necessary to protect the Company's goodwill that the Executive
agree,  and accordingly  the Executive does agree,  that he will not directly or
indirectly (except where authorized by the Board of Directors of the Company for
the  benefit  of the  Company),  for  or on  behalf  of  himself  or any  Person
(hereinafter defined):

               (i) at any time  during his  employment  by the  Company or for a
          period of five (5) years after he ceases to be employed by the Company
          for  any  reason,  divulge  to  any  Person  other  than  the  Company
          (hereinafter  referred to collectively as a "third party"),  or use or
          cause to authorize  any third  parties to use,  any such  Confidential
          Information,  or any other  information  regarded as confidential  and
          valuable  by the  Company  that he knows or should know is regarded as
          confidential  and  valuable by the Company  (whether or not any of the
          foregoing information is actually novel or unique or is actually known
          to others and whether or not the Confidential  Information is labelled
          as confidential); or

               (ii) at any time during his  employment  by the Company and for a
          period of one year after he ceases to be  employed  by the Company for
          any reason, act as or be an officer, director, stockholder, consultant
          or advisor, partner or employee of, or render any service for, or have
          any  profit-sharing  or other  interest  in, or lend money or make any
          other  financial  accommodation  for or on behalf of, or undertake any
          business  transaction  with, any Person that engages in or is planning
          or preparing to engage in either direct  competition  with the Company
          or  any  corporate  affiliate  of the  Company,  or  the  business  of
          providing,  in any state where the Company or any corporate  affiliate
          sells products or performs services, the same products and/or services
          as those  provided by the Company or any corporate  affiliate,  except
          that he may hold  securities  that are part of a publicly traded class
          of  securities  (not in excess of 5% of the  outstanding  total of any
          class  of  such  securities)  in  competitive  concerns  so long as he
          discloses such holding to the Company; or

               (iii) at any time during his  employment by the Company and for a
          period of one year after he ceases to be  employed  by the Company for
          any reason,  engage in or plan or prepare to engage in (A) competition
          with the Company or any  corporate  affiliate  or (B) the  business of
          providing,  in any state where the Company or any corporate  affiliate
          sells products or performs services, the same products and/or services
          as those provided by the Company or any corporate affiliate; or

               (iv) at any time during his  employment  by the Company and for a
          period of two years  after he ceases to be employed by the Company for
          any reason, (A) attempt in any manner to solicit, or instruct,  assist
          or provide any services in connection with the solicitation,  from any
          Person that is, or shall have been after the date hereof,  a client of
          the Company or Protective Technologies International Inc. or any other
          affiliate  of the  Company  (a  "Client")  (except  on  behalf  of the
          Company),  or  persuade,  or attempt in any  manner to  persuade,  any
          Client to cease  doing  business  or to reduce the amount of  business
          that any such Client has customarily  done or contemplates  doing with
          the  Company  or any  affiliate  of the  Company,  or (B)  serve as an
          officer,  director,  employee,  agent or  consultant  of, or otherwise
          render  services to, or become or remain a creditor or equity interest
          holder in, any  Person  that  accepts  business  competitive  with the
          business  of the  Company  from any such  Client,  whether  or not the
          relationship  between  the  Company  and such  Client  was  originally
          established  in whole or in part through the efforts of the Executive;
          or

               (v) at any time  during his  employment  by the Company and for a
          period of two years  after he ceases to be employed by the Company for
          any reason,  employ or otherwise  obtain  services from, or solicit or
          otherwise  attempt to employ or otherwise  obtain  services  from,  or
          assist any Person in employing or otherwise  obtaining  services from,
          or attempting to employ or otherwise  obtain services from, any person
          who is then, or at any time during the  preceding  twelve months shall
          have been,  in the employ of or  retained  by the  Company  and/or its
          affiliates; or

               (vi) at any time  during his  employment  by the  Company and the
          applicable period  thereafter  specified in each of the clauses above,
          negotiate   for  or  enter  into  an   agreement,   understanding   or
          arrangement,  or otherwise cause or authorize any Person,  to take any
          of the actions prohibited by such clause.

As used  herein,  the term  "Person"  means  any  person,  corporation,  limited
liability company,  partnership or other entity and the term "Client" shall mean
(i) anyone who is then a client of the  Company or any of its  affiliates,  (ii)
anyone who was a client of the  Company at any time during the  two-year  period
immediately  preceding the alleged prohibited conduct, and (iii) any prospective
client that shall have placed a purchase order with the Company.  The expiration
or termination  for any reason of the  restrictive  covenants  contained in this
Section 8(a) shall not in any manner modify, terminate or impair the restrictive
covenants  contained  in the  Non-Competition  Agreement  dated the date  hereof
between the Executive and the Company.

          (b) The Executive shall,  upon the expiration of his employment by the
Company  for  any  reason,  forthwith  deliver  up to the  Company  any  and all
drawings,  notebooks, keys and other documents and materials, or copies thereof,
in his  possession  or  under  his  control  that  relate  to  any  Confidential
Information,  including any of same that relate to any Invention relating to the
business of the Company or any  affiliate  of the Company  described  in Section
5(a),  or that are  otherwise  the  property of the Company.  In  addition,  the
Executive shall delete all copies on magnetic disk, computer hard drive or other
electronic or digital  medium in his  possession  and shall supply a certificate
signed by him confirming the  destruction of all such files.  This Section 8 and
Section  5(c)  shall  survive  any  expiration  or  other  termination  of  this
Agreement.

          (c) The Executive  agrees that any breach or threatened  breach by him
of any  provision  of this Section 8 will,  because of the unique  nature of the
Executive's  services  and  the  Confidential  Information  entrusted  to him as
aforesaid,  cause irreparable harm to the Company and shall entitle the Company,
in addition to any other legal  remedies  available to it, to apply to any court
of competent  jurisdiction to enjoin such breach or threatened  breach,  without
the need to show irreparable injury or to post any bond, which are hereby waived
by the Executive. The parties hereto understand and intend that each restriction
agreed to by the  Executive  hereinabove  shall be construed  as  separable  and
divisible from every other restriction, and the unenforceability, in whole or in
part,  of any such  restriction,  in any  jurisdiction,  shall  not  affect  the
enforceability of such restriction in any other jurisdiction or of the remaining
restrictions  in any  jurisdiction,  and  that  one  or  more  or  all  of  such
restrictions may be enforced in whole or in part as the  circumstances  warrant.
The  Executive  further  acknowledges  that the  Company  is  relying  upon such
covenants as an  inducement  to provide the  Executive  with  employment  and in
connection  therewith  to  permit  the  Executive  to have  continued  access to
Confidential Information.

     9. Entire Agreement. This Agreement, together with the Merger Agreement and
the  documents  and  instruments  referred  to  therein,   contains  the  entire
understanding  of the  parties  with  respect to the subject  matter  hereof and
supersedes any prior agreement  between the parties.  No change,  termination or
attempted  waiver of any of the  provisions  hereof  shall be binding  unless in
writing and signed by the party  against whom the same is sought to be enforced;
provided,  however,  that the Executive's  compensation  may be increased at any
time by the  Company  without in any way  affecting  any of the other  terms and
conditions of this  Agreement,  which in all other respects shall remain in full
force and  effect.  No action  by either  party  shall be deemed a waiver of any
right  hereunder,  and no  waiver of any right at any time  shall  operate  as a
waiver of any other right or as a waiver of such right at any other time.

     10. Successors and Assigns.  This Agreement shall be binding upon and shall
inure to the benefit of the respective heirs, legal representatives,  successors
and  assigns  of the  parties  hereto,  except  that this  agreement  may not be
assigned by the  Executive,  or by the  Company  except to an  affiliate  of the
Company,  in  which  case  the  Company  shall  remain  liable  for  all  of its
obligations hereunder.

     11. Governing Law. All matters  concerning the validity and  interpretation
of and  performance  under this  Agreement  shall be governed by the laws of the
State of New York, except with respect to its conflict of laws provisions.

     12.  Designations  and Notices.  Whenever notice is required to be given by
any party hereunder, such notice shall be deemed sufficient if given pursuant to
the terms of the Merger Agreement.

     13.  Severability.  The  invalidity or  unenforceability  of any particular
provision  of this  Agreement  in any  jurisdiction  shall not  affect the other
provisions hereof or such provision in other  jurisdictions,  and this Agreement
shall be  construed in such  jurisdiction  in all respects as if such invalid or
unenforceable  provisions  were omitted.  Furthermore,  in lieu of such illegal,
invalid,  or unenforceable  provision in such jurisdiction  there shall be added
automatically  as a part of this  Agreement a  provision  as similar in terms to
such  illegal,  invalid,  or  unenforceable  provision as may be possible and be
legal, valid and enforceable.

     14. Construction.  Throughout this Agreement,  each pronoun shall be deemed
to include the masculine,  the feminine and the neuter, the singular and plural,
and vice versa,  where such meanings would be  appropriate.  The headings herein
are inserted only as a matter of convenience  and reference,  and they in no way
define,  limit or  describe  the scope of this  Agreement  or the  intent of any
provisions thereof.

     15. Further  Assurances.  Each party shall execute such other documents and
instruments  as  shall  be  requested  by the  other  party  in  order  fully to
accomplish the purposes of this Agreement.

     16.  Counterparts.  This  Agreement  may  be  executed  in  any  number  of
counterparts,  all of which taken  together  shall  constitute  one and the same
instrument.

     IN WITNESS  WHEREOF,  the  Executive  has executed  this  Agreement and the
Company has caused this Agreement to be executed by its duly authorized  officer
as of the date first above written.

                                   FLENTS PRODUCTS CO., INC.




   /s/ James E. Dunn                By:  /s/ W. Thomas Davies
JAMES E. DUNN                           W. Thomas Davies
                                        President


Agreed to as to Section 4(b):

PTI HOLDING INC.




By:  /s/ Meredith W. Birrittella
     Meredith W. Birrittella
     Chief Executive Officer

<PAGE>


                      EXHIBIT A to EXHIBIT 8

                       Vacation Eligibility

Length of Service                       Vacation Days
Less than five years                       10 days
Five years to ten years                    15 days

Thereafter,  accrue one additional day of vacation for each  additional  year of
service, to a maximum of twenty-five vacation days.



<PAGE>


                      EXHIBIT B to EXHIBIT 8

                    Disability Benefit Period

Executive's Age When
Disability Begins                  Maximum Benefit Period
younger than 60                    to age 65
60                                 five years
61                                 four years
62                                 42 months
63                                 36 months
64                                 30 months
65                                 24 months
66                                 21 months
67                                 18 months
68                                 15 months
age 69 and over                    12 months

<PAGE>


                            EXHIBIT 9

               CONVERTIBLE VALUE AND REGISTRATION
                         RIGHTS AGREEMENT

     AGREEMENT  made as of August 5,  1997,  by and among PTI  HOLDING  INC.,  a
Delaware  corporation  having a mailing  address at c/o Protective  Technologies
International, Inc., One River Street, Hastings-on-Hudson,  NY 10706 ("PTI"), W.
Thomas Davies, an individual, having an address at 27 Quaker Ridge Road, Bethel,
CT 06801,  James E. Dunn,  an  individual,  having an  address  at 88  Hillcrest
Avenue, Hawthorne, NJ 07506, Stuart M. Low, an individual,  having an address at
29 Grove  Hill  Road,  Guilford,  CT 06437  ("S.  Low"),  Doris  L.  Hirsch,  an
individual  having an address at 447 Westover  Road,  Stamford,  CT  ("Hirsch"),
Peter C. Kohn, an individual having an address at 33 Ponus Avenue,  Norwalk,  CT
06850,  Robert A. Low, an individual  having an address at 527 East 84th Street,
New York, NY 10028 ("R. Low"), Lester C. Migdal, an individual having an address
at 58 East 92nd Street,  New York, NY 10028, and Mary Lou Secchi,  an individual
having an address at 3 Harvard  Street,  Norwalk,  CT 06851  (collectively,  all
individuals shall be referred to herein as the "Flents Stockholders").

     WHEREAS,  PTI, Flents Products Co., Inc., a Delaware  corporation  ("Merger
Sub"),  and Flents Products Co., Inc., a New York  corporation,  ("Flents") have
entered  into an  Agreement  and Plan of Merger  dated as of July 25,  1997 (the
"Merger Agreement") pursuant to which Flents shall be merged into Merger Sub and
all of the  outstanding  stock of Flents  shall be canceled in exchange  for the
Cash  Consideration  and the  Merger  Stock  and  Merger  Sub shall  assume  the
operations,  debts  and  obligations  of  Flents,  as  described  in the  Merger
Agreement,  and in accordance with Section  368(a)(1)(A) of the Internal Revenue
Code of 1986, as amended; and

     WHEREAS,  pursuant to the Merger Agreement, each of the Flents Stockholders
shall  receive  PTI  Common  Stock,   which  stock  shall  have  certain  demand
registration,  piggyback and convertible  value rights,  as more fully described
herein,

     NOW, THEREFORE, in consideration of the mutual covenants of the parties and
other consideration, the receipt of which is hereby acknowledged by the parties,
the parties hereby agree as follows:

     1. Undefined Terms. All terms contained herein and not defined herein shall
have the definitions attributed to them in the Merger Agreement.

     2.  Demand and Piggyback Rights.

          (a) PTI  shall on one  occasion  for each of the  Flents  Stockholders
other than R. Low, S. Low and Hirsch and on one  occasion for R. Low, S. Low and
Hirsch  collectively  register  the sale of the Merger  Stock  upon the  written
request of any of the Flents  Stockholders  other than R. Low, S. Low and Hirsch
and on the written request of the original  holders of the Merger Stock owning a
majority  of the  original  shares of Merger  Stock  owned by R. Low, S. Low and
Hirsch  collectively  (the "Demand  Right") in accordance with the terms of this
Section 2, and, in addition,  so long as the PTI Common Stock held by the Flents
Stockholders  remains  restricted,  PTI shall send written  notice to the Flents
Stockholders  at least  thirty  (30) days prior to the filing by PTI of each and
every  registration  statement  or  notification  to be filed during such period
under the Securities Act of 1933, as amended (the "Securities  Act") (other than
a registration relating to employee benefit plans, an acquisition transaction or
similar matters registered on Form S-4),  covering the sale of PTI Common Stock,
and give to the Flents  Stockholders  the right (the "Piggyback  Right") to have
the Flents Stockholder's Merger Stock (collectively,  the "Registrable  Shares")
then  held  by  such  Flents  Stockholders  included  in any  such  registration
statement  or  pre-effective  amendment  thereto  or  notification.  If a Flents
Stockholder desires to have Flents Stockholder's  Registrable Shares registered,
the Flents Stockholder must deliver a written notice to PTI. Such notice must be
received  by PTI  within 15 days after the date of PTI's  written  notice to the
Flents  Stockholder  and must  indicate  the full name and address of the Flents
Stockholder  and  the  number  of  shares  to  be  included  for  sale  in  such
registration  statement or notification  and must include  evidence showing that
the  shares  requested  to be  registered  were  issued  pursuant  to the Merger
Agreement.

          (b) The registration  rights described in Section 2(a) herein shall be
limited by the following  terms and conditions:  (i) if the Flents  Stockholders
can then sell the number of Registrable  Shares  requested to be included in any
such registration  statement in any three-month  period pursuant to Rule 144 (or
any  successor  rule) under the  Securities  Act,  PTI need not so include  such
shares in any  registration  statement;  (ii) with regard only to the  Piggyback
Right, in connection  with an offering by PTI of any of its  securities,  if the
managing  underwriter  or other  selling  agent shall impose a limitation on the
number of shares of PTI  Common  Stock and other  securities  of PTI that may be
included  in  such  registration  because,  in  its  reasonable  judgment,  such
limitation is necessary to effect an orderly public distribution or complete the
offering, such limitation shall be imposed as to all such securities as follows:
(A) all  securities,  up to such  limitation,  to be sold by PTI  may,  at PTI's
option,  be included;  and then (B) to the extent such  limitation  has not been
reached,  such  of the  Merger  Stock  as all of the  Flents  Stockholders  have
requested to be included in such registration  shall be included pro rata on the
basis of the total  number of shares of PTI Common Stock owned by all holders of
PTI's securities with demand rights similar to Flents Stockholders' Demand Right
who have requested  registration of their securities of PTI (it being understood
that the  effect of such  limitation  may be to  prevent  every  holder of PTI's
securities  from exercising any demand right at such time),  provided,  however,
that no such registration  shall count as an exercise of the Demand Right; (iii)
if requested by PTI's underwriter in writing,  Flents  Stockholders  shall agree
not to sell any Registrable Shares pursuant to such registration statement prior
to the period  ending six months after the  effective  date of the  registration
statement,  provided,  however,  that  in such  case  the  effectiveness  of the
registration  shall be  maintained  by PTI for a period of at least  six  months
after the end of such  holdback  period;  (iv)  anything  herein to the contrary
notwithstanding,  PTI may at any time  prior to the  effective  date of any such
registration statement,  in its own best judgment,  decide to withdraw, or delay
for up to 90 days,  such  registration or the effective date thereof without any
liability to Flents Stockholders therefor,  provided, however, that no withdrawn
registration  shall  count as an exercise  of the Demand  Right;  and (v) if the
offering  made  pursuant  to  such  registration  statement  is to be made by an
underwriter  and the underwriter  wishes to sell the  Registrable  Shares in the
underwritten  offering,  then  Flents  Stockholders  must  use  the  underwriter
selected by PTI for any Registrable Shares sold, and any additional underwriting
commissions or  non-accountable  expense  allowance  relating to the size of the
offering shall be deemed Flents Stockholder's  selling expenses for the purposes
of Section 4 herein.  Nothing herein shall prevent the Flents  Stockholders from
selling  Registrable Shares under Rule 144 under the Securities Act of 1933, and
counsel for PTI shall provide an opinion as to any such Rule 144 sale if, in the
opinion of such counsel, such sale is permitted under Rule 144.

     3. Flents  Stockholders'  Obligations.  ln connection with any registration
statement or notification filed pursuant to the foregoing section:

          (a) if the Flents  Stockholders  have requested that their Registrable
     Shares be covered  by such  registration  statement  or  notification,  the
     Flents  Stockholders  shall  furnish  to PTI in  writing  such  appropriate
     information  (relating to the  intention of the Flents  Stockholders  as to
     proposed  methods  of sale or other  disposition  of such  shares)  and the
     identity of and compensation to be paid to any proposed  underwriters to be
     employed  in  connection   therewith   together  with  such  other  related
     information  as  PTI,  any  underwriter,  or the  Securities  and  Exchange
     Commission ("Commission"), the Nasdaq Stock Market, or any other regulatory
     authority may request;

          (b) all Flents Stockholders registering Registrable Shares shall agree
     that they shall,  execute,  deliver  and/or file with or supply to PTI, any
     underwriters, the Commission and/or any state or other regulatory authority
     such   information,   documents,   representations,   undertakings   and/or
     agreements  reasonably  necessary  to  carry  out  the  provisions  of  the
     registration  covenants  contained in this  Agreement  and/or to effect the
     registration  or  qualification  of their shares under the  Securities  Act
     and/or  of  the  laws  and   regulations  of  any  state  or   governmental
     instrumentality where PTI's securities are to be offered;

          (c) PTI shall  furnish to each Flents  Stockholder  whose  Registrable
     Shares are being sold such number of copies of the  prospectus  or circular
     (including  each  preliminary,   amended  of  supplemental   prospectus  or
     circular) as such Flents  Stockholder  may  reasonably  request in order to
     facilitate sale of such shares; and

          (d)  Flents  Stockholders  shall  execute  such  documents  as PTI may
     reasonably  request confirming the Flents  Stockholders'  obligations under
     Rule  10b-6  promulgated  under the  Securities  Exchange  Act of 1934,  as
     amended, and any other applicable rule or statutory provision.

     4. Expenses. With respect to a registration statement or notification filed
pursuant to Section 2(a) above, all of PTI's expenses and disbursements  arising
in connection with such registration (other than expenses related to the size of
the offering, such as commissions and non-accountable expenses) shall be paid by
PTI. Each Flents  Stockholder  shall pay such Flents  Stockholder's  own selling
expenses and counsel and similar fees.

     5. Period of Effectiveness. PTI shall be obligated to keep any registration
statement or notification  filed by it under Section 2(a) herein effective for a
period  of 180  days  after  the  later  of the  actual  effective  date of such
registration  statement  or the  end of  any  period  during  which  the  Flents
Stockholders  have  refrained  from  selling  Registrable  Shares  pursuant to a
request from PTI 's underwriter  pursuant to Section 2(b) herein,  or, if later,
so long as no  amendment to the  registration  statement  or  supplement  to the
prospectus is required.

     6. Blue Sky.  PTI shall use its best  efforts to  register  or qualify  the
shares covered by any  registration  statement under the Securities Act filed on
behalf  of the  Flents  Stockholders  pursuant  to  this  Agreement  under  such
securities  or Blue Sky laws in such  jurisdictions  within the United States as
each of the Flents Stockholders may reasonably request; provided,  however, that
PTI  reserves  the  right  not  to  register  or  qualify  such  shares  in  any
jurisdiction where such shares do not meet the requirements of such jurisdiction
or where PTI is required to qualify as a foreign  corporation  to do business in
such  jurisdiction  and is not so qualified  therein or where PTI is required to
file any general consent to service of process.

     7.  Deregistration of Unsold Shares. In the event that a Flents Stockholder
has not sold all the  Registrable  Shares  included in a registration  statement
pursuant to this Agreement on or prior to the expiration of the period specified
in  Section  5  herein,  the  Flents  Stockholders  hereby  agrees  that PTI may
deregister  by   post-effective   amendment  any  such  shares  covered  by  the
registration  statement or  notification  and not sold on or prior to such date.
PTI shall notify the Flents  Stockholders  of the filing and  effective  date of
such post-effective amendment.

     8. Revision of Prospectus.  Upon notification by PTI that the prospectus in
respect of any public  offering  covered by the provisions  hereof is in need of
revision,  the  Flents  Stockholders  shall  immediately  upon  receipt  of such
notification  (i)  cease to offer or sell  any  securities  of PTI that  must be
accompanied by such  prospectus;  (ii) return all such  prospectuses to PTI; and
(iii) not  offer or sell any  securities  of PTI until PTI has given the  Flents
Stockholders  notification permitting them to resume offers and sales. PTI shall
exert its best reasonable efforts to revise such prospectus  promptly,  file any
post-effective  amendment necessary in connection  therewith,  and supply to the
Flents  Stockholders  as many  copies of the  current  prospectus  as the Flents
Stockholders reasonably requests.

     9.  Convertible Value Rights.

          (a) As of the  first  anniversary  of the  Effective  Date,  PTI  will
transfer  to each  Flents  Stockholder  PTI Common  Stock  equal in value to the
product of (i) the  difference of $10.00 minus the greater of (A) the average of
the median  closing sale prices of the PTI Common  Stock during the  immediately
preceding  twenty (20)  consecutive  trading days, and (B) $6.00,  multiplied by
(ii) the  number  of  Merger  Shares  held  beneficially  and of  record by such
shareholder; provided, however, the value of PTI Common Stock received by Flents
stockholders  under the Merger Agreement and their respective  convertible value
and registration  rights agreements in no event,  subject to Section 9(b) below,
shall  amount  to  less  than  fifty-five  percent  (55%)  of the  total  Merger
Consideration,  the value of any stock  being the last sale price on the trading
day prior to its issuance.

          (b) This  conversion  shall be subject to equitable  adjustment in the
event of any stock split,  stock dividend or reverse stock split  resulting in a
change in the  number of shares of PTI  Common  Stock  outstanding  prior to the
one-year anniversary Closing.  During the 30 trading days prior to such one-year
anniversary,  the Flents  Stockholders shall not engage in any trading activity,
directly or indirectly, in the securities of PTI.

     10.  Indemnification.  As a  condition  to  any  filing  pursuant  to  this
Agreement:

          (a) PTI shall  indemnify the Flents  Stockholders  against any and all
losses,   claims,   damages,   expenses  or  liabilities  (including  reasonable
attorneys'  fees and other expenses  reasonably  incurred in defending any claim
covered by this indemnification or enforcing a claim under this indemnification)
to which the Flents  Stockholders  may become subject under any federal or state
securities  law, at common law, or  otherwise,  insofar as such losses,  claims,
damages, expenses or liabilities are incurred in connection with claims by third
parties  and arise  directly  out of any  untrue  statement  or  alleged  untrue
statement  of a  material  fact  contained  in  any  registration  statement  or
notification  in which  securities  issued or  issuable  pursuant  to the Merger
Agreement  are included and which is filed  pursuant  hereto,  or in any related
preliminary  prospectus,  final  prospectus  or amended  prospectus  or offering
circular or other written  information filed by PTI in any jurisdiction in order
to qualify the securities  issuable  hereunder under the securities laws thereof
or with the Commission or The Nasdaq Stock Market,  or arise directly out of the
omission or alleged  omission to state  therein any material fact required to be
stated therein or necessary in order to make the statements therein, in light of
the  circumstances  under which they were made,  not  misleading,  except to the
extent that as any such  statement or omission  was made in reliance  upon or in
conformity with  information  furnished or confirmed in writing to PTI by any of
such Flents Stockholder, underwriter(s) or controlling person(s) for use in such
registration statement or notification or prospectus or offering circular; and

          (b) each Flents  Stockholders,  individually  and not  jointly,  shall
indemnify PTI, its representatives,  officers and directors, against any and all
losses,   claims,   damages,   expenses  or  liabilities  (including  reasonable
attorneys'  fees and other expenses  reasonably  incurred in defending any claim
covered by this indemnification or enforcing a claim under this indemnification)
to which PTI is or may become subject under any federal or state securities law,
at common  law,  or  otherwise,  insofar as any such  losses,  claims,  damages,
expenses or liabilities  are incurred in connection with claims by third parties
and arise directly out of any untrue  statement or alleged untrue statement of a
material fact contained in any such  registration  statement or  notification in
which  securities  issued or  issuable  pursuant  to the  Merger  Agreement  are
included or in related any preliminary  prospectus,  final prospectus or amended
prospectus or offering circular or other written information filed by PTI in any
jurisdiction  in order to qualify the securities  issuable  hereunder  under the
securities  laws thereof or with the  Commission or The Nasdaq Stock Market,  or
arise  directly  out of the  omission or alleged  omission to state  therein any
material fact required to be stated  therein or necessary to make the statements
therein,  in  light  of the  circumstances  under  which  they  were  made,  not
misleading,  and only to the extent that any such statement or omission was made
in reliance  upon or in  conformity  with  information  furnished to PTI by such
Flents  individually  Stockholders  for  use  in  such  registration  statement,
notification or prospectus,  but each Flents  Stockholders  shall be liable only
for his/her  direct acts of  commission  or  ommission  giving rise to losses or
damages and shall not be liable for the acts of  commission  or ommission by any
other Flents Stockholder.

     11.  Notices.  Whenever  notice  is  required  to be  given  by  any  party
hereunder, such notice shall be deemed sufficient if given pursuant to the terms
of the Merger Agreement and, if to Stockholder, at the address listed above.


     12. Further  Actions.  From time to time, as and when requested by PTI, the
Flents Stockholders shall execute and deliver such documents and instruments and
shall take such further or other actions as PTI may reasonably deem necessary to
carry out the intent and purposes of this  Agreement and to consummate  and give
effect to the other transactions contemplated hereby.

     13. Severability. Wherever possible, each provision of this Agreement shall
be interpreted in a manner so as to be effective and valid under applicable law.
If any provision of this Agreement  shall be held to be prohibited by or invalid
under  applicable law, such provision shall be ineffective only to the extent of
such  provision and the  remaining  provisions  of this  Agreement  shall remain
unaffected and in full force and effect.

     14. Entire Agreement.  This Agreement, and the other documents,  agreements
and  instruments  executed  and  delivered  pursuant  thereto  or in  connection
therewith, contains the entire agreement between PTI and the Flents Stockholders
with respect to the rights conferred by PTI relating to the Merger Stock and, in
conjunction  with the Merger  Agreement,  supersedes all prior  arrangements  or
understandings with respect thereto, whether written or oral.

     15. Termination. This Agreement shall remain in full force and effect until
the  later of (i) the first  anniversary  hereto  and (ii)  date upon  which the
Registrable  Shares  are no longer  owned by the Flents  Stockholders.  However,
Section 10 shall survive termination of this Agreement.

     16.  Construction.

          (a) The  descriptive  headings of this  Agreement are for  convenience
only and  shall not  control  or  affect  the  meaning  or  construction  of any
provision of this Agreement.

          (b) Each of the parties to this Agreement participated in the drafting
of this  Agreement and the  interpretation  of any  ambiguity  contained in this
Agreement will not be affected by the claim that a particular  party drafted any
provision hereof.

          (c) Any pronoun  herein shall include all genders and/or the plural or
singular as appropriate from the context.

     17.  Governing  Law. This  Agreement  shall be governed by and construed in
accordance  with the  laws of the  State of New  York  applicable  to  contracts
entered into,  executed and to be performed wholly in such state, except for its
conflict of laws provisions.


     18. Assignability. This Agreement shall not be assignable otherwise than by
operation of law by any party hereto  without the prior  written  consent of the
other parties,  and any purported  assignment without such prior written consent
shall be void,  except  that PTI may  assign  this  Agreement  to a  corporation
controlling,  controlled by or under common control with PTI, provided that such
assignment shall not relieve PTI of its obligations hereunder.

     19.  Waivers and  Amendments.  Any waiver of any term or  condition of this
Agreement,  or any  amendment or  supplementation  of this  Agreement,  shall be
effective  only if in writing  executed by the party  against  whom such waiver,
amendment or  supplementation is sought to be charged. A waiver of any breach or
failure to enforce any of the terms or conditions of this Agreement shall not in
any way affect, limit or waive a party's rights hereunder at any time to enforce
strict compliance thereafter with every term or condition of this Agreement.

     20.  Third Party  Rights.  Any other  provision  of this  Agreement  to the
contrary notwithstanding, this Agreement shall not create benefits for any third
party,  including,  without  limitation,  any subsequent  holders of Registrable
Shares,  except spouses,  children and  grandchildren of the original holders of
Registrable Shares who acquire  Registrable Shares by gift, bequest or intestate
inheritance, who shall have the rights and obligations of the donor hereunder.

     21.  Illegalities.  In the  event  that  any  provision  contained  in this
Agreement  shall be determined to be invalid,  illegal or  unenforceable  in any
respect for any reason,  the validity,  legality and  enforceability of any such
provision in every other respect and the remaining  provisions of this Agreement
shall not, at the election of the party for whose benefit the provision  exists,
be in any way impaired.

           [REMAINDER OF PAGE LEFT BLANK INTENTIONALLY]

<PAGE>


     22. Counterparts.  This Agreement may be executed in multiple  counterparts
all of which taken together shall constitute one and the same instrument.

     IN WITNESS  WHEREOF,  each of the undersigned  corporations has caused this
Agreement to be executed by its duly authorized officer, and each individual has
signed this Agreement, as of the date first above written.

FLENTS PRODUCTS CO., INC.               PTI HOLDING INC.
(a New York corporation)


By:   /s/ W. Thomas Davies                   By:   /s/ Meredith W. Birrittella
Name: W. Thomas Davies                         Meredith W. Birrittella
Title:     President                                Chief Executive Officer

FLENTS PRODUCTS CO., INC.
(a Delaware corporation)


By:   /s/ W. Thomas Davies
       W. Thomas Davies
       President


 /s/ W. Thomas Davies                         /s/ James E. Dunn
W. THOMAS DAVIES                              JAMES E. DUNN



 /s/ Stuart M. Low                             /s/ Robert A. Low
STUART M. LOW                                  ROBERT A. LOW



 /s/ Doris L. Hirsch                           /s/ Lester C. Migdal
DORIS L. HIRSCH                                  LESTER C. MIGDAL


 /s/ Peter C. Kohn                             /s/ Mary Lou Secchi
PETER C. KOHN                                    MARY LOU SECCHI



<PAGE>


                            FLENTS PRODUCTS CO., INC.

                              FINANCIAL STATEMENTS
































<PAGE>



                            FLENTS PRODUCTS CO., INC.




                                    CONTENTS






                                                                          Page
Independent auditor's report                                               1

Financial statements:
   Balance sheet                                                           2

   Statement of income and retained earnings                               3

   Statement of cash flows                                                 4

   Notes to financial statements                                           5 -11








<PAGE>















INDEPENDENT AUDITOR'S REPORT


To the Board of Directors and Stockholders
Flents Products Co., Inc.
Norwalk, Connecticut

We have audited the  accompanying  balance sheet of Flents Products Co., Inc. as
of November 30, 1996 and 1995, and the related statements of income and retained
earnings and cash flows for the years then ended. These financial statements are
the responsibility of the Company's management. Our responsibility is to express
an opinion on these financial statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the financial  statements  referred to above present fairly, in
all material respects, the financial position of Flents Products Co., Inc. as of
November 30, 1996 and 1995, and the results of its operations and its cash flows
for the years  then  ended in  conformity  with  generally  accepted  accounting
principles.

We have compiled the accompanying  balance sheet of Flents Products Co., Inc. as
of May 31, 1997, and the related  statements of income and retained earnings and
cash flows for the six months then  ended,  in  accordance  with  Statements  on
Standards for Accounting and Review Services issued by the American Institute of
Certified Public Accountants. A compilation is limited to presenting in the form
of financial statements information that is the representation of management. We
have not audited or reviewed the accompanying May 31, 1997 financial  statements
and,  accordingly,  do not express an opinion or any other form of  assurance on
them.






SACHER & CO., PC
Somers, New York

October 15, 1997




 <PAGE>
<TABLE>

                            FLENTS PRODUCTS CO., INC.

                                  BALANCE SHEET


                                              May 31,           November 30,
                                               1997          1996          1995
                                            ---------     ---------     --------
                                           (unaudited)
<S>                                               <C>           <C>        <C>
ASSETS

Current assets:
   Cash and cash equivalents ............   $  811,969   $  355,340   $  474,320
   Receivables:
     Trade ..............................      973,862      886,888      558,014
     Other ..............................      125,331      281,653         --
   Inventory ............................      718,373      748,991      805,057
   Deferred tax assets ..................       94,523       52,839       33,455
   Other current assets .................       30,578       62,012      171,192
                                            ----------   ----------   ----------

  Total current assets ..................    2,754,636    2,387,723    2,042,038
Property and equipment, net .............      183,742      218,962      239,747
Deferred tax assets .....................          -          5,336       14,883
Other assets ............................          993        2,693        6,093
                                            ----------   ----------   ----------

                                            $2,939,371   $2,614,714   $2,302,761
                                            ==========   ==========   ==========
LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
   Accounts payable and accrued expenses    $  524,477   $  443,885   $  402,398
   Dividends payable ....................      120,000        7,760        7,726
   Income taxes payable .................       66,475       10,996       61,838
                                            ----------   ----------   ----------
   Total current liabilities ............      710,952      462,641      471,962
                                            ----------   ----------   ----------

Stockholders' equity:
   Common stock .........................        1,555        1,552        1,545
   Additional paid-in capital ...........       83,797       79,870       73,134
   Retained earnings ....................    2,143,067    2,070,651    1,756,120
                                            ----------   ----------   ----------
   Total stockholders' equity ...........    2,228,419    2,152,073    1,830,799
                                            ----------   ----------   ----------

                                            $2,939,371   $2,614,714   $2,302,761
                                            ==========   ==========   ==========


See notes to financial statements.

</TABLE>

<PAGE>

<TABLE>

                            FLENTS PRODUCTS CO., INC.

                    STATEMENT OF INCOME AND RETAINED EARNINGS

                  SIX MONTHS ENDED MAY 31, 1997 AND YEARS ENDED
                           NOVEMBER 30, 1996 AND 1995



                                           1997           1996           1995
                                      -----------    -----------    -----------
                                      (unaudited)
<S>                                          <C>            <C>            <C>
Net sales .........................   $ 3,196,826    $ 6,309,270    $ 5,446,006

Cost of sales .....................     1,721,412      3,575,153      2,996,841
                                      -----------    -----------    -----------
Gross profit ......................     1,475,414      2,734,117      2,449,165

Selling, general and
   administrative expenses ........     1,169,801      2,212,787      1,951,781
                                      -----------    -----------    -----------
Income from operations ............       305,613        521,330        497,384
Interest income ...................        12,422          7,953          2,219
                                      -----------    -----------    -----------

Income before income taxes ........       318,035        529,283        499,603
                                      -----------    -----------    -----------
Income taxes (benefit):
   Current ........................       161,967        216,829        228,476
   Deferred .......................       (36,348)        (9,838)       (34,275)
                                      -----------    -----------    -----------

                                          125,619        206,991        194,201
                                      -----------    -----------    -----------

Net income ........................       192,416        322,292        305,402

Retained earnings, beginning ......     2,070,651      1,756,120      1,466,603

Dividends .........................      (120,000)        (7,761)       (15,885)
                                      -----------    -----------    -----------

Retained earnings, ending .........   $ 2,143,067    $ 2,070,651    $ 1,756,120
                                      ===========    ===========    ===========




See notes to financial statements.

</TABLE>

<PAGE>


<TABLE>

                            FLENTS PRODUCTS CO., INC.

                             STATEMENT OF CASH FLOWS

                  SIX MONTHS ENDED MAY 31, 1997 AND YEARS ENDED
                           NOVEMBER 30, 1996 AND 1995


                                                1997          1996        1995
                                            ----------   ----------    ---------
                                           (unaudited)

<S>                                               <C>       <C>            <C>
Cash flows from operating activities:
   Net income                               $ 192,416    $ 322,292    $ 305,402
   Adjustments to reconcile net
      income to cash provided by
      operating activities:
     Depreciation                              19,332       54,405       42,620
     Deferred income tax (benefit)            (36,348)      (9,837)     (34,275)
     Stock-based compensation                    --          3,930        6,743
     Loss on disposal of equipment             17,588         --           --
     Increase (decrease) in operating assets:
         Receivables                           69,348     (610,527)     (89,387)
         Inventory                             30,618       56,066     (220,613)
         Other current assets                  31,434      109,180      (79,229)
     Increase (decrease) in operating
         liabilities:
         Accounts payable and accrued
            expenses                           84,522       44,300      231,868
   Income taxes payable                        55,479      (50,842)      20,513
                                            ---------    ---------     --------
   Net cash provided by operating
    activities                                464,389      (81,033)     183,642
                                            ---------    ---------     --------
Cash flows (used in) investing activities:
   Purchase of property and equipment            --        (30,220)    (103,209)
                                            ---------    ---------     --------
Cash flows from financing activities
   Dividends paid                             (7,760)       (7,727)     (16,289)
   Redemption of common stock                   --            --       (100,000)
                                            ---------    ---------    ---------

   Net cash (used in) operating activities    (7,760)       (7,727)    (116,289)
                                            ---------    ---------    ---------
   Net increase (decrease) in cash and
     cash equivalents                        456,629      (118,980)     (35,856)

   Cash and cash equivalents, beginning      355,340       474,320      510,176
                                           ---------     ---------     --------
   Cash and cash equivalents, ending       $ 811,969     $ 355,340    $ 474,320
                                           =========     =========     ========


   See notes to financial statements.

</TABLE>

<PAGE>

                            FLENTS PRODUCTS CO., INC.

                          NOTES TO FINANCIAL STATEMENTS

            (INFORMATION PERTAINING TO MAY 31, 1997 AND THE SIX-MONTH
                         PERIOD THEN ENDED IS UNAUDITED)



1.   Organization and nature of operations:

     Organization:

     On August 5, 1997,  Flents Products Co., Inc., a New York  corporation (the
     "Company"),   was  acquired  by  Flents  Products  Co.,  Inc.,  a  Delaware
     corporation  ("Flents   Delaware").   Flents  Delaware  is  a  wholly-owned
     subsidiary of PTI Holding Inc. ("PTI").  From and after August 5, 1997, the
     Company had no separate or independent  existence,  having been merged into
     Flents Delaware.  For purposes of financial  accounting and income tax, the
     acquisition  was deemed to have  occurred  as of the opening of business on
     June 1, 1997.

      Nature of operations:

     The Company manufactures and distributes personal care products sold in the
     health and beauty  aid  departments  of major  retail  food,  drug and mass
     merchandiser  chains.  A minor  portion  of the  business  pertains  to the
     distribution  of  hearing  protection  products  in the  industrial  safety
     market.

2. Summary of significant accounting policies:

     Use of estimates:

     The  preparation  of financial  statements  in  conformity  with  generally
     accepted  accounting  principles  requires management to make estimates and
     assumptions  that affect the reported amounts of assets and liabilities and
     disclosure  of  contingent  assets  and  liabilities  at  the  date  of the
     financial  statements,  and the  reported  amounts of revenues and expenses
     during the reporting period.

     Cash and cash equivalents:

     The  Company  considers  all highly  liquid  investments  with an  original
     maturity of three months or less to be cash equivalents.

     The  Company  is  subject  to a credit  risk  resulting  from  balances  in
     financial  institutions  that  may  at  times  exceed  amounts  covered  by
     insurance provided by the Federal Deposit Insurance Corporation (FDIC). The
     Company has not  experienced  any losses in such  accounts and believes its
     cash is not exposed to any significant credit risk.


<PAGE>


                            FLENTS PRODUCTS CO., INC.

                          NOTES TO FINANCIAL STATEMENTS

            (INFORMATION PERTAINING TO MAY 31, 1997 AND THE SIX-MONTH
                         PERIOD THEN ENDED IS UNAUDITED)


2. Summary of significant accounting policies (continued):

     Inventory:

     Inventory is stated at the lower of cost or market.  Cost is  determined by
     the average cost method. Inventory consists of the following:

                                         May 31,           November 30,
                                          1997          1996          1995
                                        --------     --------      --------

               Raw materials            $393,332     $350,416      $495,255
               Finished goods            325,041      398,575       309,802
                                        --------     --------      --------

                                        $718,373     $748,991      $805,057
                                        ========     ========      ========

     Property and equipment:

     Property and equipment is carried at cost.  Depreciation  is computed using
     straight-line  and accelerated  methods over the estimated  useful lives of
     the  assets,  or for  leasehold  improvements,  the term of the  lease,  if
     shorter.

     Impairment of long-lived assets:

     During March 1995, the Financial Accounting Standards Board issued SFAS No.
     121,  "Accounting  for the  Impairment of Long-Lived  Assets and Long-Lived
     Assets to Be Disposed of." The Statement  requires that  long-lived  assets
     and certain  identifiable  intangibles be reviewed for impairment  whenever
     events or changes in  circumstances  indicate that full  recoverability  is
     questionable.  Management  evaluates the  recoverability  of its intangible
     assets and other  long-lived  assets and  several  factors  are used in the
     valuation  including,  but not  limited  to,  management's  plan for future
     operations,  recent operating results and projected cash flows. The Company
     adopted  SFAS No.121 in fiscal  1997,  the adoption of which did not have a
     material   adverse  effect  on  the  results  of  operations  or  financial
     condition.

     Income taxes:

     Income taxes have been provided  using the  liability  method in accordance
     with SFAS No. 109 "Accounting  for Income Taxes." Under SFAS 109,  deferred
     tax assets and liabilities are determined based on differences  between the
     financial  reporting  and tax  basis  of  assets  and  liabilities  and are
     measured by applying estimated tax rates and laws to taxable years in which
     such differences are expected to reverse.

<PAGE>


                            FLENTS PRODUCTS CO., INC.

                          NOTES TO FINANCIAL STATEMENTS

            (INFORMATION PERTAINING TO MAY 31, 1997 AND THE SIX-MONTH
                         PERIOD THEN ENDED IS UNAUDITED)


2. Summary of significant accounting policies (continued):

    Advertising:

    The cost of  advertising  is  expensed  as  incurred.  Advertising  expense
    totaled  $10,833 for the six months  ended May 31,  1997,  $330,570  for the
    fiscal year 1996, and $135,391 for fiscal year 1995.


3.  Receivables:

    Trade:

    Trade receivables are net of allowances for returns and doubtful collections
    of $20,000 (May 31, 1997), $25,000 (November 30, 1996) and $10,000 (November
    30, 1995).

    Other:

    The other  receivable  of  $125,331  at May 31,  1997 is due from PTI.   The
    receivable  pertains to acquisition costs funded by the Company on behalf of
    PTI.

    The Company was a defendant in patent infringement litigation. In connection
    with the lawsuit,  the Company  incurred legal fees that were  reimbursed by
    their insurance  carrier.  The amount recovered is shown on the November 30,
    1996  balance  sheet  as  an  other  receivable.   The  patent  infringement
    litigation was settled in January,  1997 for $20,000. This amount is carried
    as an accrued liability as of November 30, 1996.


4.  Property and equipment:

                                             May 31,           November 30,
                                              1997          1996         1995
                                           ---------     --------     ---------

      Machinery and equipment              $ 264,112    $ 264,112    $ 264,112
      Plates, dies and molds                  49,429       71,277       71,277
      Furniture, fixtures and improvements   354,469      350,209      319,989
                                           ---------    ---------    ---------
                                             668,010      685,598      655,378
      Less accumulated depreciation         (484,268)    (466,636)    (415,631)
                                           ---------    ---------    ---------
                                           $ 183,742    $ 218,962    $ 239,747
                                           =========    =========    =========

<PAGE>


                            FLENTS PRODUCTS CO., INC.

                          NOTES TO FINANCIAL STATEMENTS

            (INFORMATION PERTAINING TO MAY 31, 1997 AND THE SIX-MONTH
                         PERIOD THEN ENDED IS UNAUDITED)

5.   Common stock:

     Stock split:

     In September 1995, the Board of Directors  authorized a 5 for 1 stock split
     of the  Company's  $.10 par value common  stock.  As a result of the split,
     61,272 shares were issued.  All  references in the financial  statements to
     the per share  amounts  for 1995 have been  restated  to reflect  the stock
     split.

     Stock redemption:

     Also in September  1995, the Company  redeemed 1,000 shares of its $.10 par
     value common stock at a cost of $100,000  reducing common stock by $100 and
     additional  paid-in-capital by $99,900. The shares purchased by the Company
     were retired.

     Common shares:

     Common stock information for May 31, 1997,  November 30, 1996, and November
     30, 1995 is presented below.

         Par value                                                $.02
         Authorized shares                                     125,000
         Issued and outstanding shares:
     May 31, 1997                                               77,756
     November 30, 1996                                          77,595
     November 30, 1995                                          77,265

    Common stock issued to employees:

    Key  employees  have been issued  shares of the  Company's  common  stock in
    consideration  for  services  rendered  to  the  Company.   The  shares  are
    restricted  and cannot be pledged,  transferred  or sold without first being
    offered for sale to the Company.  If the employee is terminated prior to the
    date of expiration of the restriction,  the shares are to be returned to the
    Company and no payment by the Company is required.

6.  Significant customers:

    For the six months  ended May 31, 1997 and for the years ended  November 30,
    1996  and  1995,  two  major  retail  chain   organizations   accounted  for
    approximately  20% to 27% of net  sales.  A loss  of one or  both  of  these
    established  major  customers  could cause a  significant  loss of sales and
    affect operating results adversely.


<PAGE>


                            FLENTS PRODUCTS CO., INC.

                          NOTES TO FINANCIAL STATEMENTS

            (INFORMATION PERTAINING TO MAY 31, 1997 AND THE SIX-MONTH
                         PERIOD THEN ENDED IS UNAUDITED)

7.   Employment agreement:

     The Company  entered into an employment  contract with a key employee which
     was effective through fiscal 1996. Annual  compensation  consists of a base
     salary  established  annually plus a stock bonus based upon meeting certain
     pre-tax   operating   profit  goals.   The  agreement   provides  that  the
     additionalcompensation  can be paid up to 40% in stock and the  balance  in
     cash.  One hundred sixty one (161) shares of restricted  stock (see Note 5)
     were  earned for fiscal  1996 and three  hundred  thirty  (330)  shares for
     fiscal 1995. The 161 shares were issued during the six months ended May 31,
     1997 and the 330 shares were issued in fiscal 1996. Operations were charged
     $3,930 in 1996 and $6,743 in 1995 for the  compensation  expense related to
     the stock bonus.  At November 30, 1996 and 1995,  there were 549 shares and
     588 shares  respectively  issued to the  employee,  which  were  subject to
     restrictions.

8.   Pension plan:

     The Company  maintains a  noncontributory  defined  benefit  plan  covering
     substantially  all of its  employees.  Plan benefits for most employees are
     based on years of service and the  highest  consecutive  five-year  average
     earnings prior to retirement.
                                                            1996         1995
                                                          --------     --------
Components of net pension expense:
   Service cost (benefits earned during the period)      $  52,426    $  55,179
   Interest cost on the projected benefit obligation        36,017       28,829
   Actual loss (return) on assets                            9,093       (9,573)
   Net amortization and deferral                           (34,604)     (12,390)
                                                         ---------    ---------

  Net pension expense                                    $  62,932    $  62,045

Funded status of the plan:
   Actuarial present value of benefits:
    Vested benefits                                      $ 398,300    $ 345,580
    Nonvested benefits                                       6,520         --
                                                         ---------    ---------
   Accumulated benefit obligation                          404,820      345,580
   Effect of projected future compensation increases       152,737      109,677
                                                         ---------    ---------
   Projected benefit obligation                            557,557      455,257
   Fair value of plan assets                               420,921      364,703
                                                         ---------    ---------
   Projected benefit obligation in excess of plan assets   136,636       90,554
   Unrecognized net losses                                 (90,433)     (16,062)
  Unrecognized net obligation                              (56,923)     (60,595)
                                                         ---------    ---------

  Accrued pension liability (pension asset)              $ (10,720)   $  13,897
                                                         =========    =========

<PAGE>

                            FLENTS PRODUCTS CO., INC.

                          NOTES TO FINANCIAL STATEMENTS

            (INFORMATION PERTAINING TO MAY 31, 1997 AND THE SIX-MONTH
                         PERIOD THEN ENDED IS UNAUDITED)




8. Pension plan (continued):
                                                         1996      1995
                                                        ------    ------
Principal assumptions:
   Weighted average discount rate                        7.5%      7.5%
   Weighted average rate of compensation increase        4.5%      4.5%
   Expected long-term rate of return on assets           7.5%      7.5%


9.  Rent:

     Rent expense totaled $46,852 for the six months ended May 31, 1997, $92,503
     for fiscal year 1996, and $92,262 for fiscal year 1995.


10. Income taxes:

     The tax  effects of  temporary  differences  that give rise to  significant
     portions of the deferred tax assets as of May 31, 1997,  November 30, 1996,
     and November 30, 1995 are presented as follows:

                                                   1997        1996        1995
                                                --------    --------    --------
Accounts receivable due to the allowance
     for returns and doubtful collections       $ 8,000    $  6,000    $  4,000
Inventories due to additional costs
   inventoried for tax purposes                  33,000      47,000      30,000
Equipment and improvements
   due to depreciation                           (7,000)     (6,000)     (4,000)
Accounts payable and accrued expenses due
   to accrued bonuses and severance costs        61,000        --          --
Common stock restrictions due to stock bonuses     --        11,000      18,000
                                               --------    --------    --------

Total deferred tax assets                      $ 95,000    $ 58,000    $ 48,000
                                               ========    ========    ========

     The  difference  between the actual income tax provision and the income tax
     provision  computed by applying the  statutory  federal  income tax rate to
     income  from  continuing   operations  before  income  taxes  is  primarily
     attributable  to state income  taxes,  allowances  for returns and doubtful
     collections, inventory costs, depreciation and compensation costs.



<PAGE>
                            FLENTS PRODUCTS CO., INC.

                          NOTES TO FINANCIAL STATEMENTS

            (INFORMATION PERTAINING TO MAY 31, 1997 AND THE SIX-MONTH
                         PERIOD THEN ENDED IS UNAUDITED)



11.   Prior period adjustments:

     The Company  has  restated  its  financial  statements  for the years ended
     November 30, 1996 and 1995. The restatements is summarized below.


                                                          1996           1995
                                                       ---------    -----------

Net income, as previously reported                   $   335,193    $   320,998

Cost of sales                                              8,203        (17,420)
Provision for returns and doubtful collections           (15,000)          --
Pension expense                                            6,284         (3,205)
Depreciation                                              (3,454)        (4,098)
Provision for compensated absences                          (111)        (4,338)
Income taxes                                              (8,823)        13,465
                                                       ---------     ----------
Net income, as restated                              $   322,292    $   305,402
                                                       =========     ==========



                                                     As Previously
                                                       Reported     As Restated
                                                     -----------    -----------
Retained earnings:
   December 1, 1994                                  $ 1,505,209    $ 1,466,603
   November 30, 1995                                   1,810,321      1,756,120
   November 30, 1996                                   2,137,755      2,070,651

     The Company has also  reclassified its costs of sales and selling,  general
     and administrative expenses for the years ended November 30, 1996 and 1995.


12. Statement of cash flows:

                                             1997         1996        1995
                                           --------     --------    --------
Supplemental disclosures:
  Income taxes paid .....                  $106,488     $267,671     $170,962




<PAGE>




                        PTI HOLDING INC. AND SUBSIDIARIES
                   PRO FORMA FINANCIAL INFORMATION (UNAUDITED)


     On August 5,  1997,  Flents  Products  Co.,  Inc.,  a New York  corporation
("Flents"),  was acquired by Flents  Products Co., Inc., a Delaware  corporation
("Flents Delaware"). Flents Delaware is a wholly-owned subsidiary of PTI Holding
Inc.  From and after  August 5, 1997,  Flents  had no  separate  or  independent
existence,  having been merged into Flents  Delaware.  For purposes of financial
accounting and income tax, the acquisition was deemed to have occurred as of the
opening of business June 1, 1997.

     The  acquisition  is to be  accounted  for  using  the  purchase  method of
accounting  whereby  assets and  liabilities  are  carried at fair value and the
excess of purchase price over the fair value of the net assets acquired is shown
as goodwill.  The following pro forma consolidated  balance sheet as of June 30,
1997 presents  unaudited pro forma  financial  information  giving effect to the
acquisition as if it occurred on that date. The following pro forma consolidated
statements  of income  for the six months  ended June 30,  1997 and for the year
ended  December 31, 1996  presents  unaudited  pro forma  financial  information
giving  effect to the  acquisition  as if it  occurred  on  January  1, 1997 and
January  1,  1996,  respectively.  The  objective  of this pro  forma  financial
information is to show what the significant effects on the historical  financial
information  might have been  assuming the  acquisition  was  effective on those
dates.  The unaudited  pro forma  consolidated  balance  sheet and  consolidated
statements of income are not  necessarily  indicative of the financial  position
and results of operations that would have been attained had the acquisition been
effective on those dates, or of the financial position and results of operations
which may  exist or occur in the  future.  The  following  pro  forma  financial
information should be read in conjunction with the related historical  financial
information.


<PAGE>
<TABLE>

                        PTI HOLDING INC. AND SUBSIDIARIES
                PRO FORMA CONSOLIDATED BALANCE SHEET (Unaudited)
                                  JUNE 30, 1997


                                                    PTI Holding Inc.
                                                          and        Flents Products
                                                     Subsidiaries      Co., Inc          Adjustments       Pro forma
                                                   ---------------  ---------------    -------------       ----------
<S>                                                         <C>            <C>                 <C>              <C>
ASSETS
Current assets:
    Cash and cash equivalents ....................   $    247,000  $     812,000 (1)  $   (120,000)   $       939,000
    Receivables ..................................      5,493,000      1,099,000 (2)      (125,000)         6,467,000
    Inventories ..................................      5,311,000        718,000                            6,029,000
    Deferred tax asset ...........................        118,000         79,000                              197,000
    Prepaid expenses and
     other current assets ........................      1,298,000         31,000 (2)      (100,000)         1,229,000
                                                     ------------   ------------      ------------       ------------

Total current assets .............................     12,467,000      2,739,000          (345,000)        14,861,000

Deferred tax asset ...............................        113,000         16,000                              129,000
Equipment and improvements .......................        670,000        184,000                              854,000
Intangible assets ................................      1,465,000          1,000 (3)     3,020,000          4,486,000
                                                     ------------    -----------      ------------       ------------

                                                     $ 14,715,000    $ 2,940,000      $  2,675,000       $ 20,330,000
                                                     ============    ===========      ============       ============


LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
    Loan payable, bank ...........................   $  4,128,000    $      --   (4)    $2,135,000       $  6,263,000
    Accounts payable and accrued expenses ........      1,142,000        524,000 (2)       187,000          1,853,000
    Income taxes payable .........................         76,000         67,000                              143,000
    Dividends payable ............................           --          120,000 (1)      (120,000)              --
                                                      -----------    -----------      ------------       ------------

Total current liabilities ........................      5,346,000        711,000         2,202,000          8,259,000

Stockholders' equity .............................      9,369,000      2,229,000 (5)       473,000         12,071,000
                                                      -----------    -----------      ------------       ------------

                                                     $ 14,715,000    $ 2,940,000      $  2,675,000       $ 20,330,000
                                                      ===========    ===========      ============       ============


    In preparing the pro forma unaudited  consolidated  balance sheet as of June
    30, 1997,  adjustments were made to the historical  financial  statements to
    reflect:

    (1) dividend payments to Flents shareholders at closing ($120,000),

    (2)   a net  increase in accounts  payable and accrued  expenses  ($187,000)
          consisting of total  acquisition  costs ($412,000) less the portion of
          acquisition costs advanced by Flents on behalf of PTI ($125,000),  and
          less the  portion of  acquisition  costs paid  through  June 30,  1997
          ($100,000),

    (3) goodwill resulting from the acquisition ($3,020,000),

    (4) an increase in loan payable,  bank  ($2,135,000)  pertaining to the cash
portion of the purchase price paid at closing, and

    (5)   a net increase in stockholders'  equity  ($473,000)  consisting of the
          270,165  shares of common stock  issued at $10 per share  ($2,702,000)
          less the net assets acquired ($2,229,000).
</TABLE>

<PAGE>

<TABLE>

                        PTI HOLDING INC. AND SUBSIDIARIES
             PRO FORMA CONSOLIDATED STATEMENT OF INCOME (Unaudited)
                          YEAR ENDED DECEMBER 31, 1996


                                           PTI Holding Inc.
                                                 and        Flents Products
                                             Subsidiaries      Co., Inc          Adjustments   Pro forma
                                           ---------------  ---------------    -------------   ----------
<S>                                               <C>            <C>                 <C>            <C>
Net sales                                      $17,530,000   $ 6,309,000      $      --      $ 23,839,000

Cost of sales                                   12,141,000     3,575,000             --        15,716,000
                                               -----------   -----------       -----------    -----------
Gross profit                                     5,389,000     2,734,000             --         8,123,000

Selling, general and
  administative expenses                         2,718,000     2,213,000 (1)       75,000       5,006,000
                                               -----------   -----------       -----------    -----------

Income from operations                           2,671,000       521,000          (75,000)     3,117,000

Interest income, net of
  interest expenese                                   --           8,000             --            8,000
                                               -----------   -----------       -----------    ----------

Income from operations
  before income taxes                            2,671,000       529,000          (75,000)     3,125,000

Income taxes                                       980,000       207,000 (2)      (25,000)     1,162,000
                                               -----------   -----------       -----------    ----------

Net income                                     $ 1,691,000   $   322,000      $   (50,000)   $ 1,963,000
                                                ==========   ===========       ===========    ==========


Income per share of
  common stock                                 $      0.43                                   $      0.46                         
                                                ==========                                    ==========

Weighted average shares
  outstanding                                    4,103,964                        270,165      4,374,129
                                                ==========                     ==========     ==========


    In preparing the pro forma  unaudited  consolidated  statement of income for
    the year ended  December 31, 1996,  adjustments  were made to the historical
    financial statements to reflect:

    (1)  amortization  expense  ($75,000)  resulting  from the  amortization  of
goodwill over 40 years, and

    (2) the income tax benefit of the amortization of goodwill ($25,000).

    In addition,  the pro forma weighted average shares outstanding  (4,374,129)
    reflect a pro forma common stock issuance (270,165 shares).


</TABLE>

<PAGE>
<TABLE>

                        PTI HOLDING INC. AND SUBSIDIARIES
             PRO FORMA CONSOLIDATED STATEMENT OF INCOME (Unaudited)
                         SIX MONTHS ENDED JUNE 30, 1997


                                               PTI Holding Inc.
                                                  and                 Flents Products
                                               Subsidiaries              Co., Inc            Adjustments        Pro forma
                                               ----------------    ------------------     ---------------  ----------------
<S>                                                    <C>                    <C>                 <C>              <C>
Net sales                                          $ 15,634,000          $ 3,197,000                 $ -      $ 18,831,000

Cost of sales                                        10,619,000            1,721,000                   -        12,340,000
                                               -----------------   ------------------     ---------------  ----------------

Gross profit                                          5,015,000            1,476,000                   -         6,491,000

Selling, general and administrative expenses          5,818,000            1,170,000  (1)         38,000         7,026,000
                                               -----------------   ------------------     ---------------  ----------------

Income (loss) from operations                          (803,000)             306,000             (38,000)         (535,000)

Interest income, net of interest expense                (88,000)              12,000                   -           (76,000)
                                               -----------------   ------------------     ---------------  ----------------

Income from before income taxes                        (891,000)             318,000             (38,000)         (611,000)

Income taxes                                          1,222,000              126,000  (2)        (13,000)        1,335,000
                                               -----------------   ------------------     ---------------  ----------------

Net income (loss)                                  $ (2,113,000)           $ 192,000           $ (25,000)     $ (1,946,000)
                                               =================   ==================     ===============  ================


Income (loss) per share of common stock                $ (0.49)                                                   $ (0.43)
                                               =================                                           ================

Weighted average shares outstanding                   4,152,317                                  270,165         4,422,482
                                               =================                          ===============  ================


    In preparing the pro forma  unaudited  consolidated  statement of income for
    the six months ended June 30, 1997,  adjustments were made to the historical
    financial statements to reflect:

    (1)  amortization  expense  ($38,000)  resulting  from the  amortization  of
goodwill over 40 years, and

    (2) the income tax benefit of the amortization of goodwill ($13,000).

    In addition,  the pro forma weighted average shares outstanding  (4,422,482)
    reflect a pro forma common stock issuance (270,165 shares).


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission